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ABSTRACT 
      In contrast to conventional wisdom, bacteria are capable of forming highly organized 
organelles in the cytoplasm to optimize metabolic processes. Salmonella enterica can degrade 
the carbon source 1,2-propanediol (1,2-PD) within a proteinaceous organelle named the 1,2-PD 
utilization microcompartment (Pdu MCP). Prior enzymatic assays indicated that a 
phosphotransacylase (PTAC) was required for 1,2-PD degradation but the enzyme involved was 
not identified. Here we showed that the PduL enzyme is an evolutionarily distinct PTAC used for 
1,2-PD degradation and that it is associated with the Pdu MCP where it plays a role in coenzyme 
A homeostasis. A series of genetic and growth studies showed that the house-keeping 
phosphotransacetylase Pta was not required for 1,2-PD metabolism in Salmonella while pduL 
mutants were impaired for aerobic and anaerobic growth on 1,2-PD. High-pressure liquid 
chromatography (HPLC) and enzymatic assays determined that PduL catalyzes the 
interconversion of propionyl-CoA and propionyl-PO42-. Biochemical studies indicated that PduL 
has kinetic properties appropriate to a role in 1,2-PD degradation. Bioinformatics analysis 
showed that the PduL enzyme doesn’t share sequence homology with known PTAC enzymes, 
indicating that it represents a new enzyme class.  
      Recent studies suggested that the cofactors required for MCP-associated metabolism, Ado-
B12 and NAD+ and HS-CoA are internally recycled within MCPs. We performed in vivo as well 
as in vitro studies to show that PduL is a component of the Pdu MCP and that it is used to 
regenerate coenzyme A inside the Pdu MCP. Western blots showed enrichment of PduL and also 
a PduL-green fluorescent protein (GFP) fusion in purified MCPs compared to crude cell extracts, 
indicating that PduL is an MCP component. Tests of genetic effects of breaking MCPs on PduL 
suggested that PduL is required for proper functions of intact MCPs. Further genetic studies 
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showed that PduL in MCPs can’t utilize acetyl-CoA in the cytosol to support Salmonella growth, 
and PduL recycling coenzyme A in the Pdu MCP is indicated. In addition, our studies also 
identified an N-terminal targeting sequence on PduL which mediates its encapsulation into the 
Pdu MCP. This short targeting sequence could also mediate the encapsulation of GFP. Together 
with recent publications, these studies indicate that cofactor recycling is a general mechanism 
used by MCPs of various types to optimize metabolic efficiency. The targeting studies advance 
our knowledge on spatial organization of enzymes into MCPs. 
      We also initiated studies on the higher order structure of the Pdu MCP by exploring the 
binding interactions among varied Pdu proteins. These studies identified two possible binding 
interactions: PduL with PduBB’ and PduU with PduV. These results were consistent with an 
interactome network formulated using computational models. A better understanding of 
architecture of the Pdu MCP provide a basis for further study on its mechanisms of assembly. 
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CHAPTER 1. GENERAL INTRODUCTION 
1.1. Salmonella and Salmonella Infection 
      Salmonella is facultative intracellular pathogen and leads predominantly a host-associated 
lifestyle. It is usually isolated from contaminated food or water sources, which act as the bacteria 
reservoirs. Salmonella can be divided into two groups, nontyphoidal and typhoidal serovars. 
Nontyphoidal serovars usually cause self-limiting gastrointestinal diseases. Most cases of 
invasive nontyphoidal Salmonella infections (iNTS) are caused by S. typhimurium and S. 
Enteritidis. Typhoidal serovars S. typhi and S. paratyphi A cause more severe typhoid fever and 
systemic infections. According to CDC (centers for disease control and prevention), Salmonella 
is one of the leading causes of food-borne illness. Every year, Salmonella causes one million 
illnesses in the United States, with 19,000 hospitalizations and 380 deaths. Infection with 
Salmonella becomes a global economic and health burden. 
      Salmonella utilizes sophisticated strategy to infect human beings. Ingestion of food 
containing a high concentration of Salmonella is usually required to cause infection in healthy 
adults. Infection may occur due to the ingestion of a small amount of the bacteria for infants and 
young children or inhalation of Salmonella-containing dust in infants. Salmonella has evolved to 
tolerate acid environment to certain extent and a portion of the bacterial cells survive the gastric 
acid and manage to reach the intestine, where they start to move towards the intestinal epithelial 
cells using flagella. Then Salmonella docks to the host cells and injects effector proteins 
including SipA, SopA, SopB, SopD, and SopE2 via the Salmonella pathogenicity island-1 (SPI-
1)-encoded type III secretion system (TTSS) which are required for invasion and 
enteropathogenesis (1). Salmonella can survive in phagocytic and non-phagocytic cells, which 
requires a second TTSS encoded by the Salmonella pathogenicity island 2 (SPI-2) (2).  
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      In humans, non-typhoidal Salmonella (NTS) serovars induce a strong Th1 response with high 
levels of IFN-γ, TNF-α, IL-18, IL-12, IL-15 and IL-10 detected in serum. Several chemokines 
induced upon NTS infection lead to the recruitment and activation of macrophages and dendritic 
cells as well as a significant influx of neutrophils into the intestinal lumen. While typhoidal 
serovars usually are not associated with a strong neutrophil infiltration or acute diarrhea. The 
immune response to infection with typhoidal serovars is complicated and involves both humoral 
and cell-mediated immune responses (3). Clinical studies showed a significant CD4 and CD8 T 
cell response to specific S. typhi antigens during typhoid fever, with elevated levels of IFN-γ, 
TNF-α, IL-6, IL-8 and IL-10, indicating that the human immune response to S. typhi infection is 
predominantly Th1-associated.  
      S. typhimurium and S. typhi share about 96% DNA sequence homology while inducing very 
different clinical manifestations and immune responses in humans. About 200 genes in S. typhi 
are inactivated while most of their homologs in S. typhimurium are intact. Many of these 
inactivated genes in S. typhi genome are involved in motility and chemotaxis or encode for TTSS 
effectors, fimbriae, or adhesins that play a role in Salmonella pathogenicity (4). It is possible that 
differences in virulence and colonization factor composition affect interactions between the host 
and the pathogens and disease outcome in humans. It was proposed that the polysaccharide 
capsular antigen Vi in S. typhi enables resistance to phagocytosis and complement killing. Vi 
may also mask host access to pattern recognition molecules, causing less production of IL-8, a 
neutrophil chemoattractant, which limits neutrophil infiltration and thereby reduces intestinal 
inflammation (5, 6).  
      As part of the host innate immunity, the inflammatory process, to some extent, prevents the 
spread of Salmonella infection. Salmonella is prone to spread more efficiently and cause 
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systemic infection in the absence of a neutrophilic response both in mice and cattles. S. typhi 
which causes systemic infections doesn’t elicit a significant intestinal neutrophilic response (7, 8, 
9). However, Salmonella evolved to take advantage of the host intestinal inflammatory response. 
A small fraction of the Salmonella population actively invades the intestinal mucosa and triggers 
a massive acute inflammatory response. The resulting acute neutrophil infiltration effectively 
restrict the infection mostly to the enteric sites to prevent systemic dissemination of this 
pathogen, while at the same time also creates an intestinal environment which favors the 
remaining large fraction of Salmonella population which stays in the intestinal lumen for 
effective transmission to the next hosts (10).  
      In a healthy individual, the microbiota in the intestinal system prevents translocation of 
pathogenic bacteria to the mesenteric lymph node and hence prevent an undesirable immune 
response. Earlier studies demonstrated that disruption of the intestinal microbiota due to 
antibiotic treatment promotes translocation of S. typhimurium by phagocytes to mesenteric 
lymph node and results in increased susceptibility to Salmonella infection (11). Under certain 
circumstances, carbohydrates metabolized by commensal microbiota provide energy source for 
Salmonella. Bacteroides thetaiotaomicron encodes sialidase which releases sialic acid from 
glycoconjugates, but doesn’t have enzymes to utilize sialic acid as a food source. The free sialic 
acid can feed S. typhimurium which lacks sialidase (12). S. typhimurium can also utilize fucose 
and rhamnose as well as their fermentation product 1,2-propanediol which are readily present in 
the gut and can’t be used by even the closely related enteric bacterial species E. coli. Besides the 
enzymatic machinery to degrade the above carbon molecules, Salmonella can use tetrothionate 
generated by host during intestinal inflammation as an alternative respiratory electron acceptor to 
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actually keep the degradation processes running in the microaerobic/anaerobic gut environment 
(see section 1.1.7).  
      Several other mechanisms by which Salmonella takes advantage of intestinal inflammation 
have emerged recently as well. Lipocalin-2, a host antimicrobial peptide, is generated during 
inflammation in response to IL-17 and IL-22. It binds enterobactin, a siderophore produced by 
enteric bacteria and inhibits iron acquisition by bacterial organisms. Salmonella produces 
salmochelin, another siderophore which is not bound by lipocalin-2, and shows competitive 
advantage over other intestinal bacteria (13). Besides, iron deprivation in the inflamed intestine 
induces expression of colicin Ib by Salmonella, which is a bacteriocin against other 
Enterobacteriaceae and provides additional competitive advantage (14). In the inflamed gut, 
calprotectin produced by neutrophils damages bacterial growth by sequestering zinc. However, 
Salmonella overcomes this host self-protective mechanism by expressing a zinc transporter with 
high affinity called ZnuABC (14).  
      It is estimated that over 20% of malignancies worldwide are attributed to infectious agents 
(15). It has been shown that bacteria can produce potent carcinogens including nitrite and 
suitable amines. A cohort study showed that chronic carriers of S. typhi/paratyphi have greatly 
increased risks of cancers of the biliary tract and hepatobiliary carcinoma, and also with 
malignancy in the colorectum, pancreas and lung (16, 17). Salmonella infection may increase 
risk for the high prevalence disease IBS (irritable bowel syndrome) by eight times (18).  
      Antibiotic treatment may prolong the duration of excretion of NTS and therefore is only 
recommended for infants, elderly, and immunocompromised individuals. Whereas, typhoid fever 
is always immediately treated with antibiotics. However, multidrug-resistance is an increasing 
problem in S. enterica serovars. Resistance to multiple antibiotics is especially common in S. 
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typhimurium and is linked to more severe disease outcome (19). New resistant strains of S. 
enterica are emerging worldwide. Currently, three types of vaccines against S. typhi are 
commercially available, but there is no licensed vaccine against S. paratyphi A. Vaccines against 
NTS serovars typhimurium are only effective in poultry. There are no vaccines for NTS in 
humans or other animals such as cattles or pigs. These significant limitations in treatment and 
prevention strategies created urgent needs for the complete understanding of Salmonella 
pathobiology. The ultimate goal is to identify potential targets for future therapeutic and vaccine 
development.  
1.2. Bacterial Microcompartment (MCP) 
1.2.1. Discovery 
      Prokaryotic cells were previously thought to have no intracellular compartmentalization. In 
1969, “crystalline bodies” were first discovered under electron microscope in blue-green algae 
(20). The next year, polyhedral structured bodies were reported by Shively et al. (21) in seven 
Thiobacillus species. They were later named carboxysomes, the first identified bacterial 
microcompartments (MCPs). In the late 1990s, Salmonella enterica was found to form a 
polyhedral organelle during growth on 1,2-propanediol (1,2-PD), which was named 1,2-PD 
utilization MCP (Pdu MCP) (22). Later studies identified ethanolamine utilization 
microcompartment (Eut MCP), another type of MCPs in S. enterica which was associated with 
ethanolamine utilization. Since their discoveries, MCPs have been called polyhedral bodies, 
enterosomes and sometimes metabolosomes. The name bacterial microcompartments will be 
used throughout the rest of this thesis.  
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Figure 1.1. Electron micrograph of MCPs. a the carboxysomes of H. neapolitanus; b the organelles formed 
during growth of S. enterica on 1,2-PD. Triangles point to the MCPs (23).  
 
      The bacterial MCPs that have been well studies are similar in structure and architecture. 
They are polyhedral in shape and about 100-150 nm in cross section as shown in Figure 1.1. 
They consist of a 3-4 nm multiple protein shell encapsulating a series of enzymes which function 
together in a specific metabolic pathway. The presence of three MCPs, carboxysomes, Pdu 
MCPs, and Eut MCPs have been experimentally confirmed and their structures and functions 
have been investigated. All identified MCPs have protein shells composed primarily of bacterial 
microcompartment (BMC) domain proteins while each specific type of MCPs encapsulate 
different metabolic processes and have related functions. To date, MCPs have only been found in 
bacteria, no MCPs have been reported in eukaryotic cells or archaea. MCPs are purely protein 
complexes, and there is no evidence for lipid components. 
1.2.2. Distribution and Diversity 
      Comparative genomics approaches identified BMC-domain containing proteins in genomes 
of 358 bacterial species across 11 different bacterial phyla, indicating about 14.6% of bacteria 
may form different types of MCPs with diverse functionalities (24, 25). The major proposed 
functions for MCPs are to retain toxic or volatile intermediates and increase metabolic efficiency 
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by substrate channeling. The function of each distinct MCP type is related to a specific 
metabolism process. 
1.2.2.1.Carboxysomes 
      First discovered 45 years ago, carboxysomes have been extensively investigated. They were 
found in bacteria which use Calvin cycle for carbon fixation including probably all cyanobacteria, 
for example, Phormidium uncinatum, Nostoc punctiforme, Synechococcus elongates, and many 
chemoautotrophs, especially sulphur and nitrifying bacteria like Thiobacillus, Halothiobacillus, 
and Thiomonas (26-28). There are two types of carboxysomes defined by organization of related 
genes and by protein sequence comparisons. α-type carboxysomes are present in α-cyanobacteria 
(cyanobacteria which express form 1A ribulose bisphosphate carboxylase/oxygenase (RuBisCO)) 
and many chemoautotrophic proteobacteria (23, 29). The composition of α-type carboxysomes 
was investigated in representative species facultative chemoautotroph Halothiobacillus 
neapolitanus. β-type carboxysomes are found in β-cyanobacteria which are cyanobacteria 
producing form 1B RuBisCO and represented by Synechocystis spp. PCC 6803 as shown in 
Figure 1.2. Both α- and β-carboxysomes are composed of RuBisCO and carbonic anhydrase (CA) 
encapsulated within a protein shell made of homologous polypeptides (30, 31). In α-
carboxysomes, CsoS1 proteins (homologous proteins CsoS1A-C) are the major shell components 
and they count for around 17% of total weight of carboxysomes. In β-carboxysomes, CcmK1-4 
and CcmO are the homologues of Csos1 and they contribute to the formation of β-carboxysome 
shell.  
1.2.2.2. Pdu MCP 
      In 1994, a protein containing a BMC domain was found to be involved in vitamin B12-
dependent 1,2-PD utilization in Salmonella enterica serovar Typhimurium (referred to hereafter 
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as S. enterica) (33). Four years later, Pdu MCPs were observed in S. enterica and K. oxytoca by 
electron microscopy as shown in Figure 1.3 (34). 1,2-PD can be utilized as a sole carbon and 
energy source by several enteric bacteria including Salmonella, Listeria, Klebsiella, Shigella and 
Yersinia. Pdu MCPs are around 120-160 nm in diameter, appear polyhedral in shape but slightly 
larger and more irregular compared to carboxysomes (35-37). Pdu MCP has a mass of about 600 
MDa and consists of 18,000 individual polypeptides of 16-18 different types (37). Pdu MCPs are 
the most complicated MCPs elucidated so far at the molecular level in that more enzymes are 
encapsulated in the lumen of MCPs, the shell is made of more different types of polypeptides, 
the shape is less geometrically regular and the size is slightly larger (vs 80-140 nm for 
carboxysome shell) (22, 34, 38). Besides, 1,2-PD metabolism requires multiple enzymatic 
cofactors adenosyl-cobalamin (AdoCbl), coenzyme A and Nicotinamide adenine dinucleotide 
(NAD+) and also a route for them to be taken up by the Pdu MCPs.  
 
              
Figure 1.2. Thin-section electron micrograph of A a dividing cell of the cyanobacterium Synechocystis spp. 
PCC6803 (scale bar, 200 nm); B enlargement of a single carboxysome (scale bar, 50 nm) (32).  
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Figure 1.3. Electron micrograph of Pdu MCPs of S. enterica. Left panel a representative image of wild-type S. 
enterica (39); right panel purified Pdu MCPs from S. enterica (40). 
 
1.2.2.3. Eut MCP 
      Back in 1999, while Pdu MCP-related studies were ongoing, Kofoid et al. found that besides 
the capability of forming Pdu MCPs, S. enterica can grow on ethanolamine as the only carbon, 
nitrogen and energy source (41). When observed by electron microscopy, Eut MCPs from K. 
oxytoca show similar size and appearance to Pdu MCPs during growth on ethanolamine (34). 
Many bacteria classes including Gammaproteobacteria like Erwinia, Salmonella, Escherichia, 
Klebsiella and Pseudomonas, Betaproteobacteria like Achromobacter, Firmicutes such as 
Clostridium, Actinobacteria such as Arthrobacter, Mycobacterium and Corynebacterium, as well 
as Enterococcus and Flavobacterium, can use ethanolamine as a sole source of carbon and/or 
nitrogen (42, 43).  
1.2.2.4.Glycyl Radical-Based Propanediol Utilization Microcompartment (Grp MCP) 
      Compared to the well-known carboxysomes, Pdu MCPs and Eut MCPs, the Grp type MCP 
encoding operon was relatively new. The grp operon encodes four core enzymes including a 
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glycyl radical diol dehydratase (DDH), glycyl radical activase, aldehyde dehydrogenase and a 
chaperone protein (44, 45). Further evidence indicated that 1,2-PD is the primary substrate in this 
system. The enzyme glycyl radical diol dehydratase has since been referred as B12-independent 
1,2-PD dehydratase. This enzyme catalyzes a similar reaction as DDH in the Pdu MCPs and 
produces propionaldehyde. The proposed function for Grp MCPs is to mediate 1,2-PD 
degradation in a manner similar to that of 1,2-PD metabolism associated with Pdu MCPs. The 
major difference that distinguishes Grp MCP from Pdu MCP is that the first reaction which 
generates aldehyde is carried out by a B12-independent glycyl radical enzyme rather than the B12-
dependent DDH. Also, the glycyl radical enzyme is sensitive to oxygen due to the presence of a 
glycyl radical in its activated state, which indicates that the Grp MCPs may be most important in 
strict anaerobic conditions (44). Whereas Pdu MCP-encapsulated 1,2-PD degradation could 
occur in both aerobic and anaerobic environments.  
1.2.2.5.Other Prospective MCPs 
      Recently, Clostridium phytofermentans was found to contain three loci encoding MCP-
related genes in the genome. Petit et al. (46) reported genomic, transcriptional and physiological 
evidence which indicates that the MCP encoding locus is involved in the metabolism of fucose 
and rhamnose and converts both deoxyhexose sugars into a variety of fermentation products such 
as propanol, propionate, ethanol, lactate and acetate through the pathways partially enclosed in a 
MCP. Polyhedral structures resembling classical MCPs were visible by transmission electron 
microscopy of the cells growing on fucose. A model (46) proposed that fucose and rhamnose are 
taken up by C. phytofermentans through ABC transporters into the cell where they are converted 
to lactaldehyde and dihydroxyacetone phosphate (DHAP) by an aldolase encoded within the 
MCP locus. DHAP can feed into glycolytic pathway and generate fermentation products 
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including ethanol, acetate, lactate and formate, while lactaldehyde may be converted to 1,2-PD 
by a PD-oxidoreductase. 1,2-PD could be used to generate propanol or propionate through MCP-
associated 1,2-PD degradation pathway. Comparative genomic analysis suggested that the 
proposed pathway might be present in other Clostridium species as well (46).        
      Another unique MCP operon is present in four Mycobacterium species and contains two 
BMC shell proteins and a minor vertex shell protein genes as well as four functional proteins or 
enzymes. Two of the enzymes have been shown to be involved in metabolizing amino alcohols 
(44). 
1.2.3. Genetics 
      Diverse MCPs share genomic characteristics. All MCP-associated proteins are encoded 
within operons consisting of multiple copies of paralogous genes encoding the shell proteins 
along with the genes for the associated enzymes. This unique genomic signature was used to 
predict the presence of multiple types of MCPs across a broad range of bacterial phyla.  
1.2.3.1.Carboxysome Encoding Gene Clusters 
      Carboxysomes can be divided into α- and β- types which differ in their protein composition 
and the organization of their respective genes. α-carboxysomes belong to α-cyanobacteria which 
have a single operon to include type 1A RuBisCO and their carboxysome genes, whereas 
organisms with β- types have 1B RuBisCO and their carboxysome genes arranged in multiple 
gene clusters (47). The two type carboxysomes have homologous but specific shell proteins 
which are not present in the other type of carboxysomes. The main protein constituent of the α-
carboxysome shell from H. neapolitanus is CsoS1A which shares significant sequence similarity 
with CcmK and CcmO of β-carboxysomes (47, 48). The csoS2 and csoS3 genes are exclusively 
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found only in α-carboxysomes while the ccmM and ccmN genes only occur in β-carboxysomes. 
The genomic organization of the two types of carboxysomes are listed in Fig. 1.4. 
 
                                                  
      
Figure 1.4. Genomic organization of carboxysomes. a composition of α-carboxysomes from H. neapolitanus. 
Paralogous genes have same colors. The SDS gel in the center showed proteins identified in purified 
carboxysomes. The main constituents of carboxysomes are RuBisCO (green) and the shell proteins CsoS1A, 
CsoS1B and CsoS1C (blue); b carboxysome gene cluster from β-carboxysomes. CcaA is colored orange to 
indicate its status as a β-type carbonic anhydrase. CcmM is colored in two parts to indicate homology to ɣ-type 
carbonic anhydrase at its N-terminus and homology to RuBisCO small subunit at the C-terminus. White-
colored genes don’t show homology within the bacterial MCP clusters that are shown (47). 
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1.2.3.2.The pdu Operon 
      The genes specifically required for 1,2-PD utilization by S. enterica form a single contiguous 
cluster, the pdu locus, which is contiguous to the cobalamin B12 synthesizing gene clusters (cob 
operon) at minute 44 of the genome (22). The pdu operon includes 23 genes 
pduABCDEFGHJKLMNOPQSTUVWX and pocR as shown in Figure 1.5 (22, 49). Based on 
experimental and bioinformatics analyses, seven pdu genes pduCDEPQLW are thought to 
encode five enzymes needed for the 1,2-PD degradative pathway which are diol dehydratase 
(PduCDE, DDH), propionaldehyde dehydrogenase (PduP), phosphotransacylase (PduL), acetate 
kinase (PduW), and alcohol dehydrogenase (PduQ) (50-53); pduF encodes a hydrophobic protein 
with 65% sequence identity to the GlpF protein of E. coli which facilitates the diffusion of 
glycerol across the cytoplasmic membrane (33). Based on the homology between PduF and GlpF 
protein as well as the chemical similarity of 1,2-PD and glycerol, PduF may function as a 1,2-PD 
diffusion facilitation protein (33). The pocR gene is located between the pdu and cob operons 
(the cob operon contains genes needed for de novo B12 synthesis, see section 1.2.1). C-terminus 
of PocR shares 55% similarity with AraC family of transcriptional regulatory proteins, and both 
PocR and AraC contain a DNA-binding helix-turn-helix motif. Genetic study indicated that pocR 
codes for a positive transcriptional regulator of both the pdu and cob operons (33, 54); pduGH 
code for the large (PduG) and small (PduH) subunits of a putative DDH-reactivating factor and 
are probably involved in DDH reactivation (22); pduSO-encoded cobalamin reductase (PduS) 
and adenosyltransferase (PduO) are used for the conversion of inactive vitamin B12 
hydroxycobalamin (OH-Cbl) to active coenzyme B12 (AdoCbl) (55, 56); seven genes 
pduABB’JKNTU encode shell components (22, 34, 40, 49), and pduM has been shown to be 
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another structural gene (39); pduX is involved in cobalamin synthetic pathway (57). And finally 
pduV has unknown functions.  
 
  
Figure 1.5. The pdu operon of S. enterica. The genes involved in 1,2-PD degradation cluster at a single locus 
with shell protein encoding genes interspersed with enzyme encoding genes (58). 
 
      Analysis of purified Pdu MCPs showed that the MCPs constitute around 10% of total cell 
proteins which matches with the abundant occupancy of these structures under electron 
microscopy. Two-dimensional electrophoresis followed by densitometry determined that diol 
dehydratase PduCDE is the most abundant Pdu enzyme with the approximate molar ratio of 
C:D:E:P:G:H:O as 8:4:8:4:2:2:1 (49). PduABB’J are major shell components and PduKTU are 
minor shell proteins with the approximate molar ratios as A:B:B’:J:K:T:U=10:6:7:15:1:1:2. 
Deletion of pduA, pduBB’, pduJ or pduN gene significantly impaired MCP formation and caused 
toxic levels of propionaldehyde accumulated in the cell, indicating damaged integrity of the 
MCP shell (59). Deletion of pduU or pduT had no phenotype under the conditions tested.  
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1.2.3.3. The eut Operon 
      Ethanolamine metabolism in S. enterica is encoded by the 17-gene cluster eut operon as 
shown in Figure 1.6 (41). The eut operon located at 50 min on the S. enterica chromosome (60). 
The eut operon codes for five structural proteins including four BMC proteins EutK, EutL, EutM, 
EutS and a pentameric protein EutN, four enzymes EutB, EutC, EutE, EutD which break down 
ethanolamine, two enzymes EutA and EutT for enzyme reactivation and cofactor recovery, an 
ethanolamine transport protein EutH, and a positive regulatory protein EutR for induction of eut 
operon transcription (41, 61-64). Besides, three proteins expressed from the eut operon including 
a chaperone protein EutJ and two other proteins EutPQ have unknown functions. Induction of 
eut operon depends on the presence of transcriptional activator EutR, ethanolamine and 
adenosylcobalamin.  
 
 
Figure 1.6. The ethanolamine utilization (eut) operon of S. enterica (58). 
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1.2.4. Functional Models 
      As a subcellular organelle, the unique feature of MCPs is the use of a dense protein shell 
instead of lipid bilayer membrane. The unique MCP shell plays a crucial role in the functions of 
diverse MCPs (47, 58, 65, 66). First of all, the shell functions as a diffusion barrier, which 
protect volatile intermediates from being lost through diffusion, while at the same time 
preventing contact-mediated toxicity caused to bacterial genomic DNA and cytoplasm proteins 
by the toxic intermediates (aldehyde in Pdu MCP and Eut MCP). Also, the shell shields the 
interior metabolic enzymes from reacting with reactive or competing molecules. Secondly, 
intensive structural studies indicated shell proteins bear central pores in their structures which 
may selectively transport substrates, products and even large cofactors involved in specific 
encapsulated pathways. Thirdly, several shell proteins have been found to interact with and 
encapsulate the core enzymes into the lumen of the specific MCP during MCP assembly and also 
possibly regulate the spatial organization of the enzymes for their optimal functions. Molecular 
transport through the shell will be discussed in this section. Interaction between shell proteins 
and core enzymes will be illustrated in chapter 4. Besides sharing the common features among 
different types of MCPs, the specific function of each MCP is defined by the metabolic processes 
which is involved in.  
1.2.4.1.Carboxysomes-Carbon Fixation 
      Autotrophic prokaryotic cells accumulate inorganic carbon and improve carbon fixation 
through carbon-concentrating mechanism (CCM) as shown in Figure 1.7. During the first stage 
of CCM, bicarbonate (HCO3
-) is transported into the cell by transmembrane pumps and is 
concentrated inside the cell. The second stage of CCM starts with the translocation of 
bicarbonate into carboxysome. There carbonic anhydrase (CA) converts bicarbonate to CO2 
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which is incorporated into ribulose-1,5-bisphosphate (RuBP) by RuBisCO to form two 
molecules of 3-phosphoglycerate (3-PGA) which is then released from carboxysomes. RuBisCO 
is a kinetically inefficient enzyme. It catalyzes the competing fixation of both O2 (known as 
photorespiration) and CO2, it has relatively low Kcat value to substrate CO2, and it must bind a 
nonsubstrate CO2 at the activation site for the optimal activity (37, 67). Carboxysomes contribute 
to carbon fixation by retaining high concentration of CO2 in the vicinity to RuBisCO in a 
confined space to optimize the function of RuBisCO and hence minimize photorespiration. Since 
most of the oceanic microorganisms (cyanobacteria) carry out CO2 fixation in MCPs, it was 
estimated that >25% of global CO2 fixation occurs within carboxysomes (68, 69). 
 
                     
Figure 1.7. Carbon concentration and the carboxysome. The carboxysome is involved in the second part of the 
CCM. The two enzymes CA and RuBisCO in the carboxysome and their reactions are shown in reactions 1 
and 2. Phosphoglycolate is generated from the side reaction where O2 is the substrate for RuBP instead of CO2 
(47). 
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1.2.4.2.Pdu MCP-Cobalamin B12-Dependent 1,2-PD Metabolism 
      The current model for 1,2-PD metabolism associated with Pdu MCPs proposes that, by 
retaining this metabolic pathway in MCPs, bacteria are able to utilize 1,2-PD as carbon and 
energy source while avoiding cellular toxicity caused by aldehyde accumulation, preventing 
diffusive carbon loss and increasing metabolism efficiency by substrate channeling.  
      A working model was developed over time as pdu operon was identified in S. enterica. Like 
the gene clusters for α-carboxysomes, shell protein encoding genes were found interspersed with 
enzyme encoding genes, which provided a first clue that 1,2-PD metabolism pathway is 
associated with MCPs (33). As propionaldehyde was identified as an intermediate during 1,2-PD 
degradation, it was suggested that MCPs may form to sequester the toxic aldehyde (70). Later a 
comprehensive genetic study found that deletion of major Pdu shell components PduA, PduBB’, 
PduJ and PduN significantly damaged MCP formation and resulted in accumulation of aldehyde 
and cellular toxicity during growth on 1,2-PD, which is consistent with the proposed function for 
Pdu MCP (59). The propionaldehyde toxicity was represented by growth arrest for about 20 
hours and then growth of S. enterica resumed, which was interpreted as the aldehyde 
intermediate accumulated until 1,2-PD in the medium was depleted, then the aldehyde level 
dropped due to the consumption by PduP and PduQ (59). Thus, it was reasonable to propose that 
MCPs retain the toxic intermediate aldehyde while allowing Salmonella to utilize 1,2-PD as 
carbon and energy source. Recent structural studies on MCP shell proteins suggested the shell is 
composed of molecular layers formed from BMC-domain proteins with pentameric non-BMC 
proteins closing the vertices of the MCPs and giving rise to the icosahedral structures. Further 
studies suggested vitamin B12 and NAD
+, the required cofactors for enzymes PduCDE and PduP, 
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are recycled inside the Pdu MCP. With all of the studies described above, the current model for 
Pdu MCP emerged. 
      According to this model as shown in Figure 1.8, 1,2-PD is taken up by S. enterica from the 
growth medium probably by the diffusion facilitator PduF and then is transported into the lumen 
of Pdu MCP by an unclear mechanism. Recent crystallographic and genetic studies suggested it 
is possible that 1,2-PD may be transported through central pores on hexameric shell component 
PduA or pseudohexameric shell protein PduB (36, 71-73). The first enzymatic reaction in the 
lumen is the conversion of 1,2-PD into propionaldehyde by AdoCbl-dependent diol dehydratase 
PduCDE. Propionaldehyde is oxidized by CoA-dependent propionaldehyde dehydrogenase PduP 
to produce propionyl-CoA or alternatively reduced by alcohol dehydrogenase PduQ to generate 
1-propanol. By forming and excreting propanol, the cells can keep internal redox balance (74). 
Propionyl-CoA can feed into methylcitrate pathway or be consumed by phosphotransacylase 
PduL to produce propionyl-PO4
2- (according to our study in chapter 2).  Propionyl-PO4
2- exits 
MCP and is converted to propionate by propionate kinase PduW.  
      1,2-PD degradation generates one ATP by substrate level phosphorylation catalyzed by 
PduW, one electron sink (propionaldehyde), and a three-carbon intermediate propionyl-CoA 
which may feed into the central metabolism via methylcitrate pathway (75, 76). Under anaerobic 
conditions, the methyl citrate pathway is inoperative due to the absence of an exogenous electron 
acceptor. Since both propanol and propionate are excreted, anaerobic 1,2-PD metabolism 
produces an electron sink and a source of ATP but can’t generate cell carbon (75, 77).  
      Recent studies propose that cofactor AdoCbl for DDH, cofactors NAD+ and HS-CoA for 
PduP may be recycled internally inside the Pdu MCP by cobalamin reductase PduS as well as 
adenosyltransferase PduO (see section 1.2.5), 1-propanol dehydrogenase PduQ and 
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phosphotransacylase PduL (see chapter 3), respectively. In a recent study, Cheng et al. (52) 
showed that PduQ functions to help regenerate electron carriers and retain redox balance during 
1,2-PD fermentation by converting a portion of the propionaldehyde to 1-propanol and NADH to 
NAD+ to avoid depleting NAD+ within the Pdu MCP lumen. Extensive structural studies 
suggested that substrate, cofactors and products of 1,2-PD metabolism might be transported 
through the pores in the shell proteins (see section 1.1.5). Further studies are needed for a 
thorough understanding of the molecular transport mechanisms of MCPs. 
 
                
Figure 1.8. Model for 1,2-PD degradation by S. enterica. 1,2-PD is transported through the shell and is 
degraded within the Pdu MCP. The MCP protein shell functions as a diffusion barrier to retain 
propionaldehyde to eliminate toxicity and carbon loss. Propionaldehyde is converted to propionyl-CoA which 
either feeds into methyl citrate pathway or is used to produce propionate (58). 
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1.2.4.3. Eut MCP-Ethanolamine Degradation 
      Ethanolamine degradation in Salmonella is carried out analogously to Pdu MCP-associated 
1,2-PD degradation except ethanolamine is utilized instead of 1,2-PD and acetaldehyde is the 
toxic intermediate generated during the process rather than propionaldehyde. As shown in Figure 
1.9, the first step is carried out by vitamin B12-dependent EutBC to convert ethanolamine to 
ammonia and acetaldehyde which is further metabolized to alcohol and CoA-esters within Eut 
MCP. By retaining acetaldehyde within Eut MCP eliminates the damage to cellular DNA and 
also prevent carbon loss by diffusion of aldehyde out of MCP and across cell membrane.  
 
              
Figure 1.9. Model for ethanolamine catabolism and Eut MCP function. The outer double rectangle represents 
the cell membrane, the dashed line confines the Eut MCP. Two large cofactors HS-CoA and NAD+ are 
recycled within the MCPs by enzyme EutE, EutD and EutG. This model proposes that acetaldehyde is retained 
inside the Eut MCP (white arrow) while substrate ethanolamine as well as intermediate ethanol and acetate can 
diffuse freely through the MCP shell (black arrows). According to this model, enzyme EutBC is located on the 
outside surface of the MCP and converts ethanolamine to acetaldehyde, which is released into the lumen of 
MCP and retained there (78).  
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1.2.5. BMC Domain and MCP Shell 
      MCPs are subcellular compartments with a specific function in bacteria cell, and the protein 
shell acts as a selective barrier, which fits the conventional definition of an organelle, except that 
MCPs are exclusively proteinaceous bodies instead of membrane bound organelles.  
      Many bacterial MCP shell proteins share a conserved sequence referred to as bacterial 
microcompartment (BMC) domain (Pf00936). All genomes associated with MCPs usually have 
multiple paralogous copies of BMC shell proteins encoded together. Several thousand copies of 
these shell proteins of different types constitute a single microcompartment shell. Functionally 
diverse MCPs are all assembled from this protein family. To date, the BMC domain containing 
MCP shell proteins have been found in only bacteria, no BMC proteins were found in archaea or 
eukaryotes. The only exception is that carboxysome shell proteins were once reported in the 
amoeboid Paulinella chromatophora (79). 
      English et al. (48) first reported the sequence of a major carboxysome shell peptide encoding 
gene csoS1 from proteobacteria T. neapolitanus, the organism from which carboxysomes were 
first purified in 1973 (30). The sequence shares homology with several ORFs from cyanobacteria 
Synechococcus. All the other types of MCPs were discovered basically by identifying genes for 
BMC domain-containing shell protein clustered with genes encoding metabolic enzymes during 
genomic sequence analysis followed by biophysical confirmation of observed polyhedral bodies 
by electron microscopy. Since the first crystal structure of a BMC domain protein was published 
in 2005 (35), crystallography has been an important tool for investigating assembling 
mechanisms in MCPs.  
      Early structural studies focused on shell proteins which are about 100 amino acids long and 
contain a single BMC domain. In 2005, the first crystal structures of BMC domain-containing 
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shell proteins CcmK2 and CcmK4 of β-carboxysomes were determined (35). N-terminal 80 
amino acids of the BMC domain adopt an α/β-fold, six identical monomers self-assemble to form 
a wedge-shaped symmetric hexamer with a narrow pore down the center of the hexameric 
structure. The following key shell components from different types of MCPs also apply the 
symmetric hexameric structures and also have the central pores but with different sizes and 
charge properties due to the residues in the pore area which may be relate to their different 
molecular transport specificities on the shell (36, 80). These unique disc-shaped symmetric 
hexamers serve as the main building blocks for the facets of the MCP shell. According to 
Crowley et al. (36), Pdu MCP key shell protein PduA forms a symmetric homohexamer and 
retains a disk-like hexagon, which is consistent to the majority of the BMC shell protein 
hexamers from other types of MCPs. Unlike other shell proteins that form flat hexameric 
structures, EutS shows bent hexamers which presumably form the edges where two facets of the 
BMC shell meet (24, 66).  
      More recently, structure studies revealed two minor carboxysome shell components CcmL 
from Syn. 6803 and OrfA in H. neapolitanus assembling to form symmetric pentamers instead of 
hexamers (38). These pentameric proteins don’t contain BMC domains. Their subunits are 
packed tightly around the axis of symmetry with narrow pores around 3-3.5 Å in the center. Only 
60 copies of the CcmL or OrfA are present among four to five thousand hexameric shell subunits. 
Electron microscopy studies confirmed that carboxysomes are approximately icosahedral in 
shape (81, 82). Usually the architecture of large icosahedral structures shows a combination of 
hexamers and pentamers with hexamers constituting flat hexagonal sheet and pentamers 
generating curvature on the sheets and occupying the vertices of an icosahedron (83, 84). 
Homologues to pentameric CcmL and OrfA were also found in other types of MCPs such as 
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EutN, PduN, and GrpN. Crystal structures of GrpN confirmed that it is pentameric (85). The 
original structural study indicated that PduN formed a hexamer, but further study demonstrated 
that EutN is a pentamer (85, 86). The name bacterial microcompartment vertex (BMV) was 
proposed to emphasize the special role of pentameric vertical proteins (85). Based on the 
resolved structures of hexameric and pentameric components of BMC-domain shell proteins, it 
was proposed, as shown in Figure 1.10, that the several thousand of BMC proteins self-assemble 
into cyclic hexameric units packed in a tile-like molecular layers forming the flat facets; minor 
BMV proteins assemble into pentagonal units close the vertices of the MCPs giving rise to 
roughly icosahedral structures.  
      The structural studies suggested that the MCP shell doesn’t just function as a segregating 
device, but is also involved in controlling metabolic flow (54). The selectivity features of MCPs 
are opposite to those of lipid membranes in that MCP protein shell favors passage of polar 
instead of nonpolar molecules. Compared to carboxysomes, Pdu MCP and Eut MCP have special 
needs to transport large metabolic cofactors for 1,2-PD and ethanolamine degradation 
(nicotinamide, cobalamin, coenzyme A and phosphorylated ATP derivatives). Current theories 
based on structural and genetic studies propose that the cofactors could be either moved across 
the MCP shell or regenerated internally in the MCPs, and both scenarios may partially contribute 
the supply of the bulky cofactor molecules. Structural and genomic studies indicated that double-
BMC-domain protein encoding genes are present in both pdu and eut operons. These proteins 
usually have open and closed conformations with large gated pores which may help transport 
bulky cofactors through the shell (66, 87). Systematic experimental studies are needed to confirm 
the involvement of gated pores in transport of cofactors. 
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Figure 1.10. A model for assembly of bacterial microcompartments. BMC-domain proteins (top left) form 
hexamers or pseudohexameric trimers which pack into a tile-like molecular layer (top right) as the majority of 
the shell. BMV proteins (bottom left) occupy the vertices of the polyhedron. Together they form a closed 
icosahedron (bottom right). BMC proteins have central pores possibly for molecular transport. (65). 
     
      Carboxysome shell proteins CcmK2 and CcmK4 have pores about 7 Å and 4 Å in diameter, 
respectively. Since each of the six subunits contribute a positively charged amino acid residue 
Lys36 or Arg38 to the pore, a large net positive electrostatic potential is present in the pore region, 
which may attract negatively charged metabolites, particularly substrate bicarbonate, to the pore 
(35). While the hydrophobic CO2 intermediate will not have the same electrostatic attraction to 
the pore as bicarbonate and hence is retained in the lumen of carboxysomes. At the same time the 
neutral O2 which competes with CO2 for binding RuBisCO doesn’t show any advantage of 
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passing through the positively charged pore area hence can’t get into carboxysomes. The PduA 
central pores with about 10 Å in diameter are mostly polar due to the presence of hydrogen bond 
acceptors in the center of the pores. This favors transport of the substrate 1,2-PD compared to the 
intermediate propionaldehyde (36, 73). X-ray diffraction data showed a glycerol molecule which 
is a 1,2-PD analog is found in the central pore of one PduA point mutant, indicating the possible 
function of PduA is to move 1,2-PD into the lumen of the Pdu MCP (71). Based on the fact that 
PduJ, another Pdu BMC shell protein, has 86% sequence identity with PduA and identical pore-
lining residues, it is possible that PduJ has similar structure and pores as PduA. Pang et al. (72) 
investigated another major MCP shell component PduB in Lactobacillus reuteri and found three 
glycerol molecules present in each pore within the trimeric structure of PduB. The amino acid 
residues lining in the pore area have affinity for glycerol and may function as a channel for 
substrate glycerol, whereas the hydrogen bonds at the glycerol-binding sites may also prevent 
efflux of hydrophobic intermediate aldehyde from the MCPs (72). 
      In 2009, the structures of the shell protein with tandem BMC-domain was first solved for 
CsoS1D from α-carboxysome (87). Tandem BMC domain proteins contain two BMC domains 
duplicated in conjunction with each other to form trimers with a total of six BMC domains in a 
pseudohexameric symmetric arrangement, which are structurally similar to hexagonal shape of 
single BMC domain shell proteins. CsoS1D has a conserved Arg side chain which goes through 
conformational changes and causes the pores to either close or open up to 14 angstrom in 
diameter. Later structural studies suggested the presence of gated pores within another tandem 
BMC protein EutL (88). EutL has three pores per pseudohexameric unit which may allow 
increased flux across the shell compared to one pore per unit area. Based on these observations, a 
gated opening in response to specific conditions or signals was suggested. For Pdu, Eut and Grp 
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systems, transport of large cofactors might explain the existence of the large gated pores. In 
carboxysomes, the gated pores might allow transport of substrate ribulose bisphosphate. 
      Tandem BMC shell protein PduT and some Grp MCP proteins bear an iron-sulfur cluster in 
the center of the pore region (36, 44). In the case of PduT, each subunit from the homotrimer 
contributes a single cysteine ligand to the 4Fe-4S cluster, which calls for the 4th ligand to an iron 
atom. This specific feature suggested that PduT may contribute to the regeneration of 
encapsulated redox cofactors by moving electrons across the shell. Alternatively, PduT may 
transport intact [4Fe-4S] clusters into the MCPs to replace the damaged [4Fe-4S] clusters in the 
lumen enzyme PduS (36).  
      Most recently, it has been found that point mutations replacing conserved edge lysine 
residues with alanine on PduA, PduJ or PduB are severely impaired for edge contacts with 
neighboring shell components, which cause unstable MCP sheet or blocking closing of the shell 
due to weak and nonspecific edge contact with other BMC domain proteins (73). Specifically, 
K26, N29 and R79 on PduA are key residues which form hydrogen bonds within same hexamer 
and also with neighboring hexameric structures. This interaction hub strengthens the edges 
between the hexamers and thus stabilize the MCP shell. K26 and R79 are conserved across 
several BMC domain proteins among different MCPs, hence this could be a general mechanism 
for stabilizing MCP architecture.  
1.2.6. Stability 
      Sinha et al. (73) initiated the investigation of the phenotypic effects of structural mutations of 
Pdu MCP by identifying key surface residues in one major Pdu MCP protein PduA that are 
crucial to stabilize the MCP shell. Shortly after that, Kim et al. (89) tested the robustness of Pdu 
MCP shell with regard to time, pH and temperature, and concluded that Pdu MCPs retain 
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integrity in various physiological relevant conditions which makes MCPs suitable for a diversity 
of applications esp. in vivo applications. MCPs are stable for at least 6 days at either 4°C or room 
temperature in vivo and remain stable in vitro for a longer period of time.  MCPs display normal 
morphology between pH 6 and pH 10, although TEM images showed aggregates at pH 9 and 
above. Buffers with pH range below 5 or above 11 caused deterioration of MCP structure and 
reduced size. Also purified MCPs can tolerate temperatures up to 60°C without visible structural 
degradation under EM.  
1.2.7. Association of MCPs with Salmonella Pathogenesis 
      1,2-PD is a main fermentation product of rhamnose and fucose (90, 91). L-rhamnose is a 
common component of plants cell walls and the outer cell membrane of certain Mycobacteria 
species (92). L-fucose is also present in the glycoconjugates of intestinal epithelial cells (50).  
Hence, 1,2-PD is readily available in the anaerobic environment in the human and animal gut as 
well as aquatic sediments. Ethanolamine is present in the gastrointestinal tract of mammals as a 
product of degradation of phosphatidylethanolamine which is an essential component of 
membrane in both prokaryotic and eukaryotic cells and is constantly shed together with intestinal 
epithelial cells into the lumen of the gut (93).  
      1,2-PD and ethanolamine are present in the intestinal system but don’t not serve a role as 
carbon sources without a terminal electron acceptor (94). In the normal gut environment, 
anaerobic metabolism of microbiota constantly produce large amounts of hydrogen sulfide (H2S) 
which binds to mitochondrial respiratory enzymes and prevents oxidative phosphorylation during 
cellular respiration and hence causes cellular anoxia. Large intestinal mucosa convert H2S to 
thiosulfate (S2O3
2-) to prevent the toxicity. S. enterica, when introduced into the gut, employs 
two type III secretion systems T3SS-1 and T3SS-2 to effectively elicit acute intestinal 
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inflammation, penetrate the intestinal epithelial cells and survive in tissue macrophages (95). 
During acute inflammation, neutrophils migrate from blood vessels to the site of infection via 
chemotaxis and release nitric oxide radicals (NO) and reactive oxygen species, the process 
known as host respiratory burst, which results in oxidation of thiosulfate to tetrothionate. Genetic 
studies indicated that tetrothionate can serve as an alternative electron acceptor to support 
anaerobic respiration hence promote anaerobic growth on ethanolamine or 1,2-PD (75).  
      The ability of S. enterica to take advantage of host-generated 1,2-PD as well as ethanolamine 
clearly provides growth advantages for Salmonella in an inflamed gut. By using tetrothionate as 
alternative electron acceptor, Salmonella can utilize 1,2-PD and ethanolamine as the only carbon, 
nitrogen and energy source, which may be one of the virulence strategies that S. enterica utilizes 
to exploit inflammation to overcome colonization resistance (protection by high density of 
commensal microbiota inhabiting the intestine and shielding from infection) as well as 
competing with other enteropathogenic bacteria. By using in vivo expression technology (IVET), 
Conner et al. (96) pinpointed that genomic region containing pdu and cob operons are 
specifically induced during infection. Competitive index assay (CI) showed that removal of the 
pdu region conferred virulence defect in systemic survival, which indicated that the capability of 
using alternative carbon sources in the gut contribute to Salmonella virulence (96, 97). The 
findings that the pdu operon is induced in host cells may provide a starting point for drug and 
vaccine development against certain enteropathogenic bacterial infections. Further structural 
studies are needed to identify exposed peptide regions on BMC shell proteins.  
      One comparative genomic study identified a 55-kb gene locus in another enteric pathogen 
Listeria monocytogenes genome which is highly homologous to cob-pdu regulon and eut operon 
in S. enterica suggested a role of this locus in anaerobic growth and perhaps also in virulence of 
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L. monocytogenes in the host (98). Indeed, by analyzing the transcriptional profile of intracellular 
L. monocytogenes and validating the biological relevance of the intracellular gene expression 
profile, Joseph et al. (99) showed that, instead of competing with the host cells for their dominant 
carbon and nitrogen sources, L. monocytogenes can utilize alternative carbon and nitrogen source 
ethanolamine during replication in epithelial cells, which allows the longer survival in the host. 
Thus, MCP-dependent 1,2-PD and ethanolamine utilizations contribute to pathogenesis and 
dissemination of enteric pathogens containing pdu and/or eut operons.  
1.2.8. Applications 
1.2.8.1.Bioreactor 
      Recently studies have been testing the feasibility of encapsulate metabolic pathways for 
producing high-value compounds within MCPs. It has been shown that coordinated expression 
of shell proteins PduA-B-J-K-N-U in E. coli generated empty MCPs and it is possible to target 
proteins to outside (PduV) or inside (PduC, PduD) of MCPs (100). Choudhary et al. (101) 
successfully expressed Salmonella enterica Eut MCP shell proteins in E. coli resulting in the 
formation of polyhedral protein shells. They also found one single shell protein EutS sufficiently 
formed the MCPs. By tagging a pyruvate decarboxylase and an alcohol dehydrogenase with 
PduP N-terminal targeting sequence, Lawrence et al. (102) was able to efficiently generate 
ethanol from pyruvate and showed that the strains with modified empty MCPs produce alcohol 
with higher yield. Heterologous GFP proteins and β-galactosidase were successfully 
encapsulated into recombinant Eut MCPs by N-terminal 19 amino acids of EutC (101). Enzyme 
RuBisCO from heterologous species was also been engineered into carboxysomes (103). These 
studies provide a proof-of-concept for engineering of MCPs for biosynthesis and biocatalysis. 
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1.2.8.2.Drug Delivery 
      Many common chemotherapeutic agents are small hydrophobic molecules and the use of 
potentially toxic organic solvents are required for effective delivery (104). Moreover, the use of 
therapeutic proteins and peptides is prevented by the fast elimination from the circulation, 
enzymatic degradation and accumulation in normal organs and tissues (105). Current nanoscale 
drug delivery systems include liposomes, polymer particles and virus like particles (VLPs) (106). 
Liposomes and polymers may cause reduced activities of the peptides/enzymes due to chemical 
linking and liposomes sometimes exhibit drug leaking issues. VLPs have advantages compared 
to the lipid vesicles and polymers but have limited capacity (hundreds of proteins) and well-
documented immunogenicity (107).    
      The main function of MCPs is to retain small hydrophobic and toxic aldehyde within the 
shell, which makes MCPs suitable for delivering the chemotherapeutic drugs as well as peptide-
based anticancer drugs. Compared to the above mentioned delivering systems, the use of MCPs 
as drug carriers may results in higher active moiety: carrier ratio, better protection against 
degradation of drug activity without affecting normal cells because of their large internal volume 
and the demonstrated capability of keeping the activities of interior enzymes.  
      Two recent studies identified phenotypic effects of structural mutations of Pdu MCP and 
investigated the stability of Pdu MCPs over time, at elevated temperatures as well as in a diverse 
range of pH (73, 89). MCPs were found to retain the integrity in various physiological relevant 
conditions in regard to temperature and pH range which make MCPs great candidate for drug 
delivery (89). The robustness of MCPs helps prevent unspecific release of toxic or 
chemotherapeutic drugs. More importantly the breaking of the MCPs can be controlled by 
changing pH value of the buffers, meaning it is possible to regulate the release of the 
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encapsulated molecules, which opens the possibility of applying MCP in medical field, 
especially for drug delivery. 
1.2.8.3.Reuterin Production in Probiotics 
      Probiotic bacterium Lactobacillus reuteri produces reuterin by fermentation of glycerol. 
Reuterin is an equilibrium of 3-hydroxypropioaldehyde (3-HPA), HPA-hydrate and HPA-dimer. 
It has a broad spectrum of antimicrobial activity against viruses, prokaryotes (Gram+ and Gram- 
bacteria) as well as eukaryotes (fungi and parasites) and is also described as anti-cancer agent 
(108). Sriramulu et al. (109) reported that maximal reuterin production by L. reuteri was 
achieved with preincubation with 1,2-PD together with glycerol compared to glycerol alone. 
Further evidence indicated that Pdu MCP-associated diol dehydratase is responsible to produce 
3-HPA from glycerol. Probiotic bacteria are known to beneficially affect the host by inhibit 
pathogenic bacteria due to the excretion of reuterin while not interfere with normal microbiota in 
the gut. One problem of producing reuterin using probiotic bacteria is the low yield. To utilize 
MCPs as a reuterin bioreactor may increase the production of this molecule and may have further 
application in pharmaceutical industry.  
1.2.9. MCP Shell vs. Viral Capsid 
      When carboxysomes were first discovered by electron microscopy, they were thought to be 
viral particles, and attempts were made to induce a viral lytic response without success (110). 
Through years of studies on MCPs, now it is clear that MCPs have complete different contents 
and functions compared to viral capsids. Still, structural studies drew an architectural parallel 
between bacterial MCPs and viral particles esp. the ultrastructure and the underlying design 
principles. Both MCP shell and capsid have symmetrical structural featuring icosahedral shape. 
In MCPs, the conserved BMC domain shell proteins form cyclic hexamers, which bind side by 
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side to form layers representing the flat facets of the icosahedral shell (32). Certain minor shell 
components tend to form pentamers which serve as vertex to close the flat sheets and finally for 
a closed shell. The fact that different shell proteins may serve different roles in the architecture 
of the MCP shell resembles the structures of many viral capsids which also features combination 
of hexamers and pentamers, which applies to certain virus structure architecture as well.   
      So far there is no evident sequence resemblance or structural similarities between MCP shell 
proteins and viral capsid protein components, partly because there are relatively small number of 
viral capsid proteins have their structures solved by crystallization. The structural similarity 
between bacterial MCPs and virus may reflect geometric discipline of self-assembling 
macromolecular protein complex (24).  
      Crystal structures on MCP shell proteins proposed possibilities that hexameric central pores 
as well as the gaps between hexamers of BMC shell proteins. Similarly, certain viruses contains 
interstitial spaces between the capsid protein subunits which may also mediate the flow of 
metabolites. Yeast L-A viral capsid particle has 18 angstrom diameter openings at the 
icosahedral five-fold axes which provides a portal for the entry of nucleotide triphosphates and 
exit of the viral mRNA (111). The crystal structure of bluetongue virus icosahedral protein 
capsid disclosed that the pores on the 5-fold icosahedral axis allow the egress of mRNA through 
the interaction of RNA backbone phosphates with the amino acid side chains that line the pore 
(112). Also a different binding site on the capsid provides a selective channel for input and 
output of substrates and byproducts. However, bluetongue virus differs from MCPs shells in that 
encountering the physiological environment rich in Mg2+ and other ions results in the overall 
expansion of the capsid esp. around the 5-fold axes which was not observed in MCPs. The 
structural studies also showed that interactions between the C-terminal tails of the BMC domain 
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proteins could influence microcompartment domain assembly in the same way that the flexible 
termini of certain viral capsid proteins often participate as switches for distinct types of 
interactions in the mature viral capsid (35). 
      Cowpea Chlorotic Mottle Virus (CCMV) capsid can dissemble and reassemble depending on 
pH (113). There has been one report that showed that Pdu MCPs are sensitive to pH and the 
stability requires pH between 6 and 10 (89). Whether Pdu MCPs also fall apart and reform 
according to pH is unclear and future studies are needed to clarify it.  
1.3. Vitamin B12 
      Vitamin B12, also known as cobalamin, is a water-soluble vitamin with a crucial 
physiological role in cellular metabolism. Vitamin B12 is the largest and most structurally 
complicated vitamin and is synthesized only in bacteria and archaea. Adenosylcobalamin 
(AdoCbl) and methylcobalamin (CH3Cbl) are two cofactors for a variety of enzymes found in 
bacteria and higher animals. Animals assimilate cobalamin through diet, while fungi and plants 
don’t utilize B12. 
1.3.1. Control of the cob/pdu Regulon  
      The cob operon is located at minute 44 of the genetic map of S. enterica genome, which is 
adjacent to the pdu operon (see section 1.1.3.2). Enzymes encoded from cob operon are used for 
B12 synthesis. The two operons are induced by 1,2-PD using a single regulatory protein PocR 
(77). Two global regulatory systems Crp/Cya and ArcA/ArcB regulate inducibility of both cob 
and pdu operons in that both operons are activated aerobically and anaerobically by Crp protein 
and anaerobically by ArcA protein (77, 114). During anaerobic respiration of a poor carbon 
source, the Crp and ArcA proteins function additively and produce the maximum inducibility. 
The control of the cob/pdu regulon relies on five promoters which are all located in the central 
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region between the two operons and four of them are activated by PocR. As shown in Figure 
1.11, the cob and pdu operons are transcribed divergently from promoters Ppdu and Pcob, 
respectively. Ppdu and Pcob are activated when both PocR and 1,2-PD are present. Global control 
of the regulon is carried out by regulating PocR protein level. Transcription of the pocR gene is 
controlled by Ppoc which is regulated only by Crp/cAMuP, P2 which is autoregulated by PocR 
and requires ArcA and P1 whose regulation may involves Fnr or Crp in addition to PocR. 
      
 
Figure 1.11. Control of the cob/pdu regulon in S. enterica. Boxes indicate structural genes. Black arrows 
designate transcripts. Gray arrows indicate regulatory effects. Dashed gray arrows indicate that higher level of 
PocR may be required to activate the promoter (77). 
 
      The regulon is proposed to have three states (77). During aerobic growth on glucose, the 
regulon is in the off state, all promoters are at their lowest level and PocR is expressed by the 
basal levels of Ppoc, P1 and P2. During aerobic growth on a poor carbon source and/or anaerobic 
growth, cells switch to a standby state. At this state, cells grow under global conditions 
appropriate for induction while no 1,2-PD is present, PocR expression increases, but the regulon 
remains uninduced. The presence of 1,2-PD is sensed by PocR resulting in the induction of both 
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P1 and P2, which increase PocR level and pushes the system to the on state. Thus, the high level 
of PocR/1,2-PD induces the expression of Ppdu and Pcob. 
      There are 30 genes used for cobalamin synthesis (25 constitute the cob operon) and 22 genes 
used for 1,2-PD metabolism (pduX from the pdu operon used for cobalamin synthesis), which 
together count for >1% of Salmonella genome (53 of 4747 genes in S. enterica LT2) (115). 
Maintenance of such large collection of genes requires a strong selective force during evolution. 
The co-regulation of the cob operon and pdu operon suggested that B12-dependent utilization of 
1,2-PD could be a main reason for B12 synthesis in Salmonella spp (77).  
1.3.2. Structure 
      Cobalamin has three parts: a central ring, a nucleotide loop, and a variable moiety, for 
example, a cyano group (-CN), a hydroxyl group (-OH), a methyl group (-CH3) or a 5’-
deoxyadenosyl group, which yields the four B12 forms cyanocobalamin, hydroxocobalamin, 
methylcobalamin and adenosylcobalamin, respectively. The structure of cobalamin is based on a 
central corrin ring, which is structurally and biosynthetically similar to the porphyrin ring found 
in heme, chlorophyll, and a cytochrome. The central ring of B12 differs from other related rings 
by the lack of a carbon bridge between the A and D porphyrins, the ring oxidation state, the 
distribution of ring decorations, and by the unique central metal ion cobalt. Four of the six 
coordination sites are occupied by the corrin ring, while cobalt’s lower (Coα) axial ligand is N-7 
of dimethylbenzimidazole (DMB) which is covalently bonded to the corrin ring as part of a 
nucleotide loop (58) (Fig. 1.12). Ado-B12 also has a 5’ deoxyadenosyl moiety acting as its upper 
(Coβ) axial ligand, and the 5’ carbon of this group is joined by a covalent bond to the cobalt 
within the corrin ring. In the case of methylcobalamin, the deoxyadenosyl moiety is replaced by 
a methyl group (77).  
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1.3.3. Biosynthesis 
      Only bacteria and archaea contain the enzymes required for de novo synthesis of the central 
corrin ring. Certain bacterial species synthesize the corrinoid ring under aerobic conditions, 
others generate the corrin ring anaerobically. The two pathways may use nonhomologous 
enzymes to produce analogous intermediates during the biosynthesis. The first part of the process 
is identical between the aerobic and anaerobic routes, then at the later stage, the aerobic pathway 
incorporates oxygen as a prerequisite for the ring formation, while anaerobic route takes 
advantages of the chelated cobalt ion for the ring contraction (Fig. 1.13).  
 
            
Figure 1.12. Structure of cobalamin. The central carbon atoms are numbered, and peripheral amidated carboxyl 
groups are lettered. The R group stands for -CN, -CH3, and adenosyl group (115). 
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      Four major stages are required to synthesize cobalamin from the five-carbon precursor 5-
aminolaevulinic acid (ALA). The first stage is the biosynthesis of uroporphyrinogen III (Uro III) 
from ALA. Uro III is a precursor of corrins as well as heme, siroheme, chlorophylls and factor 
F430. Its biosynthesis from ALA involves the utilization of the enzymes ALA dehydratase 
(HemB), porphobilinogen deaminase (HemC) and uro’gen III synthase (HemD). The second 
stage entails the conversion of Uro III to cobinamide by a series of reactions including extensive 
methylation of the porphyrin ring, amidation of carboxyl groups, removal of a ring carbon, 
addition of the R group and the aminopropanol side chain. In the aerobic pathway, this stage 
results in the precorrin 6, while the anaerobic pathway is distinguished by the early incorporation 
of cobalt and results in cobalt-precorrin 6 rather than precorrin 6. On stage II, DMB moiety is 
synthesized possibly from flavin molecules. Stage III involves the covalent linkage of 
cobinamide, DMB, and a phosphoribosyl moiety derived from an NAD precursor.  
 
             
Figure 1.13. Biosynthesis of precorrin 6 through aerobic pathway (light arrows) and cobalt-precorrin 6 by 
anaerobic pathway (bold arrows) during B12 synthesis (116). 
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      In mammals, exogenous cobalamin precursors cyanocobalamin (CNCbl) and 
hydroxycobalamin (OH-Cbl) are obtained through the diet and converted into cofactors AdoCbl 
and CH3Cbl. As shown in Figure 1.14, assimilation of CNCbl is carried out by the conversion of  
CNCbl to cob(II)alamin by decyanation, further to cob(I)alamin by reduction, and finally to 
AdoCbl by transfer of a 5’-deoxyadenosyl group from ATP. The enzymes involved in this 
process are β-ligand transferase, cob(III)alamin reductase, cob(II)alamin reductase and 
adenosyltransferase, respectively (56, 63, 117-123). Assimilation of OH-Cbl occurs in a similar 
pathway except that the first step is the reduction of OH-Cbl to cob(II)alamin by cobalamin 
reductase or the reducing environment of the cell (124, 125).  
 
 
Figure 1.14. Proposed pathway for the conversion of CNCbl into AdoCbl (originally from (126), modified in 
(74)) 
 
1.3.4. Cobalamin-Dependent Reactions 
      AdoCbl and CH3Cbl act as cofactors for three types of enzymes: isomerases, 
methyltransferases, and dehalogenases (127). In humans, AdoCbl-dependent methylmalonyl-
CoA mutase MUT and CH3Cbl-dependent methionine synthase MTR play a key role for the 
formation of blood and in the normal functions of central nervous system. 
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1.3.4.1. AdoCbl-Dependent Isomerases 
      In bacteria, isomerases are the largest family of cobalamin-dependent enzymes which are 
important in fermentation pathways. These enzymes catalyze concomitant exchange of hydrogen 
atoms as well as a second substituent which can be a carbon atom, an oxygen atom of an alcohol, 
or a nitrogen atom of an amine. The isomerases in this family include methylmalonyl-CoA 
mutase, glutamate mutase, methyleneglutarate mutase, isobutyryl-CoA mutase, lysine 5,6 
aminomutase, diol dehydratase and ribonucleotide reductase, etc. (127).  
      In enteric bacteria, the primary role of the cofactor B12 may be to support fermentation of 
small molecules by generating both an oxidizable molecule and an electron sink for balancing 
redox reactions. This role has been observed in Ado-B12-dependent degradation of ethanolamine, 
1,2-PD and glycerol by ethanolamine ammonia lyase, propanediol dehydratases and glycerol 
dehydratase, respectively. The intermediate aldehyde can be oxidized to provide ATP and the 
oxidation reactions can be balanced by reducing part of aldehyde to an alcohol which is later 
excreted outside the cell. Ethanolamine is present in nature as components of lipids, phosphatidyl 
ethanolamine and phosphatidyl choline. Ethanolamine ammonia lyase produces ethanol and 
acetaldehyde which can be utilized to provide carbon and energy through acetyl-CoA in a Eut 
MCP-dependent manner. Similarly, 1,2-PD is converted by dehydratase to propionaldehyde 
which is used as carbon and energy source by the function of Pdu MCPs. In nonenteric bacteria, 
AdoCbl-dependent amino mutases catalyze similar reactions that support fermentation of 
glutamic acid, lysine, leucine, and ornithine.  
      The only AdoCbl-dependent isomerase that is also found in human beings is methylmalonyl-
CoA mutase MUT. The MUT function is necessary for proper myelin synthesis and is important 
in proper function of the central nervous system.  
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1.3.4.2. CH3Cbl-Dependent Methyltransferases 
      CH3Cbl-dependent methyltransferases play a crucial role in amino acid metabolism in both 
humans and bacteria. They are also important in carbon metabolism and CO2 fixation in 
anaerobic microbes (127). The enzymes catalyze the transfer of a methyl group from a methyl 
donor to a methyl group acceptor. Cofactor CH3Cbl is cleaved heterolytically and acts as a 
methyl group carrier. Methionine synthetase transfers a methyl group from methyl-
tetrahydrofolate to homocysteine as the last step in methionine synthesis. Salmonella and E. coli 
both express a B12-dependent methionine synthase MetH and a B12-independent MetE which 
catalyze the same reaction. MetH is preferred when CH3Cbl is available, while MetE is induced 
to respond to homocysteine accumulation when MetH is inactive (128). The only CH3Cbl-
dependent enzyme in human beings is methionine synthase MTR, which is important in blood 
formation.  
1.3.4.3. B12-Dependent Reductive Dehalogenases 
      Bacteria containing B12-dependent reductive dehalogenases provide benefits for the 
environment by detoxification of aromatic and aliphatic chlorinated organics, many of which, for 
example, chlorinated phenols, chlorinated ethane, and polychlorinated biphenyls (PCBs), are on 
the top list of EPA (Environmental Protection Agency) priority pollutants (127). Even though 
both anaerobic and aerobic microbes can carry out dehalogenation, anaerobic bacteria are more 
efficient in removing halogen atoms from polyhalogenated molecules (129). Anaerobic 
organisms with the capability of reductive dehalogenation include Desulfomonile, Dehalobacter, 
and Desulfitobacterium (130). These organisms have different preference for the chlorine 
substituent they can remove (131, 132).   
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1.3.5. A Cobalamin Recycling System in the Pdu MCP 
      As mentioned above, the first step of 1,2-PD degradation in the lumen of Pdu MCP is the 
conversion of 1,2-PD into propionaldehyde catalyzed by AdoCbl-dependent diol dehydratase 
(DDH). The adenosyl-group of AdoCbl is unstable and constantly lost and replaced by a 
hydroxyl group, resulting in inactivation of DDH by tight binding of inactive OH-Cbl to the 
active site (133, 134). DDH reactivase PduGH releases OH-Cbl and apo-DDH. Next OH-Cbl 
goes through reduction catalyzed by reductase PduS to cob(I)alamin and then adenosylation by 
adenosyltransferase PduO to active AdoCbl. AdoCbl automatically associates with apo-DDH to 
form active holoenzyme.  
       
                        
Figure 1.15. The proposed model for B12 recycling inside the Pdu MCP in S. enterica. Recycling of the 
inactive OH-Cbl-DDH into active AdoCbl is carried out by diol dehydratase reactivase (PduGH), cobalamin 
reductase (PduS) and adenosyltransferase (PduO). The process results in reactivation of AdoCbl and DDH (55).  
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      All of the enzymes (PduGH, PduS and PduO) involved in B12 recycling have been 
established as components of the Pdu MCP, which suggested that cobalamin recycling occurs 
completely within the lumen of the MCPs as shown in Figure 1.15 (49, 55). The recycling of 
AdoCbl is required for the proper activity of PduCDE and hence is essential for of 1,2-PD 
metabolism. 
1.3.6. B12-Related Diseases 
      In humans, tetrahydrofolate (THF) plays a vital role in DNA synthesis and reduced THF 
levels caused by B12 deficiency results in loss of functionality of MTR enzyme which causes 
rapid turnover of red blood cells and intestinal epithelial cells and causes megaloblastic anemia 
and Pernicious anemia. Also the accumulation of homocysteine in the blood and urine may cause 
long term damage to arteries and clotting with increased risk of stroke and heart attack.  
      Myelin is a dielectric material which forms the myelin sheath around the axon of a neuron. 
The main function of myelin sheath is to increase the speed of impulses propagation and prevent 
the electrical current from leaving the axon which are essential for the proper functions of the 
nervous system. B12 deficiency abolishes the function of human MUT, which causes elevated 
level of methylmalonic acid (MMA), a myelin destabilizer. Increased MMA level prevents 
normal fatty acid synthesis, and MMA may be assimilated into fatty acid rather than the normal 
malonic acid. Myelin with MMA incorporated becomes fragile resulting in demyelination, which 
is associated with degeneration of central nervous system and spinal cord, but the mechanisms 
involved are unclear (135).  
      Damaged MTR reactions due to B12 deficiency also have neurological effects. MTR reaction 
produces methionine which is required to generate S-adenosyl-methionine (SAM) is necessary 
for the methylation of myelin sheath phospholipids. In addition, SAM is involved in production 
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of neurotransmitters and hormones including epinephrine, norepinephrine and dopamine, and 
also in brain metabolism. Inadequate levels of SAM thus may cause depression as well as 
neurodegeneration (136).  
1.4. Coenzyme A (HS-CoA) 
1.4.1. Discovery and Structure 
      HS-CoA is an essential intermediate in many biosynthetic and energy-yielding metabolic 
pathways and also a crucial regulator of several key metabolic reactions. Every genome 
sequenced so far encode enzymes that utilize coenzyme A as a substrate. Coenzyme A was 
discovered by Fritz Lipmann accidently when he studied acetylation on the amino group of the 
drug sulfonamide in 1940s. He named it coenzyme A (CoA) where “A” stood for “activation of 
acetate”. Lipmann shared the Nobel Prize in Physiology or Medicine in 1953 with Hans Adolf 
Krebs “for his discovery of co-enzyme A and its importance for intermediary metabolism” 
(Krebs won the Prize “for his discovery of the citric acid cycle”). Later, Lipmann showed that 
CoA consists of adenosine 5’-phosphate pantothenic acid and a sulfhydryl moiety (137, 138).  
 
       
Figure 1.16. The structure of coenzyme A. A 2D structure cited from http://pubchem.ncbi.nlm.nih.gov/; B 3D 
stick model cited from Wikimedia Commons.  
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      The structure of coenzyme A, as shown in Figure 1.16, was defined in the early 1950s. It is a 
coenzyme containing among its constituents pantothenic acid and a terminal thiol group that 
forms high-energy thioester linkages with various acids.  
1.4.2. Biosynthesis 
      Biosynthesis of coenzyme A is a highly conserved process in all living organisms. CoA is 
synthesized from pantothenate and cysteine in a five-step process which consumes four ATP 
molecules and the pathway intermediates are common in prokaryotic and eukaryotic cells. 
Pantothenate is commonly known as vitamin B5, which can be synthesized de novo in plants, 
fungi and most bacterial species, but is an essential nutrient for animals and certain microbes. 
Vitamin B5 is usually present in sufficient quantities in the diet and is also produced by bacteria 
in human intestines. Pantothenate is taken into cells through specific carrier pantothenate 
permease (PanF) in E. coli, a hydrogen symporter in yeast or a sodium-dependent multivitamin 
transporter in the intestinal epithelium of mammals (139). In eukaryotic cells, the biosynthesis 
process starts with phosphorylation of pantothenate to 4'-phosphopantothenate by pantothenate 
kinase (PanK), which is rate-limiting step in most organisms (140, 141). 4’-P-pantothenate is 
condensed with cysteine consuming one ATP to generate 4’-P-pantothenoylcysteine by 4′-
phosphopantothenoylcysteine synthase (PPCS). 4′-phosphopantothenoylcysteine decarboxylase 
(PPCDC) catalyzes the decarboxylation of 4′-phosphopantothenoylcysteine to yield 4′-
phosphopantetheine. Next, 4′-phosphopantetheine adenosyltransferase (PPAT) catalyzes the 
second rate-limiting reaction in CoA biosynthesis--transfer of AMP to form dephospho-CoA, 
which is finally phosphorylated to produce CoA by dephospho-CoA kinase (DPCK). A couple of 
studies pointed out the specific interaction between PanK1β and Coenzyme A synthase (CoAsy), 
the first and last enzymes of the CoA biosynthetic pathway, and showed CoAsy might be present 
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in a complex (142, 143). Although no publication to date demonstrated the existence of a CoA 
biosynthetic complex in mammals.  
 
       
Figure 1.17. Schematic diagram of a universal pathway for CoA biosynthesis and its key players in bacteria, 
yeast and mammals (139).  
 
      In bacteria, the above five enzymes are instead called CoaA, CoaBC (bifunctional enzyme), 
CoaD and CoaE respectively (141, 144, 145). To date, at least three types of CoaA/PanK have 
been identified. Type I is expressed in E. coli and is efficiently inhibited by CoA. Type II is 
present in S. aureus and is not inhibited by CoA and derivatives at all. The more recently 
identified type III enzyme is the only known PanK found especially in pathogenic bacterial 
species. PanK-III adopts a different structural fold compared to that of E. coli CoaA, and hence 
is resistant to CoA feedback inhibition (144). Exploration of inhibitors targeting PanK-III may 
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result in development of novel antibiotics (146). These bacterial CoA synthetic enzymes are 
usually present in quaternary structure: CoaA is a homodimer, CoaBC is a homododecamer, 
CoaD and CoaE are trimers. Unlike in the yeast, where the enzymes for CoA biosynthesis are 
grouped together, bacterial Coa enzymes don’t associate in multienzyme complexes.  
      Intensive investigation has been focusing on subcellular localization of CoA biosynthetic 
enzymes, esp. the rate limiting PanK and CoAsy, in mammalian cells. PanK1α isoform is 
exclusively localized in the nucleus while PanK1β shows cytosolic localization. Human PanK2 
possesses an N-terminal regulatory region which shows functional nuclear localization as well as 
export signals and is observed in the nucleus and the mitochondria (147).  
1.4.3. CoA and its Thioester Derivatives 
      The unique structure of CoA relates to its function as a major acyl group carrier and 
carbonyl-activating group, the reactions generate various metabolically active thioester 
derivatives, including acetyl-CoA, malonyl-CoA and 3-hydroxy-3-methylglutaryl-CoA (HMG-
CoA) (Fig. 1.18). The levels of CoA and its derivatives in mammalian cells and tissues are 
tightly regulated by various extracellular stimuli, including nutrients, hormones and cellular 
metabolites. The ratio between CoA and its thioester derivatives is important for cellular 
homoeostasis. 
1.4.4 Regulation of CoA Biosynthesis 
      The levels of CoA and its thioester derivatives are tightly regulated at various levels and in 
different cellular compartments by extracellular and intracellular signals. The regulatory 
mechanisms may include gene expression of the biosynthetic enzymes; posttranslational 
modifications; compartmentalization; metabolic flux of CoA/CoA thioester; and CoA 
degradation. Fasting, glucagon and glucocorticoids increase the level of CoA (149, 150), while 
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insulin, glucose, fatty acids and pyruvate cause decrease of CoA level (151, 152). Pathological 
conditions, such as diabetes, Reye’s syndrome, cancer, vitamin B12 deficiency and cardiac 
hypertrophy as well as treatment with hypolipidaemic drugs have been reported to change 
intracellular coenzyme A level (149, 153-155).  
 
 
Figure 1.18. Chemical structures of CoA thioester derivatives (148). 
 
1.4.4.1 Feedback Regulation 
      Feedback regulation of PanK is carried out by CoA and CoA thioesters and controls the 
overall availability of CoA in response to a cell’s metabolic state. In E. coli, culturing condition 
with different carbon sources basically decide the total abundance of CoA pool as well as the 
relative distribution of CoA species (156). Growth on glucose generates 15 times more 
pantothenate than the amount utilized for CoA synthesis, indicating that CoaA enzymatic 
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reaction is rate limiting for conversion from pantothenate to CoA (157). The CoaA activity is 
reduced in vivo with she shift from glucose to acetate, reflecting that CoaA is less sensitive to 
inhibition by acetyl-CoA (the major CoA species growing on glucose) compared to the inhibition 
by free CoA (the main CoA species growing on acetate). In bacteria, this lower sensitivity to 
acetyl-CoA allows the fasting expansion of the CoA pool to meet the metabolic requirements of 
fast growing cells on glucose. The eukaryotic PanK is also under the feedback regulation by the 
CoA pool. The mouse PanK1 isoforms (mPanK1α and mPanK1β) are differentially regulated by 
CoA species. The human PanK2 is localized in mitochondria and is very sensitive to inhibition 
from long-chain acyl-CoA, acetyl-CoA and malonyl-CoA, suggesting its enzymatic activity is 
diminished in most metabolic circumstances. All the other PanK enzymes are present in cytosol 
and hence are not sensitive to the levels and changes of the CoA pool.  
      Changes in the most abundant CoA species and ATP concentration work cooperatively 
modulate the rate of CoA biosynthesis (141). Mammalian CoAsy is present in complex with 
proteins involved in diverse signaling pathways, such as p85α regulatory subunit of 
phosphoinositide 3-kinase (PI3K) (158), Src homology 2 domain-containing protein tyrosine 
phosphatase (Shp2PTP) and tyrosine kinase Src (158), and enhancer of mRNA-decapping 
protein 4 (EDC4) (159). Tyrosine phosphorylation of CoAsy by Src tyrosine kinase family 
members is required for its interaction with PI3K. Moreover, EDC4 was shown to inhibit the 
dephospho-CoA kinase activity of CoAsy in vitro (159). The mechanisms behind these 
interactions are not very clear, their roles in regulation of formation of a possible CoA 
biosynthetic complex can’t be ruled out.  
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1.4.4.2 Regulation by Compartmentalization 
      In mammalian cells, CoA level varies with different compartments. CoA concentrations are 
estimated to be 0.7 mM and 2.2-5.0 mM in peroxisomes and mitochondria, respectively. The 
high level of mitochondrial CoA is used as a cofactor in the TCA cycle and fatty acid β-
oxidation, and the concentrations of CoA pool regulate the rate of these processes. The level of 
free CoA determines the speed of oxidation-dependent energy production in both peroxisomes 
and mitochondria. Whereas CoA levels as low as 0.02 to 0.14 mM have been observed in 
cytosols of different tissues and organs, where it is utilized for lipid synthesis, fatty acid 
oxidation, protein modification and also membrane trafficking. The endoplasmic reticulum is 
another compartment for CoA. Acetyl-CoA is transported into the lumen of this organelle for 
formation of O-acetylated gangliosides and other sugar components. How CoA generated from 
these processes returns to the cytoplasm is unknown. 
1.4.4.3. Various Size and Composition in CoA/CoA Thioester Pool in Bacteria 
      In bacteria E. coli, growing in different carbon sources lead to various size and composition 
in CoA pool. The CoA level is as high as 400 uM when E. coli grows on glucose and acetyl-CoA 
is the major derivative (156). While growing in amino acids mixture derived from hydrolyzed 
casein, the pool is only around 100 uM. This comparison indicates that coenzyme is important 
for the generation of amino acids from glucose through the Krebs cycle. Acetyl-CoA is the 
dominant component of the CoA pool (79.8%) during exponential growth in glucose minimal 
medium (160). Total amount of acetate in the cell controls the levels of CoA in bacteria. When 
the number of acetyl-CoA decreases significantly in an acetate auxotroph of E. coli, the amount 
of free CoA drops accordingly, and the excessive CoA is converted to 4′-phosphopantetheine and 
pumped out of the cell (161). While the increase of intracellular CoA by overexpressing CoaA 
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enzyme in E. coli causes increased carbon flux to acetate production (162). In S. aureus, CoA 
level accumulates to millimolar levels due to the facts that the CoaA enzymatic activity from this 
bacterium is not feedback-regulated by CoA pool. It actually meets the physiological needs of S. 
aureus since it lacks glutathione and hence depends on CoA/CoA disulfide reductase to keep the 
redox balance and protect from the oxidative damage (163).  
1.4.4.4. Regulation by Gene Expression 
      In most bacterial species, coaA gene expression level controls the upper limit for the 
intracellular CoA concentration. The coaA promoter doesn’t share homology with consensus 
promoter sequence in E. coli, and the coaA sequence contains codons with low frequency of 
usage, which result in lower abundance of CoaA protein relative to the average E. coli proteins 
(164). Even though CoaA was manipulated to be overexpressed from a multicopy plasmid in E. 
coli, feedback inhibition of the enzyme limit the increase of the CoA level (164). On the other 
hand, in higher animals, PanK expression is modulated in a long-term response to diet and 
diseases, while the mechanisms were unclear (141). 
1.4.4.5. Regulation by CoA Degradation  
      CoA can be degraded by dephosphorylation to dephospho-CoA, cleavage of the 
phosphodiester bond to release 4'-phosphopantothenate, or direct transfer of the 4'-
phosphopantetheine moiety on CoA to other carrier proteins such as acyl carrier protein (ACP) in 
bacteria and fatty acid synthase (FAS) in eukaryotic cells. ACP is the essential acyl group carrier 
which interacts with enzymes in fatty acid synthesis and FAS is a multi-enzyme protein that 
generate long-chain saturated fatty acid from acetyl-CoA and malonyl-CoA. In bacteria, another 
regulatory mechanism is mediated by a phosphodiesterase. Fast decrease of acetate supply 
stimulates the response from the CoA pool and results in reduction of acetyl-CoA level, increase 
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of free CoA transiently and finally CoA degradation and transported outside of the cells (161). 
Nudix hydrolase has been identified to contribute in the above reactions (165). 
1.4.5. Functions of CoA and CoA Derivatives 
      CoA is an essential metabolic cofactor for all living organisms. CoA basically functions as an 
acyl group carrier and carbonyl-activating group contributing to central metabolism including 
citric acid cycle and fatty acid synthesis. Around 4% of enzymes use it as an obligate cofactor. 
It’s involved in more than 100 metabolic reactions (166, 167). CoA and its derivatives are 
involved in the catabolism of proteins, carbohydrates and lipids through metabolic reactions 
which releasing the energy from food in the form of acetyl-CoA.  
1.4.5.1. The Citric Acid Cycle 
      Acetyl-CoA is the starting point for the citric acid cycle. The primary sources of acetyl-CoA 
are decarboxylation of pyruvate which comes from the breakdown of sugars and the oxidation of 
fatty acids. The citric acid cycle begins with the transfer of the acetyl group from acetyl-CoA to 
oxaloacetate to form six-carbon citrate. The carbons from acetyl-CoA become part of the 
oxaloacetate carbon backbone after the first TCA cycle. After several turns of TCA cycle, acetyl-
CoA-donated carbons are released as CO2. The TCA cycle utilizes acetyl-CoA derived from 
carbohydrate, fats and proteins to generate chemical energy in the form of adenosine 
triphosphate (ATP).  
1.4.5.2. Synthesis of Fatty Acids 
      Acetyl-CoA and malonyl-CoA are used to generate palmitate by fatty acid synthase I (FAS I) 
in animals and yeast, and by FAS II in bacteria, plants, fungi, parasites and mitochondria. In the 
presence of NADPH, long-chain saturated fatty acids are produced. Desaturation of fatty acids in 
bacteria occurs in the anaerobic conditions and is dependent on β-hydroxydecanoyl-ACP 
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dehydrase FabA and β-ketoacyl-ACP synthase FabB in E. coli or their homologues in other 
bacteria to add the double bond before elongation by using the fatty acid synthesis machinery. 
Aerobic desaturation is utilized by all eukaryotic and some prokaryotic cells and it uses 
desaturases to produce unsaturated fatty acid from full-length saturated fatty acid.  Unsaturated 
fatty acid is essential component of prokaryotic and eukaryotic cell membrane, signal molecules, 
Fatty acid synthesis is an important part of the lipogenesis process. Lipogenesis and glycolysis 
together contribute to create fats from sugar molecules in blood stream in living organisms.  
1.4.5.3. Synthesis of Cholesterol and Ketone Bodies 
      Two acetyl-CoA molecules can be condensed to generate acetoacetyl-CoA, which is 
hydrated together with another acetyl-CoA molecule to form HMG-CoA. HMG-CoA feeds into 
mevalonate pathway/HMG-CoA reductase pathway to produce dimethylallyl pyrophosphate 
(DMAPP) and isopentenyl pyrophosphate (IPP). The mevalonate pathway is present in all higher 
eukaryotes and many bacteria as well. This pathway is used to produce cholesterol and ketone 
bodies. Cholesterol has diverse functions in cell membrane maintenance, intracellular transport, 
cellular signaling and nerve conduction within the cell membrane. Cholesterol is also the 
precursor for the biosynthesis of bile, vitamin D and steroid hormones and their derivatives. 
Ketone bodies are three water-soluble molecules acetone, acetoacetic acid and beta-
hydroxybutyric acid. They are generated by the liver from fatty acids during fasting or 
carbohydrate restriction conditions, taken up by cells and converted back into acetyl-CoA to feed 
into TCA cycle for energy production. In the brain, ketone bodies are also used to produce long 
chain fatty acids since long chain fatty acids can’t pass the blood-brain barrier.  
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1.4.5.4. Balancing Carbohydrate Metabolism and Fat Metabolism 
      In animals and human beings, acyl-CoA thioesters are crucial to the balance between 
carbohydrate metabolism and fat metabolism. Under normal circumstances, acetyl-CoA 
generated from fatty acid metabolism feeds into the TCA cycle and is used for the cell’s energy 
supply. When circulating fatty acids accumulate to high levels, the generation of acetyl-CoA 
from fat catabolism surpasses the energy requirement of the cell. Then ketone bodies are 
produced from acetyl-CoA in the liver and released into blood. Acetyl-CoA and malonyl-CoA 
are precursors from which fatty acid is generated by fatty acid synthases. Fatty acid synthesis is 
an important part of the lipogenesis. One major role of fatty acid in animal metabolism is energy 
production by ATP synthesis; fatty acids also contribute to energy storage, phospholipid 
membrane formation and signaling pathways.  
1.4.5.5. Protein Acetylation 
      Cell signaling networks are regulated by reversible protein post-translational modifications. 
Reversible acetylation of ε-amino group on lysine was discovered on histones 50 years ago (168). 
This transfer of an acetyl group from acetyl-CoA to the ε-amino group neutralizes lysine’s 
positive charge which is a crucial step in gene regulation in the nucleus. Studies showed that 
histone acetylation is critical in regulating global chromatin architecture and gene transcription. 
It is also involved in DNA replication, repair and heterochromatin formation (169). In bacteria, 
acetylation serves as a central regulator that coordinate metabolism in response to changes in 
different carbon sources which are concurrent with changes in cell growth as well as metabolic 
flux (135). In S. enterica, 191 proteins were identified to be lysine-acetylated and about 90% 
enzymes of central metabolism were acetylated (170). In E. coli the number reached 349 (171). 
Metabolic enzymes are common targets for acetylation. The balance between 
55 
 
 
 
acetylation/deacetylation is affected by switching carbon sources (e.g., from glucose to citrate), 
growth phase, and availability of acetylphosphate (116-118). 
      In 1985, tubulin was described as the first acetylated cytoplasmic protein (86). Tubulin is the 
principal element of microtubules which are major components of cytoskeleton and internal 
structures of cilia and flagella. Proteomic studies identified hundreds of proteins which are 
acetylated on one or multiple lysine residues. The reversible lysine acetylation in many cellular 
and even viral proteins have been found to be involved in critical signaling processes controlling 
and coordinating cytoskeleton dynamics, intracellular trafficking, vesicle fusion, metabolism, 
and stress response (91, 104-107).  
1.4.6. HS-CoA-Related Diseases 
      CoA/CoA thioesters have important signaling functions, which may tightly regulate the 
function of ATP during injury (84). Imbalance of CoA and its thioester levels may cause 
significant inhibition of platelet aggregation. Malfunction of CoA molecules may also contribute 
to cardiovascular disorders through vasoconstriction (83). Increased Long chain acyl-CoA level 
has been observed in obese or Type 2 diabetic patients possibly due to the induction of rapid and 
potent opening of ATP-sensitive K+ channel causing glucose-stimulated insulin secretion (85). 
      Neurodegeneration with brain iron accumulation (NBIA) is a group of disorders 
characterized by iron accumulation in the brain. In 2001, it was discovered that pank2, the gene 
encoding CoA biosynthetic enzymes PANK, causes a subform of NBIA featured by dystonia, 
dysarthria and intellectual disabilities. After that, the disease was named PANK-associated 
neurodegeneration (PKAN). The influence of CoA level on protein acetylation and autophagy, 
the link between reduced histone and tubulin acetylation and neurodegeneration, and CoA as an 
56 
 
 
 
anti-apoptotic signaling molecule may all contribute to the pathogenesis of PANK and NBIA 
(172). 
1.5. Protein Targeting Mechanisms 
      In the crowded living cell environment, various mechanisms are applied to control and 
regulate targeting of the proteins for their proper functions at the right time and in the right 
subcellular location. Some proteins contain intrinsic signal sequences which are recognized by 
chaperones or bind transport proteins and are targeted to cellular membranes or secreted outside 
the cell. Some proteins are involved in protein-protein interactions which allow assembly and 
regulation of protein networks. Gene clustering and gene fusion are commonly employed for 
convenient targeting and interaction of functional related proteins. Cellular compartmentalization 
and enzyme encapsulation are utilized for high efficiency of metabolic processes.  
1.5.1. Target Recognition of the PDZ Domains 
      PDZ domain represents one of the most commonly found protein-protein interaction domains 
and is widely distributed in organisms from bacteria to plants and vertebrates. It is named after 
the three unrelated proteins, mammalian postsynaptic density protein PSD95, Drosophila disc 
large tumor suppressor DLG1, and mammalian tight junction protein zonular occludens-1 ZO1, 
from which it was first identified (173). Since most PDZ proteins have multiple copies of PDZ 
domains, they establish interactions with multiple proteins which is crucial for their functions in 
coordinating signaling complex formation and scaffolding for protein-protein interactions (174-
178). In bacteria, PDZ domains are involved in diverse functions as membrane integrity, 
sporulation, lipid biosynthesis, pheromone production as well as pathogenesis.  
      The basic structure of most identified PDZ domains is similar. PDZ domain is usually 80-90 
amino acid residues in length and contains 2 α-helices and 5-6 β-strands (174). This domain 
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contains a hydrophobic pocket formed by the β1-β2 loop and side chains from strand β2 and 
helix α2, which is highly conserved among PDZ family members (179). The interaction pocket 
on PDZ domain allows binding of target proteins with consensus sequence patterns. To date, four 
types of PDZ motifs which bind to PDZ domains have been identified, which are class I (S/T-x-
Φ), class II (Φ-x-Φ), class III (Ψ-x-Φ) and class IV (D-x-V), where x is any amino acid, Φ is a 
hydrophobic residue (V, I, L, A, G,W, C, M, F) and Ψ is a basic, hydrophilic residue (H, R, K) 
(180). These motifs are usually 4 amino acids long, but recent studies indicated longer sequences 
(up to C-terminal 12-mer on rabies virus glycoprotein and 13C-ter on phosphatase and tensin 
homolog) might be involved in binding stability (181, 182).  
      More recent studies on PDZ domains indicated that the binding specificity of PDZ domain 
not only involves binding to the carboxyl-terminus of various proteins, it also achieves greater 
versatility by PDZ-PDZ domain dimerization in a “head-to-tail” mode (Fig. 1.19). For example, 
the neuronal nitric oxide synthase (nNOS) PDZ domain contains a 30 amino acid C-terminal 
extension that forms a β-hairpin structure (β-finger) which docks in the peptide-binding sequence 
of PSD-95 PDZ domain, mimicking a free C-terminus (183). Alternatively, two PDZ domains 
from some protein like Na+/H+ exchanger regulatory factor (NHERF) or Glutamate receptor-
interacting protein (GRIP) engage in homodimerization, which leaves the peptide-binding pocket 
oriented in the opposite direction for dual binding and allows the PDZ domains simultaneously 
interact with multiple proteins to form a network (172, 184). By using gel-filtration and surface 
plasmon resonance (SPR), Zimmermann et al. (185) demonstrated the existence of direct 
interaction between an abundant plasma membrane lipid component phosphatidylinositol 4,5-
bisphosphate (PIP2) and a subset of PDZ domains. It was shown that this interaction is required 
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for plasma membrane targeting. Similar binding mechanisms were suggested and a systematic 
analysis will be critical to understanding the novel interactions.  
1.5.2. Protein Targeting to the Sec Complex  
      The Sec translocon is a well-studied protein transport system which is conserved in the 
cytoplasmic membrane of bacteria and archaea (187). The two main functions of the Sec 
translocon are to transport secretory protein across the inner membrane and to integrate 
membrane proteins into the inner membrane. Targeting of many proteins begins with the 
ribosome during translation. The Sec transport system cooperates with cytosolic protein partners 
including the signal recognition particle (SRP) and the SecA/SecB system to target inner 
membrane proteins co-translationally and secretory proteins post-translationally, respectively 
(188). 
1.5.2.1. Ribosome as Docking Site for Targeting 
      Secretory proteins transported through the Sec complex usually possess an N-terminal signal 
sequence which consist of three parts—a positively charged N-terminal region followed by a 
hydrophobic region and a polar C-terminal region. The signal sequences have conserved 
architecture but various primary sequences and length (189). There is usually a cleavage site for 
signal peptidases on C-terminus of the signal sequences. Most membrane proteins use their 
highly hydrophobic N-terminal short sequences (referred to as a signal anchor sequence) as 
signal for recognition instead (190, 191).  
      Proteins are synthesized at about 10-20 amino acids per second and within several seconds 
after translation is initiated, the N-terminal signal sequences will be exposed to the outside at the 
ribosomal exit tunnel (192). To avoid undesired interactions of these hydrophobic signal 
sequences, the ribosome engages specific molecules for early substrate recognition. Studies 
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indicated that the starting signal for downstream targeting could be the organization of a nascent 
polypeptide into secondary structures within the ribosomal tunnel (193, 194). Recently, it was 
shown that the structural differences of the nascent chain in the ribosome tunnel differentially 
affect the recruitment of SRP or Trigger Factor (TF) (194, 195). Both SRP and TF contact the 
conserved ribosomal protein L23 which is located close to the tunnel exit. L23 appears to act as a 
major docking site for interactions between the transport molecules and the newly synthesized 
polypeptides (196, 197).   
 
                  
Figure 1.19. Possible PDZ interaction modes. PDZ domain proteins are involved in at least four different types 
of interaction: recognition of C-terminal motifs in peptides, recognition of internal motifs in proteins, PDZ-
PDZ dimerization, and recognition of lipids (186). 
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1.5.2.2. SRP-Dependent Co-Translational Targeting of Inner Membrane Proteins 
      In E. coli, the SRP pathway is predominantly engaged in targeting of membrane proteins 
(198, 199). SRP consists of protein Fifty-Four Homologue (Ffh, named due to its homology to 
the eukaryotic SRP54 subunit) and 4.5S RNA, both required for targeting. Ffh possesses a 
methionine-rich M-domain for signal sequence binding and an NG-domain with GTPase activity 
for binding of the membrane-bound SRP receptor (SR). The highly hydrophobic M-domain with 
high methionine content is thought to provide structural plasticity to accommodate signal 
sequences of different lengths and compositions (200). The 4.5S RNA and the Ffh M-domain 
form a binding pocket for signal sequences on newly synthesized peptides. The RNA is also 
required for the formation of stable interaction complex between Ffh and SR by modulating GTP 
hydrolysis (201).  
      During the SRP cycle, E. coli SRP rapidly scans ribosomes and its binding to the ribosomal 
tunnel exit is stabilized when a signal anchor sequence is present (202). Then the complex of the 
signal sequence binding to the M-domain is targeted to the membrane where SRP and NG-
domains on SR build a pseudo-homodimer (203). GTP binding stabilizes the interaction between 
SPR and SR which initiates the transfer of signal sequence from SRP to the Sec complex. The 
Sec translocon controls the conformational changes in the SRP-SR complex and activates GTP 
hydrolysis which releases SRP back to the cytosol to start a new cycle (204, 205).  
      The core Sec translocon consists of a heterotrimeric protein complex SecYEG in bacteria. 
SecYE are essential for protein transport while SecG is not (187). SecY channel contains 10 α-
helical transmembrane (TM) domains which are divided into two halves connected by a 
periplasmic loop, together they form the aqueous protein transport domain. SecE is located at the 
back of SecY and functions to stabilize the two halves of SecY. The translocon assumes a closed 
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conformation in the resting state with the periplasmic side of the SecY channel blocked by a 
short α-helix. The translocation of preprotein displaces the plug α-helix and results in the open 
state. The SecYEG translocon opens laterally into the lipid bilayer to facilitate insertion of the 
newly synthesized membrane protein into the IM.  
1.5.2.3. SecA/SecB Pathway for Secretory Protein Targeting 
      Nascent secretory polypeptides are escorted by cytosolic chaperones, including trigger factor 
and tetrameric SecB to the membrane. SecB shows a high affinity for ATPase SecA and the 
binding of SecB to the C-terminus of SecA potentially transfer the preprotein to SecA, which 
binds to signal sequences on the polypeptides and drives translocation through the SecYEG 
channel by ATP hydrolysis (187, 206, 207). SecB was thought to dissociate from the complex 
when SecA binds to ATP (208). Classically it was suggested the binding between SecA and the 
signal sequence occurs after the preprotein is targeted to the membrane, though some data 
indicate that SecA can bind to ribosome-nascent peptides, meaning it can also act co-
translationally (209-211). After the preprotein is targeted to the translocon, the signal sequence is 
removed by the membrane-embedded signal peptidases and then degraded by membrane bound 
signal peptide peptidases. 
1.5.3. Protein Encapsulation into Encapsulin-a Bacterial Nanocompartment  
      Encapsulin is a small protein-based organelle and is present in many bacterial species and a 
species of archaea C. methanoregula. Encapsulin is constructed from 60 copies of identical 
monomers which self-assemble into an icosahedral structure with an inner diameter of 20 nm and 
an exterior diameter of 24 nm (212). Several studies reported that encapsulin can function as a 
compartment to encapsulate dye decolorizing peroxidase (DyP) and ferritin like protein (Flp), 
both are involved in oxidative stress responses (212, 213).  
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      DyP proteins are highly conservative across microbial species. Dyp homologues from 
encapsulin-associated genomes share a conserved C-terminal extension. The C-terminal 
extension also occurs in Flp homologues when associated with encapsulin. These highly 
conserved C-terminal extensions have varied lengths (30-40 amino acids for DyP homologues) 
with a high percentage of alanine, glycine and proline residues followed by a conserved anchor 
sequence (212). This specific sequence interacts with a hydrophobic binding pocket in the 
interior side of the protein cage and the binding interaction is proposed to direct the native DyP 
enzymes inside into the B. linens encapsulin (212). DyP from B. linens is assembled as a trimer 
of dimers inside the internal cavity of encapsulin. While Flp in T. maritima forms a pentamer of 
dimers arranged in a ring-like structure. Since the encapsulated Dyp and Flp are oligomers, they 
are likely to have multiple binding contacts with the interior of the encapsulin cage. These 
multiple interactions between the encapsulated enzymes and encapsulin may contribute to the 
higher binding avidity and specificity of the encapsulation. This docking sequence on C-terminus 
of encapsulin monomers have been shown to encapsulate teal fluorescent protein (TFP) into the 
encapsulin cage of B. linens (214). 
      Like ferritin, Flp also contains ferroxidase active site. The packaged Flp enzymes can oxidize 
the reactive ferrous ions which are retained in the encapsulin. The encapsulin could keep 
significant amount of iron due to its relative large inner volume compared to the size of ferritin 
(220 Å vs 80 Å) (212). The presence of Flp in anaerobic bacteria may protect these organisms 
from accidental exposure to oxygen and from the adverse effects of metabolically produced 
peroxide (215, 216). In pathogenic bacteria like Mycobacteria, the encapsulation of peroxidase 
within encapsulin provides resistance to the killing by oxidative burst in the host and promotes 
survival in the host monocytes (217). Besides segregating the intermediates generated during 
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enzymatic reactions, encapsulin may also protect the packaged enzymes. Encapsulins in T. 
maritima and B. linens have high structural stability at various temperatures and pH conditions, 
which may significantly increase the lifetime of the interior enzymes.  
1.5.4. Vault Ribonucleoprotein Particles 
      In mammals, certain molecular compartments are built exclusively from protein components. 
One example is the vault particle which is named for its morphology with multiple arches similar 
to cathedral ceilings. Vault ribonucleoprotein particles (RNP) are the largest cytoplasmic 
ribonucleoprotein structures with dimensions of 725 x 410 x 410 Å3 and are found in the 
cytoplasm of most eukaryotic cells (218). Vault consist of a thin (≈20 Å) hollow protein shell 
made of 96 copies of major vault protein (MVP) which encapsulates 2-4 copies of telomerase 
associated protein I (TEP1), around 12 copies of poly (ADP-ribose)-polymerase (VPARP), and 
8-16 copies of a small untranslated RNA. Vaults have been implicated in multidrug resistance, 
cellular signaling, and innate immunity, however, the relevant mechanisms remain elusive (219-
224).  
      The encapsulation of the VPARP into vault is mediated by the interactions between the 
minimal size interaction (M-INT) domain on the C-terminus of VPARP and the N-terminus of 
shell protein MVP (225). Electron microscopy studies showed that M-INT domain binds to the 
inside of recombinant vaults at both above and below the waist of the particle (226). It was 
demonstrated that the 162 amino acid INT domain on VPARP (VRARP residue 1563-1724) 
could be used to target heterologous proteins GFP and luciferase to the vault cavity (227). The 
INT could be reduced to 147 amino acids (VRARP residue 1563-1709) without notable defect in 
MVP binding (228). The possible INT binding site was mapped by NMR to MVP residues 113-
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221, which are the third and fourth repeat domains of MVP (229). The NMR analysis fits well 
with the binding site determined by an independent cryo-EM difference mapping.  
      A yeast two-hybrid assay indicated that TEP1 didn’t interact with MVP monomers (230). 
Another study carried out co-infection of baculoviruses expressing TEP1 and MVP produced 
vault-like particles and showed that TEP1 and MVP were co-purified (237). These studies 
suggested that TEP1 may be able to interact with intact vault particles but not the MVP 
monomers. Later, a series of experiments using a yeast three-hybrid system with a series of 
truncated TEP1 followed by co-infection of Sf9 insect cell cultures and purification of vault 
particles showed that the p80 region of TEP1 (amino acids 201-911) contains vault-interaction 
domains (231).  
1.6. Research Overview 
      Bacterial MCPs are widely distributed among diverse bacterial phyla and contribute to the 
optimization of metabolic pathways in bacteria. Over the years crystal studies of MCP shell 
proteins suggested a route of molecular transport through the narrow pores in the shell. While 
several recent studies provided evidence that large cofactors might be recycled inside of MCPs. 
Another fundamental question about MCPs is how enzymes are packaged into the lumen of 
MCPs. This work is to trying to tackle these questions by identifying a specific lumen enzyme 
PduL and investigating its specific role in cofactor recycling and the targeting mechanism which 
directs the enzyme into MCPs.  
      The first part of this thesis characterized PduL as a new class of PTAC enzyme by using 
biochemical and bacterial genetic methods. Genomic analysis and sequence alignment indicated 
PduL doesn’t have homology with known PTACs and is distinct in evolution. PduL was 
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identified to be involved in 1,2-PD metabolism by genetic tests. The substrate and product of 
PduL reaction were determined by HPLC, and the kinetic parameters were determined.  
      The second part of this study investigated the specific role of PduL associated with Pdu MCP 
and determined the short N-terminal targeting sequence on PduL. MCP purification followed by 
Western blots showed PduL is a MCP component. Genetic studies indicated that PduL located 
inside MCP has limited access to acetyl-CoA molecules in the cytosol, which caused growth 
defect correctable by breaking MCPs. These data suggested an internal recycling of coenzyme A 
in Pdu MCPs. Growth studies and immunoblots using pduL deletion mutants lacking N-terminus 
together with GFP fusion tests indicated PduL contains a short terminal targeting sequence. 
      The third part of this work explored protein-protein network within Pdu MCP. In vivo two-
hybrid tests plus in vitro affinity pull-downs followed by Western blotting suggested possible 
protein-protein interactions of L/BB’ and U/V. Our experiment results were consistent with PPIs 
predictions by use of computational models from our collaborating group.  
      Consistent with recent relevant research results, our studies in this thesis would expand the 
understanding of MCP functions and provide a reference for the future work.   
1.7. Thesis Organization 
      This dissertation consists of five chapters. Chapter one contains an introductory review of the 
history, structure, function, application of bacterial microcompartments and their contribution to 
enteric bacteria pathogenesis and the comparison between bacterial MCPs and viral capsid as 
well as coenzyme A including its biosynthesis, functions and relatedness to diseases. Chapter 
two is a paper which was published in the Journal of Bacteriology. Chapter 3 is a paper to be 
submitted to a journal. Chapter 4 includes preliminary results of certain protein-protein 
interactions of 1,2-propanediol utilization microcompartments, partial contents of this chapter 
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has been incorporated into a paper and submitted to the journal PLoS Computational Biology. 
Chapter 5 is a general concluding chapter, where the results and conclusions from the two papers 
and chapter 4 are summarized. All of the papers were written by me with the editorial guidance 
and assistance by my major professor, Dr. Thomas A. Bobik. 
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CHAPTER 2. PDUL IS AN EVOLUTIONARILY DISTINCT 
PHOSPHOTRANSACYLASE INVOLVED IN B12-DEPENDENT  
1,2-PROPANEDIOL DEGRADATION BY SALMONELLA  
ENTERICA SEROVAR TYPHIMURIUM LT2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter, in part or in full, is a reprint of the material as it appears in the Journal of 
Bacteriology (volume 189, pp. 1589-1596, 2007). 
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2.1. Abstract 
      Salmonella enterica degrades 1,2-propanediol (1,2-PD) in a coenzyme B12-dependent 
manner. Prior enzymatic assays of crude cell extracts indicated that a phosphotransacylase 
(PTAC) was needed for this process, but the enzyme involved was not identified. Here we show 
that the pduL gene encodes an evolutionarily distinct PTAC used for 1,2-PD degradation. 
Growth tests showed that pduL mutants were unable to ferment 1,2-PD and were also impaired 
for aerobic growth on this compound. Enzyme assays showed that cell extracts from a pduL 
mutant lacked measurable PTAC activity in a background that also carried a pta mutation (the 
pta gene was previously shown to encode a PTAC enzyme). Ectopic expression of pduL 
corrected the growth defects of pta mutant. PduL fused to 8 C-terminal histidine residues (PduL-
His8) was purified and its kinetic constants determined: Vmax = 51.7  7.6 µmol min-1 mg-1; and 
Km for propionyl-PO4
2- and acetyl-PO4
2- = 0.61 and 0.97 mM, respectively. Sequence analyses 
showed that PduL is unrelated in amino acid sequence to known PTAC enzymes and that PduL 
homologues are distributed among at least 49 bacterial species, but are absent from the Archaea 
and Eukarya.  
2.2. Introduction 
      A number of bacterial genera including Salmonella, Klebsiella, Shigella, Yersinia, Listeria, 
Lactobacillus and Lactococcus include members that grow on 1,2-propanediol (1,2-PD) in a 
coenzyme B12-dependent fashion. 1,2-PD is a major product of the fermentation of rhamnose and 
fucose which are common sugars in plant cell walls, bacterial exopolysaccharides and the 
glycoconjugates of intestinal epithelial cells.  Accordingly, the ability to degrade 1,2-PD is 
thought to provide a selective advantage in anaerobic environments such as the large intestines of 
higher animals, sediments and the depths of soils. Recent studies with Salmonella enterica have 
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shown that 1,2-PD degradation is one of the most complex metabolic processes known (22, 49, 
53, 70, 119, 126). The degradation of this small molecule requires catabolic enzymes, a system 
for recycling inactive cobalamins to coenzyme B12, and an unusual polyhedral body that is 
composed of metabolic enzymes encased within a multi-protein shell.  
      A pathway for 1,2-PD degradation by S. enterica has been proposed based on enzymatic 
studies of crude cell extracts and genetic analyses (90, 232). In the first step of the pathway, 1,2-
PD in converted to propionaldehyde via coenzyme B12-dependent diol dehydratase (233). 
Propionaldehyde is then converted to 1-propanol and propionic acid by a reaction series thought 
to involve 1-propanol dehydrogenase, coenzyme A (CoA)-dependent propionaldehyde 
dehydrogenase, phosphotransacylase (PTAC), and propionate kinase (90, 224).  This pathway 
generates one ATP, an electron sink, and a 3-carbon intermediate (propionyl-CoA), which feeds 
into central metabolism via the methylcitrate pathway (76).   
      The genes specifically required for 1,2-PD utilization (pdu) by S. enterica form a single 
contiguous cluster, the pdu locus. DNA sequence analyses indicate that this locus includes 23 
genes (22, 33, 51). Based on experimental and/or bioinformatics analyses, six pdu genes are 
thought to encode enzymes needed for the 1,2-PD degradative pathway (22); two are involved in 
transport and regulation (33, 54); two are probably involved in diol dehydratase reactivation (22); 
two are used for the conversion of vitamin B12 to coenzyme B12 (119, 126); four are of unknown 
function; and seven share similarity to genes involved in the formation of carboxysomes, a 
polyhedral body found in certain cyanobacteria and chemoautotrophs (22, 33). Although the 
methylcitrate pathway is required for growth of S. enterica on 1,2-PD a sole carbon source, the 
genes for this pathway map outside the pdu locus (76). 
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Figure 2.1. Model for 1,2-propanediol degradation by S. enterica. 1,2-propanediol (1,2-PD), coenzyme B12 
(AdoCbl), coenzyme B12-dependent diol dehydratase (PduCDE), propionaldehyde dehydrogenase (PduP), 
phosphotransacylase (PduL), propionate kinase (PduW), 1-propanol dehydrogenase (PduQ). The first two 
steps of 1,2-PD degradation (conversion of 1,2-PD to propionyl-CoA) are proposed to occur within a 
microcompartment. The dashed line indicates the shell of the MCP which is composed of up to seven different 
polypeptides. ATP is generated during the conversion of propionyl-PO4
2- to propionate.  Given a suitable 
terminal electron acceptor such as O2, propionyl-CoA is degraded via the methylcitrate pathway where 
biosynthetic precursors and additional energy are produced. Two additional enzymes associated with the 
polyhedral bodies (but not shown in the figure) are a putative diol dehydratase reactivase (PduGH) and an 
ATP:cob(I)alamin adenosyltransferase (PduO) involved in B12 recycling. 
 
      It was recently shown that S. enterica forms polyhedral bodies during growth on 1,2-PD (22, 
34, 70). These bodies are extremely large macromolecular complexes that are 100-150 nm in 
cross-section and consist of metabolic enzymes encased within a protein shell. Purification of 
these structures showed that they are composed of at least 14 different polypeptides 
(PduABB'CDEGHJKOPTU) (49). This includes 4 enzymes and as many as seven shell proteins 
all of which are encoded by the pdu locus. The first two steps of 1,2-PD degradation are thought 
to occur in the lumen of the PhBs and the remaining steps in the cytoplasm of the cell (Fig. 2.1) 
(49). The function of PhBs is uncertain. Prior studies suggest they act as microcompartments that 
sequester propionaldehyde (an intermediate of 1,2-PD degradation) in order to minimize toxicity 
and/or prevent carbon loss (49, 70, 234, 235). Interestingly, recent genomic analyses tentatively 
indicate seven functionally distinct polyhedral bodies distributed among over 40 genera of 
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bacteria (23). Thus, polyhedral bodies may be a general mechanism of metabolic organization in 
the Bacteria. 
      As described above, prior enzymatic analysis of crude cell extracts indicated that a PTAC is 
used for 1,2-PD degradation (90, 232). However, the enzyme involved was not identified. Here, 
we show that the pduL gene encodes a conserved, evolutionarily distinct PTAC that functions in 
1,2-PD degradation by S. enterica.      
2.3. Materials and Methods 
      Chemicals and reagents. Antibiotics, vitamin B12 and acetyl-PO42- were from Sigma 
Chemical Company (St. Louis, MO).  Propionyl-PO4
2- was synthesized as described (236). 
Isopropyl--D-thiogalactopyranoside (IPTG) was from Diagnostic Chemicals Limited 
(Charlottesville PEI, Canada). Restriction enzymes and T4 DNA ligase were from New England 
Biolabs (Beverly, MA). Coomassie Brilliant Blue R-250, EDTA, ethidium bromide, 2-
mercaptoethanol, and SDS were from Bio-Rad (Hercules, CA). Other chemicals were from 
Fisher Scientific (Pittsburgh, PA). 
      Bacterial strains, media, and growth conditions. The bacterial strains used in this study are 
listed in Table 2.1.  The rich medium used was Luria-Bertani/Lennox (LB) medium (Difco, 
Detroit, MI) (237). The minimal media used was no-carbon-E (NCE) medium containing 
supplements indicated in the text and figure legends (238, 239). MacConkey/1,2-PD indicator 
medium contained MacConkey agar base (Difco), 1% 1,2-PD and 200 ng ml-1 of vitamin B12. 
      General molecular methods. Agarose gel electrophoresis was performed as described 
previously (240). Plasmid DNA was purified by the alkaline lysis procedure (240) or by using 
Qiagen products (Qiagen, Chatsworth, CA) according to the manufacturer's instructions.  
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Following restriction digestion or PCR amplification, DNA was purified using Promega Wizard 
PCR Preps (Madison, WI) or Qiagen gel extraction kits. Restriction digests were carried out 
using standard protocols (240). For ligation of DNA fragments, T4 DNA ligase was used 
according to the manufacturer's directions. Electroporation was carried out as previously 
described (22). 
 
Table 2.1. Bacterial strains used in this study. 
 
Strain  Genotype Source 
 aS. enterica serovar Typhimurium LT2 
BE47      thr-480::Tn10dCam 
BE188  ∆pduL670 T.A.Bobik lab collection 
BE281  pta-406::Tn10 T.A.Bobik lab collection 
BE284  pduL670 /pLAC22-pduL (AmpR) T.A.Bobik lab collection 
BE285  pduL670 /pLAC22-no insert (AmpR) T.A.Bobik lab collection 
BE286  pLAC22-pduL (AmpR) T.A.Bobik lab collection 
BE287  pLAC22-no insert (AmpR) T.A.Bobik lab collection 
BE291  ∆pduL670, pta209::Tn10 T.A.Bobik lab collection 
BE527  pta209::Tn10 T.A.Bobik lab collection 
BE529  pta-209::Tn10 /pLAC22-no insert (AmpR) T.A.Bobik lab collection 
BE530  pta-209::Tn10 /pLAC22-pduL (AmpR) T.A.Bobik lab collection 
BE548  pta-209::Tn10 /pBE522-no insert (KanR) T.A.Bobik lab collection 
BE549  pta-209::Tn10 /pBE522-pta (KanR) T.A.Bobik lab collection 
                 E. coli BL21(DE3)RIL (E. coli B) F-ompT hsdS (rB-mB-) dcm+ Tetr gal 1 (DE3)  
                endA Hte (argU ileY leuW Camr) 
BE119  BL21 DE3 RIL/ bpTA925-no insert (Kanr) T.A.Bobik lab collection 
BE554  BL21 DE3 RIL/ pTA925-pduL-His8 This study 
S17.1pir  recA(RP4-2-Tc::Mu)pir T.A.Bobik lab collection 
 
aformerly S. typhimurium LT2 
bT7 expression vector containing a minimal clone for production of PduL-His8, Kan
r 
             
      Protein methods. Polyacrylamide gel electrophoresis (PAGE) was performed using Bio-Rad 
Redigels and Bio-Rad Mini-Protean II electrophoresis cells according to the manufacturer’s 
instructions. Following gel electrophoresis, Coomassie Brilliant Blue R-250 was used to stain 
proteins. The protein concentration of solutions was determined using Bio-Rad Protein Assay 
Reagent (Bio-Rad).  
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      P22 transduction. Transductional crosses were performed as described using P22 HT105/1 
int-210 (241), a mutant phage that has high transducing ability (242). Transductants were tested 
for phage contamination and sensitivity by streaking on green plates against P22 H5.                          
Construction of plasmids for production of PduL and PduL-His8. PCR was used to amplify 
the pduL coding sequence from template pMGS2 (70). The primers used for amplification were 
5’-GCCGCCAGATCTATGGATAAAGAGCTTCTGCAATCA-3’ and 5’-
GCCGCCAAGCTTATTATCGCGGGCCTACCAGCCG-3’. These PCR primers introduced 
BglII and HindIII restriction sites that were used for cloning into vector pLAC22 (243).  
Following ligation, clones were introduced into E coli DH5α by electroporation and 
transformants were selected by plating on LB agar supplemented with 100 g ml-1 ampicillin 
(Amp) (119). Pure cultures were prepared from selected transformants. The presence of insert 
DNA was verified by restriction analysis or PCR, and the DNA sequence of selected pduL clones 
was determined. Clones having the expected DNA sequence were used for further study. 
      A similar procedure was used to clone PduL fused to eight C-terminal histidine residues 
(PduL-His8) with the following differences. The primers used for PCR amplification were 5'-
GCCGCCAGATCTATGGATAAAGAGCTTCTGCAATCA-3' and 5'-
GCCGCCAAGCTTATTAATGATGATGATGATGATGATGATGTCGCGGGCCTACCAGCC
G-3.  The PCR product was ligated to T7 expression vector pTA925 (119). Transformation was 
done by electroporation and LB plates supplemented with 25 µg ml-1 kanamycin (Kan) were 
used to select for transformants. 
      Growth of the PduL-His8 production strain.  A T7 expression plasmid (pTA925) was used 
for production of PduL-His8. The host used for protein expression was E. coli BL21DE3 RIL 
(Stratagene). This strain expresses T7 RNA polymerase as well as rare tRNAs for arginine, 
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isoleucine and leucine. Expression and control strains (BE554 and BE119) were grown in 400 ml 
LB broth containing 25 g/ml Kan and 10 µg/ml chloramphenicol. Cultures were incubated at 15 
C with shaking at 275 rpm in a 1 liter baffled Erlenmeyer flask. Cells were grown to an optical 
density of 0.6-0.8 at 600 nm and protein expression was induced by the addition of 1 mM IPTG. 
Cells were incubated for an additional 16 hours, and harvested by centrifugation at 8,000 x g for 
10 minutes and at 4 C using a Beckman JA-10 rotor and Avanti J-25 centrifuge.   
      Purification of PduL-His8. The PduL-His8 production strain (BE554) was grown as 
described above. One gram of cells (wet weight) was suspended in 3 ml of buffer containing 50 
mM Tris-HCl, pH 7.2, 200 mM (NH4)2SO4 and 0.4 mM AEBSF. Cells were broken using a 
French pressure cell at 20,000 psi, and the resulting cell extract was centrifuged at 20,000 x g 
using a Beckman JA-17 rotor.  The supernatant fraction was filtered through a 0.45 µm syringe 
filter.  A chromatography column containing 1 ml of Ni-NTA resin (Qiagen) was equilibrated 
with 5 ml of buffer A: 50 mM Tri-HCl, pH 7.7, 25 mM KCl, 300 mM NaCl, 200 mM (NH4)2SO4 
10 mM imidazole and 5 mM 2-mercaptoethanol. Filtered cell extract (2.5 ml, about 50 mg 
protein) was applied to the column. The column was washed with 15 ml of buffer A 
supplemented with 10% glycerol and 80 mM imidazole. The column was eluted with 10 ml of 
buffer A (in two of 5 ml steps) supplemented with 10% glycerol and 400 mM imidazole.  
      Preparation of cell extracts of S. enterica.  Cells were grown under conditions that induce 
the pdu operon (54). Cell paste was suspended in 25 mM Tris-HCl, pH 7.2 containing 0.4 mM 
protease inhibitor 4-(2-Aminoethyl)benzenesulfonylfluoride.HCl (AEBSF) (3 ml of buffer per 
gram cells wet weight). Cells were broken using a French pressure cell (Thermo Electron Corp., 
Waltham, MA) at 20,000 psi.  
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      PTAC assays. PTAC assays measured the conversion of acyl-PO4
2- + HS-CoA to acyl-CoA, 
and were performed as described (244). Standard assays contained 50 mM Tris-HCl, pH 7.2, 20 
mM KCl, 0.2 mM HS-CoA, and 1 mM acyl-PO4
2- in a total volume of 1 ml. For kinetic studies, 
the concentrations of certain assay components were varied as indicated in the text. Activity was 
determined by following absorbance at 232 nm over time and by using E232 = 5.5 mM
-1 cm-1 for 
calculations.  
      Construction of a nonpolar PduL deletion.  Bases 22 to 612 of the pduL coding sequence 
were deleted via a PCR-based method (245). The deletion was designed to leave all predicted 
translational start and stop signals of pdu genes intact. The following primers were used for PCR 
amplification of the flanking regions of the pduL gene:  primer 1, 5’-
GCTCTAGAGCCGAAATCAGCCTAATCGATGGCG-3’; primer 2, 5’-
CGTTCATCGCGGGCCTACCAGCCGATCCATTACGCTTCACCTCGC-3’; primer 3, 5’-
CGGCTGGTAGGCCCGCGATGAACG-3’; and primer 4, 5’-
CGAGCTCGCCAGATGCATGATTTACTC-3’.  Primers 1 and 2 were used to amplify a 498 
base-pair region upstream of the pduL gene, and primers 3 and 4 were used to amplify 527 bases 
downstream of pduL gene. The upstream and downstream amplification products were purified 
then fused by a PCR reaction that included 1 ng/µl of each product and primers 1 and 4.  The 
fused product was digested with XbaI and SacI (these sites were designed into primers 1 and 4, 
respectively), and ligated to suicide vector pCVD442 that had been similarly digested. The 
ligation mixture was used to transform E. coli S17.1 by electroporation and transformants were 
selected on LB medium supplemented with Amp (100g/ml). Six transformants were screened 
by restriction analysis and all released an insert of the expected size (1058 bp). One of these 
transformants was used to introduce the pduL deletion into the S. enterica chromosome using the 
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procedure of Miller and Mekelanos (245) with the following modification. For the conjugation 
step, strain BE47 was used as the recipient and exconjugants were selected by plating on LB agar 
supplemented with Amp (100 g/ml) and chloramphenicol (20 g/ml). Deletion of the pduL 
coding sequence was verified by PCR using chromosomal DNA as a template. Lastly, the thr-
480 dCAM insertion used for selection of exconjugants was "crossed-off" by P22 transduction 
using a phage lysate prepared with the wild-type strain and by selecting for prototrophy on NCE 
glucose minimal medium. 
      Aerobic growth curves. Growth media are described in the figure legends. For strains 
carrying pLAC22, media were also supplemented with 100 g/ml Amp and 0.2 mM IPTG. To 
prepare the inoculum, LB cultures (2 ml) were incubated overnight at 37 C, and then cells were 
collected by centrifugation and resuspended in growth curve medium. Media were inoculated to 
a density of 0.15 AU and growth was followed by measuring optical density at 600 nm using a 
BioTek Synergy microplate reader as follows: 48-well flat bottom plates (Falcon); 0.5 ml of 
growth medium per well, 37 C; and shaking set a level 4. A relatively low volume of growth 
medium (0.5 ml) in a 48-well microplate was necessary for adequate aeration and controls 
showed that growth under these conditions was similar to growth in shake flasks (data not 
shown). 
      Anaerobic growth curves. A procedure similar to that for aerobic growth curves was used 
to measure the fermentation of 1,2-PD, but with the following differences. Cultures were 
inoculated to an initial density of 0.1 AU. Microplates were sealed with polyolefin membranes 
(Fisher Scientific) inside an anaerobic growth chamber (Coy Laboratory Products, Grass Lake, 
MI). To monitor whether anaerobic conditions were maintained within the microplate, NCE 
glycerol minimal medium was added to several wells and inoculated with wild-type S. enterica. 
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S. enterica cannot ferment glycerol; therefore, growth on glycerol would indicate the presence of 
oxygen. For the experiments described in this study, no growth was observed in wells containing 
glycerol minimal medium indicating that the headspace contained minimal amounts of oxygen 
(data not shown). 
      DNA sequencing and analysis.  DNA sequencing was carried out at the Iowa State 
University (ISU) DNA Facility using Applied Biosystems Inc. automated sequencing equipment. 
The template for DNA sequencing was plasmid DNA purified using Qiagen 100 tips or Qiagen 
mini-prep kits. BLAST software was used for sequence similarity searching (246). 
      High-pressure liquid chromatography (HPLC). A Microsorb C18 column (150 x 4.6 mm) 
was used with a Varian ProStar system that included a model 230 solvent delivery module, a 
model 430 autosampler and a model 325 UV-Vis detector (Varian, Palo Alto, CA). Buffer A and 
B contained 10 mM NH4 formate pH 4.6 and 10% or 90% methanol, respectively. The flow rate 
was 1 ml min-1 and the buffer composition was varied as follows: (minute:%B), 0:0, 5:0, 17:100, 
22:100, 23:0, 28:0.  
      HPLC electrospray ionization mass spectrometry (HPLC-ESI-MS). An Agilent ion trap 
model 1100 mass spectrometer (Agilent, Palo Alto, CA) was operated in the positive mode. The 
ion source parameters were optimized for the formation of [M + H]+ ions with source 
temperature of 310 C, capillary voltage of 3.2 kV, and cone voltage of 25 V. Nitrogen was used 
as the nebulizing gas and as the drying gas at flow rates of 15 and 400 L h-1, respectively. 
2.4. Results 
      The pta gene is nonessential for 1,2-PD degradation. Prior biochemical studies indicated 
that PTAC was needed for 1,2-PD degradation by S. enterica (90, 232). In the proposed 
biochemical pathway, this enzyme catalyzed the conversion of propionyl-CoA to propionyl-
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phosphate (transfer of a 3-carbon acyl-group) (Fig. 2.1). An enzyme with homology to known 
PTAC enzymes is not encoded by the pdu locus (22). However, S. enterica produces a 
phosphotransacetylase (Pta) encoded by the pta gene which maps outside the pdu operon at 
centisome 50 (247). Pta is used for growth on acetate and inositol and plays a key role in the 
interconversion of acetyl-CoA and acetyl-PO4
2- (transfer of a 2-carbon acyl-group) (247). In 
vitro, Pta not only mediates the interconversion of acetyl-CoA and acetyl-phosphate, it also 
catalyzes the interconversion propionyl-CoA and propionyl-PO4
2- (247, 248). This raised the 
question of whether pta plays a role in 1,2-PD degradation. Two independent pta mutants 
(BE281 and BE527) were examined for growth on 1,2-PD. Aerobically, both grew slightly faster 
than wild-type S. enterica. The doubling times for the wild-type were typically 7.5-8.5 h and 
those for the pta mutants were 6-7 h. Both pta mutants were reconstructed via P22 transduction 
to assure that they were isogenic with the wild-type and both still exhibited a small increase in 
growth rate on 1,2-PD (not shown). These results confirmed prior studies which showed that pta 
is nonessential for aerobic growth of S. enterica on 1,2-PD minimal medium (249).  
      Similarly, pta was unnecessary for the fermentation of 1,2-PD. Strains with pta mutations 
and wild-type S. enterica both had doubling times of 5-6 h during 1,2-PD fermentation. 
Phenotypic test showed that the pta mutants used in the above studies were impaired for grow on 
acetate or inositol minimal medium and lacked detectable pta activity in cell extracts as is 
expected for pta mutants (247). In addition, the growth defects on acetate and inositol were 
corrected by a pta minimal clone and the chromosomal location of both pta insertions was 
verified by PCR (data not shown). Hence, we conclude that the pta gene is nonessential for B12-
dependent 1,2-PD degradation under either aerobic or anaerobic growth conditions.  
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      Strains with pduL mutations produce less propionic acid on MacConkey/1,2-
propanediol indicator medium. The finding that the pta gene was unnecessary for 1,2-PD 
degradation suggested that S. enterica expresses an additional PTAC that is sufficient to mediate 
this process. As part of ongoing studies of 1,2-PD degradation by S. enterica, we constructed a 
series of precise pdu deletion mutations using PCR-based methods (245, 250). Tests with 
MacConkey/1,2-PD medium (251) indicated that three independent pduL deletion mutants each 
produced less propionic acid from 1,2-PD than did wild-type S. enterica. The enzymes that 
convert 1,2-PD to propionic acid were proposed to include coenzyme B12-dependent diol 
dehydratase, propionaldehyde dehydrogenase, propionate kinase and PTAC (Fig. 2.1) (90, 232). 
Of these, only the gene for the PTAC was unidentified (51, 53, 249). Hence, these results 
tentatively suggested that the pduL gene encodes a PTAC enzyme. 
      Enzyme assays indicate that pduL encodes a PTAC enzyme. Wild-type S. enterica, as 
well as pduL and pta null mutants were grown under conditions that induce the pdu operon (54). 
Cell extracts were prepared and PTAC activity was measured using an assay that follows the 
conversion of acyl-phosphate + HS-CoA to acyl-CoA and inorganic phosphate (the reverse 
reaction with respect to 1,2-PD degradation). Both propionyl-PO4
2- and acetyl-PO4
2- were used as 
substrates. Cell extract from the wild-type strain had 8.9 µmol min-1 mg-1 PTAC activity with 
propionyl-PO4
2- (Table 2.2). Extracts from pta or pduL mutants had partial activity (6.0 and 2.6 
µmol min-1 mg-1, respectively) (Table 2.2). PTAC activity was undetectable in cell extracts from 
the double mutant (pta pduL). The simplest interpretation of these results is that pduL and pta 
each encode PTAC enzymes which was previously shown for pta (247). Furthermore, the pta 
pduL double mutant lacked detectable PTAC activity demonstrating that the activity in Pta- 
PduL+ cell extracts required PduL. 
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Table 2.2. Phosphotransacylase activity in cell extracts from selected strains of S. enterica. 
aPTAC activity (µmol min-1 mg-1) 
Relevant genotype propionyl-PO4
2- acetyl-PO4
2- bpropionyl-PO4
2- preference 
wild type (PduL+ Pta+)          8.9       3.5 2.5 
BE188 (PduL- Pta+)          2.6       3.2 0.8 
BE527 (PduL+ Pta-)          6.0       0.4                    15.0 
BE291 (PduL- Pta-)         ND      ND - 
 
aPTAC assays contained .2mM HS-CoA and 1mM propionyl-PO4
2- or acetyl-PO4
2- and assay buffer. Activity 
was determined by following the absorbance of reactions at 232 nm. 
bPropionyl- PO4
2- preference = (activity with propionyl-PO4
2-)/(activity with acetyl-PO4
2-) 
cND none detected (the lower detection limit of the assay is estimated to be 0.03umol min-1 mg-1). 
Cells were grown on NCE succinate minimal medium supplemented with 1,2-PD to ensure induction of the 
pdu operon. 
      
      Enzyme assays also showed that the PTAC in Pta- PduL+ cell extracts was 15-fold more 
active with propionyl-PO4
2- compared to acetyl-PO4
2- (6 µmol min-1 mg-1 compared to 0.4 µmol 
min-1 mg-1) (Table 2.2). This is consistent with a role for PduL in 1,2-PD degradation. On the 
other hand, the PTAC activity in Pta+ PduL- cell extracts was 1.6-fold more active with acetyl-
PO4
2- consistent with the role of Pta in acetyl-group metabolism (247).  
      For the above enzyme assays, controls showed that detectable PTAC activity required acyl-
phosphate and HS-CoA, and in all cases PTAC activity was linear with enzyme concentration 
(data not shown).  
      PduL mutants are impaired for aerobic growth on 1,2-PD. Compared to wild-type S. 
enterica, a pduL mutant (BE188) was impaired for aerobic growth on 1,2-PD (Fig. 2.2A). The 
doubling time for S. enterica was 7.9  0.5 h and that of a pduL mutant was 12.6  0.6 h. Further 
impairment of growth was not seen in the pduL pta double mutant even though this mutant 
lacked measurable PTAC activity (data not shown). These findings are consistent with the idea 
that PduL is a PTAC involved in 1,2-PD degradation. Aerobically, growth on 1,2-PD is expected 
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to proceed in the absence of PTAC since propionyl-CoA (which is formed prior to the PTAC 
reaction) can be metabolized via the methylcitrate pathway (Fig. 2.1) (76). The observed growth 
impairment of the pduL mutant was likely due to reduced ATP synthesis resulting from a block 
in the oxidative branch of the 1,2-PD degradative pathway although other explanations cannot be 
ruled out. 
      pduL mutants are unable to obtain energy from 1,2-PD under fermentative conditions. 
In the absence of an exogenous electron acceptor, the methylcitrate pathway is inoperative, and S. 
enterica is unable to grow on 1,2-PD as a sole carbon source (48).  Under these conditions, S. 
enterica converts 1,2-PD to 1-propanol and propionate (Fig. 2.1). This stimulates growth on 
minimal medium supplemented with a small amount of yeast extract by providing a source of 
ATP (48).  The production of ATP via the conversion of 1,2-PD to propionate is expected to 
require PTAC (Fig 2.1). Therefore, we tested the effect of a pduL mutation on this process. The 
doubling times of wild-type S. enterica in the presence and absence of 1,2-PD under 
fermentative conditions were 5.5  0.35 h and 10.7  0.29 h, respectively (Fig. 2.2B); the 
fermentation of 1,2-PD stimulated the growth rate about 2-fold which is consistent with previous 
studies (48). The doubling times of the pduL mutant (BE188) under fermentative conditions in 
the presence and absence of 1,2-PD were 13.1  1.0 and 13.3  0.95 h, respectively.  This 
indicated that energy production via 1,2-PD fermentation was completely eliminated by the pduL 
mutation. This is consistent with a role for PduL in 1,2-PD degradation.  
      The pduL mutant used in the above studies contained a wild-type pta gene indicating that Pta 
did not substitute for PduL under the conditions used to measure the 1,2-PD fermentation. 
Furthermore, a pta null mutation (alone or in combination with a pduL null mutation) did not 
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affect the fermentation of 1,2-PD (data not shown). These results indicate that the Pta enzyme is 
insufficient to support the fermentation of 1,2-PD and that PduL is required.   
     
          
Figure 2.2. Growth a pduL null mutant on 1,2-PD. A. Aerobic growth of wild-type S. enterica and a pduL 
mutant (BE188) on 1,2-PD minimal medium. B. Fermentation of 1,2-PD. BE188 carries a precise deletion of 
the pduL gene made by a PCR-based method. The observed growth defects of the BE188 were corrected by a 
pduL minimal clone. Each growth curve was performed 3 times in quadruplicate. Representative curves are 
shown. Log phase doubling times with standard deviations are given in the text. The aerobic growth medium 
was NCE supplemented with 52 mM 1,2-PD, 200 ng ml-1 vitamin B12 and 0.3 mM valine, isoleucine, leucine 
and threonine. The fermentation medium was NCE supplemented with 52 mM 1,2-PD, 200 ng ml-1 vitamin 
B12 and 0.2% yeast extract. The inoculation and incubation procedures are described in materials and methods. 
 
      The observed phenotypes of a pduL mutant are complemented by a pduL minimal clone.  
Growth tests showed that the aerobic and anaerobic growth phenotypes described above for a 
pduL mutant (BE188) were fully corrected by expression of a pduL minimal clone using a tightly 
regulated expression vector, pLAC22. Under aerobic conditions, the doubling times BE287 
(wild-type S. enterica/pLAC22-no insert) and BE286 (wild-type S. enterica/pLAC22-pduL) were 
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5.4  0.12 h compared to 6.0  0.32 h, respectively. The doubling times for strains for BE285 
(pduL/pLAC22-no insert) and BE284 (pduL/pLAC22-pduL) were 8.2  0.71 and 5.5  0.25 h, 
respectively. Under anaerobic conditions, the doubling times S. enterica/pLAC22-no insert, S. 
enterica/pLAC22-pduL, pduL/pLAC22-no insert and pduL/pLAC22-pduL were 5.0  0.22, 5.2  
0.37, 11.1  0.19, and 5.3  0.40 respectively. Thus, under aerobic and anaerobic conditions, a 
pduL minimal clone complemented the growth defect to the pduL mutation. On the other hand, 
vector without insert did not correct the observed growth defects of the pduL mutant. These 
results show that observed phenotypes of pduL mutant (BE188) resulted from the deletion of the 
pduL gene, but not from polarity or a mutation acquired during strain construction.  
            
                                 
 
 
 
 
 
 
 
Figure 2.3. Ectopic expression of a pduL minimal clone corrects the growth defect of a pta mutant on acetate 
minimal medium.  S. enterica harboring expression vector pLAC22 without insert (control), a pta mutant 
carrying pLAC22 without insert (Pta-/no insert), a pta mutant harboring a pduL minimal clone in pLAC22 
(Pta-/pduL). The relevant strain numbers are BE287, BE529 and BE530 (Table 2.1). Controls showed that 
pLAC22 with or without the pduL insert did not observably affect the growth of the wild-type strain on acetate 
minimal (data not shown). In addition, the growth defect of the pta mutant was fully corrected by a pta 
minimal clone showing that the effects of this mutation were not due to polarity (data not shown). The growth 
medium was NCE supplemented with 0.2% Na acetate, and 0.2 mM IPTG. Each growth study was performed 
twice in quadruplicate. Representative curves are shown. Log phase doubling times with standard deviations 
are given in the text. 
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      PduL substitutes for Pta in vivo during acetate utilization. Growth tests were performed 
to determine whether PduL could substitute for Pta in vivo.  Prior studies showed that pta 
mutants grow very slowly on minimal medium with >30 mM acetate (247). Here we show that 
ectopic expression of PduL corrects this defect (Fig. 2.3). The doubling times of the Pta+ strain 
and the pta mutant on acetate minimal medium were 4.4  0.41 h and 28.6  1.4 h, respectively. 
The doubling time of a pta mutant producing PduL from expression vector pLAC22 was 3.7  
0.1 h which was slightly faster than the control (4.4  0.41 h). Hence, ectopic expression of pduL 
fully corrected the growth defect of the pta mutant on acetate minimal medium. Since Pta is a 
well-studied PTAC enzyme, this finding indicates that PduL also has PTAC activity.   
      Propionyl-CoA is a product of the PduL reaction. The finding that HS-CoA was required 
for PduL activity (see above) indicated that an acyl-CoA was formed in assay mixtures. 
Moreover, the PTAC assay used to measure PduL activity followed absorbance at 232 nm which 
monitors the formation of thioester bonds (252). To confirm that an acyl-CoA was formed in 
PduL enzyme assays, HPLC and HPLC-mass spectrometry were performed. Assays containing 
cell extract from BE527 (Pta- PduL+) or BE291 (Pta- PduL-), HS-CoA, propionyl-PO4
2- and 
standard components; therefore, propionyl-CoA was the expected acyl-CoA product. Reverse-
phase HPLC with UV detection at 260 nm was used to identify CoA compounds present in 
reaction mixtures. A single major compound with a retention time of 10.9 min was detected 
when Pta- PduL+ cell extracts were used. This compound co-eluted with authentic propionyl-
CoA following co-injection and produced a mass spectrum characteristic of propionyl-CoA via 
HPLC-ESI-MS (Fig. 2.4). The major peaks for authentic propionyl-CoA and the PduL reaction 
product that eluted at 10.9 min were at m/z = 824.1 or 824.2, respectively. These peaks 
correspond to [M + H]+ for propionyl-CoA. In contrast, propionyl-CoA was undetectable by 
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HPLC in assay mixtures containing cell extract from BE291 (Pta- PduL-) and the major HPLC 
peak observed corresponded to HS-CoA (retention time = 4.5 min). Our interpretation of the 
above results is that propionyl-CoA is a product of the PduL reaction. 
 
                                           
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4. Propionyl-CoA is produced by the PduL reaction. A. HPLC-ESI-MS of propionyl-CoA standard. B. 
HPLC-ESI-MS of a PduL assay after 10 min. incubation at 30 C. The assay initially contained 10 µg cell 
extract from BE527 (Pta- PduL+), 0.4 mM HS-CoA, 1 mM propionyl-PO4
2- and buffer.  
       
      Production of PduL-His8 protein.  E. coli strain BE554 was constructed to produce high 
levels of recombinant PduL fused to 8 C-terminal histidine residues (PduL-His8). Protein 
expression by BE 554 and a control strain (BE119) were examined by SDS-PAGE (not shown) 
and enzyme assay.  Relatively high amounts of a protein with a molecular mass near 27 kDa 
were present in the inclusion body fraction from the pduL expression strain, which is near the 
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predicted molecular mass for PduL-His8 (24 kDa). However, a modest amount of soluble protein 
near this mass was produced. 
      To better assess the production of PduL-His8, cell extracts were tested for PTAC activity. 
Soluble extracts from the PduL production strain typically contained about 50 mol min-1 mg-1 
activity whereas the control strain produced only 2 mol min-1 mg-1 PTAC activity. Hence, a 
reasonable amount of PduL-His8 appeared to be soluble and active under the production 
conditions used. On the other hand, although the inclusion body fraction from the expression 
strain contained high amounts of PduL-His8 protein, the PTAC activity of this fraction was 
typically about 2-fold lower than that of the soluble fraction indicating that most of the PduL in 
this fraction was inactive. No PTAC activity was detected in the inclusion body fraction from the 
control strain. The PTAC assay used measured the conversion of propionyl-PO4
2- and HS-CoA 
to propionyl-CoA and HPO4
2-. No activity could be detected when enzyme, HS-CoA or 
propionyl-PO4
2- was omitted from the assay mixture. In each case, PTAC activity was linear with 
enzyme concentration (data not shown).  
 
Table 2.3. Kinetic constants for purified recombinant PduL-His8
a. 
Substrate Km  
(mM) 
Vmax 
(µmol min-1 mg-1) 
           Kcat  
(sec-1) 
        Kcat/Km 
(mM-1 sec-1 ) 
propionyl-PO4
2- 0.61  0.06 51.7  7.6 20.7 33.9 
acetyl-PO4
2- 0.97  0.26 13.4  1.8 5.4 5.6 
 
aPTAC assays were performed by following the absorbance of reaction mixtures at 232 nm as described in 
material and methods. The kinetic constants for propionyl-PO4
2- and acetyl-PO4
2- were determined using an 
excess of HS-CoA (0.4 mM). 
 
      Purification and kinetic characterization of PduL-His8. PduL-His8 was purified from cell 
extracts of strain BE554 by nickel-affinity chromatography (Fig. 2.5). Purified PduL-His8 
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appeared homogenous following SDS-PAGE and staining Coomassie blue (Fig. 2.5). Kinetic 
analysis showed that purified PduL-His8 was 3.8-fold more active with propionyl-PO4
2- 
compared to acetyl-PO4
2- (Vmax = 51.7 and 13.5 µmol min
-1 mg-1, respectively) (Table 2.3). It 
also had a lower Km for propionyl-PO4
2- than for acetyl-PO4
2- (0.61  0.06 versus 0.97  0.26 
mM). No activity was detected when PduL-His8, HS-CoA or propionyl-PO4
2- (or acetyl-PO4
2-) 
was omitted from the assay mixture. In each case, the activity of PduL-His8 activity was linear 
with enzyme concentration (data not shown). 
 
                                   
 
 
 
 
 
Figure 2.5. SDS-PAGE analysis of PduL-His8 purification.  Lane 1, molecular mass markers; lanes 2, soluble 
crude extracts from the PduL-His8 production strain (BE554) (10 µg protein); lanes 3, fraction obtained from 
the first elution step using buffer with 400 mM imidazole (2 µg protein); lane 4, fraction obtained from the 
second elution step using buffer with 400 mM imidazole (2 µg protein).  A 12% acrylamide gel was stained 
with Coomassie Brilliant Blue R250. 
 
      For PduL-His8, crude cell extracts typically had PTAC activity of about 50 µmol min
-1 mg-1. 
Nickel-affinity chromatography yielded purified enzyme with specific activities of about 45-55 
µmol min-1 mg-1.  Visual inspection of SDS-PAGE gels indicated that PduL-His8 comprised 
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about 2-5% of the total cell protein (Fig. 2.5); hence, these results suggest that PduL-His8 lost 
activity during the course of purification. Indeed, PduL-His8 was unstable in the purified form 
and lost about 50% of its activity 48 h after purification. The reported kinetic constants are based 
on assays done as soon as possible after purification. As the activity of PduL-His8 decreased, its 
Km for HS-CoA and propionyl-PO4
2- remained unchanged within experimental error. Its activity 
with propionyl-PO4
2- and acetyl-PO4
2- decreased in direct proportion. We infer that the Km 
values reported here are representative, but the Vmax values are probably an underestimate.   
2.5. Discussion 
      Here we presented genetic and biochemical evidence that the pduL gene encodes a PTAC 
involved in 1,2-PD degradation. Growth tests showed that a pduL mutant was impaired for 1,2-
PD degradation under aerobic and anaerobic conditions indicating a role for pduL in 1,2-PD 
degradation. Growth studies also showed that ectopic expression of PduL corrected the growth 
defect of a pta mutant on acetate minimal medium indicating that PduL has 
phosphotransacetylase activity in vivo. Enzyme assays of crude cell extracts demonstrated that 
pduL was necessary for the production of detectable PTAC activity in a genetic background that 
contained a pta mutation. HPLC-ESI-MS showed that propionyl-CoA was produced from 
propionyl-PO4
2- and HS-CoA in PduL enzyme assays. PduL-His8 was purified and found to have 
a specific activity of 57.4 µmol min-1 mg-1 with propionyl-PO4
2- as substrate indicating the PduL 
is sufficient for PTAC activity.  Thus, genetic and biochemical studies indicate that PduL is a 
PTAC involved in 1,2-PD degradation. 
      Blast and PSI-Blast analyses (5 iterations) showed that PduL lacks significant similarity to 
known PTAC enzymes. Thus, PduL is evolutionarily distinct. It either evolved independently of 
known PTAC enzymes or it became highly divergent from them over time. Sequence analyses 
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also showed that PduL homologues (expect <7x10-30) are found in 49/337 (14.5%) complete 
microbial genomes present in GenBank. No homologues of PduL were found among the Archaea 
or Eukarya. Hence, PduL is apparently a conserved protein specific to the Bacteria. In addition, 
Blast analyses identified 4 PduL homologues that are fused to sequences with homology to 
acetate kinases. These may be dual function enzymes that convert acyl-CoA to its corresponding 
organic acid with the synthesis of ATP. 
      Including PduL, there are three known classes of phosphotransacylases. The S. enterica PduL, 
Pta, and EutD enzymes are representatives of these classes. PduL is comprised of 210 amino 
acids while Pta and EutD are 714 and 338 amino acids in length, respectively (234). EutD and 
the C-terminal region of Pta are homologous. PduL lacks significant similarity to EutD and Pta. 
The N-terminal region of Pta contains BioD-like and "DRTGG" domains. These two domains 
are absent from EutD and PduL. The physiological role of these domains is uncertain. In enterica 
bacteria, acetyl-group metabolism and is linked to two-component signal transduction systems 
and DNA damage and repair in a complex manner (254-256). The N-terminal domains of Pta 
may be needed to accommodate expanded physiological roles. 
      Kinetic studies were performed with purified PduL-His8 (Table 2.3). The Vmax of PduL with 
propionyl-PO4
2- as substrate was 51.7  7.6 µmol min-1 mg-1. Previously purified Pta enzymes 
were reported to have specific activities between 32 and 9006 µmol min-1 mg-1 when an acyl-
PO4
2- was used as substrate (257). The activity of PduL-His8 is at the low end of this range, but 
may be an underestimate due to its instability (see results section). 
      The Km values of PduL-His8 for HS-CoA and propionyl-PO4
2- were determined to be 0.61  
0.06 and 0.032  0.006 mM, respectively. Reported Km values of Pta homologues for HS-CoA 
range from 0.03 to 1.7 mM and for acetyl-PO4
2- range from 0.024 to 4.7 mM (257). Thus, Km 
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values of PduL for HS-CoA and propionyl-PO4
2- appear to be within a physiologically 
meaningful range. Kinetic studies found that Kcat/Km of Pdu-His8 was about 6-fold higher for 
propionyl-PO4
2- compared to acetyl-PO4
2-. The selectivity of PduL for propionyl-PO4
2- is 
consistent with a role in 1,2-PD degradation. Furthermore, its relatively low activity with acetyl-
PO4
2- may be important to minimize perturbation of acetyl-group metabolism (254, 256).  
      Two findings in this report were surprising to us: 1) the observation that pduL mutants were 
significantly impaired for growth on 1,2-PD minimal medium (Fig. 2.2) the finding that a pduL 
pta double mutant was not further impaired for growth on 1,2-PD. Because Pta is known to be 
active with propionyl-PO4
2-, we expected that Pta would partly substitute for PduL during growth 
of S. enterica on 1,2-PD. However, in the studies reported here, it did not. A simple explanation 
is that PduL is more efficient at propionyl-group metabolism in vivo. Two explanations we think 
are more interesting are differential regulation of pta and pduL, as well as the possibility that 
PduL is specifically adapted to function in concert with the microcompartment involved in 1,2-
PD degradation.  
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CHAPTER 3. PDUL RECYCLES COENZYME A IN PDU 
MICROCOMPARTMENT IN SALMONELLA ENTERICA 
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3.1. Abstract 
      Salmonella enterica is capable of growing on 1,2-propanediol, whose degradation is carried 
out in propanediol utilization microcompartments (Pdu MCPs). Our previous study showed PduL 
is a new class phosphotransacylase involved in MCP-associated 1,2-propanediol (1,2-PD) 
metabolism. Here, we demonstrated by Western blots that PduL is a component of Pdu MCP. 
Genetic studies showed PduL in MCPs can’t utilize acetyl-CoA in the cytoplasm to support 
Salmonella growth, and PduL recycling coenzyme A in the Pdu MCPs is indicated. Growth tests 
as well as protein immunoblots also provided evidence that N-terminal region of PduL functions 
as a targeting sequence for MCP encapsulation. These data, together with recent publications, 
indicate that cofactor recycling might be a general mechanism utilized among MCPs to optimize 
metabolic efficiency. The targeting study further expands our knowledge of enzyme 
encapsulation during MCP assembly. Complete understanding of MCPs might provide a basis 
for the development of nanocontainers for use in biotechnology.  
3.2. Introduction 
      Microcompartments (MCPs) are a family of subcellular proteinaceous organelles utilized by 
14.6% of bacteria to optimize metabolic pathways with toxic or volatile intermediates involved 
(24, 25,  65). These polyhedral protein complexes are 100-150 nm in size and consist of a multi-
protein shell sequestering enzymes which work sequentially in a specific metabolic pathway. 
Gene expression analysis and bioinformatics studies predicted the presence of at least seven 
types of MCPs with various functions (23, 65). The carboxysome is the first identified MCP 
which functions in retaining CO2 to increase carbon fixation efficiency (258). The two other 
MCPs that have been investigated so far are named 1,2-propanediol utilization 
microcompartment (Pdu MCP) and ethanolamine utilization microcompartment (Eut MCP). 
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They are used for metabolizing a three-carbon molecule 1,2-PD and a two-carbon compound 
ethanolamine, respectively while sequestering the toxic metabolite aldehyde generated during the 
degradation processes (23, 57). By retaining these metabolic pathways in MCPs, bacteria are 
able to utilize 1,2-PD and ethanolamine as carbon and energy source while avoiding cellular 
toxicity caused by aldehyde accumulation and increasing metabolism efficiency by substrate 
channeling. 1,2-PD and ethanolamine are present in the human gut, the ability of S. enterica of 
growing on both of them contribute to Salmonella pathogenesis (75, 94, 95, 97, 259).  
      In Salmonella enterica, degradation of 1,2-PD associated with Pdu MCPs is a coenzyme B12-
dependent process which involves multiple enzymes and cofactors. Nine different polypeptides 
PduABB’JKMNTU self-assemble to form a polyhedral shell that encapsulates key enzymes for 
metabolizing 1,2-PD (39, 49). 1,2-PD is taken into MCP by unknown mechanisms which might 
involve the selective pores on the shell (36, 58, 73). The first two reactions for 1,2-PD 
degradation are carried out in the lumen of MCP (Fig. 3.1). It starts with the conversion of 1,2-
PD to propionaldehyde by Ado-B12-dependent diol dehydratase PduCDE (22). Next, another 
major enzyme propionaldehyde dehydrogenase PduP turns propionaldehyde into propionyl-CoA 
in the MCPs (22, 49). Our previous model claimed that the following rest steps of 1,2-PD 
degradation happen outside of MCPs. Propionyl-CoA is either utilized by phosphotransacylase 
PduL to produce propionyl-PO4
2-, which is converted to final product propionate by the reaction 
of propionate kinase PduW or feeds into methylcitrate pathway (50). Alcohol dehydrogenase 
PduQ could alternatively convert propionaldehyde to 1-propanol. Recently Cheng et al. (52) 
showed that PduQ was also associated with Pdu MCPs and it catalyzed propionaldehyde 
reduction inside MCPs to regenerate NAD+, the cofactor required for PduP reaction. Besides the 
enzymes and shell components, Ado-B12, is an active form of coenzyme B12 and is required for 
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the reaction catalyzed by diol dehydratase PduCDE, another two cofactors NAD+ and HS-CoA 
are required for the function of PduP. 
 
 
 
 
 
 
 
 
 
 
                            
Figure 3.1. A model for 1,2-PD metabolism associated with Pdu MCPs and the role of PduL. The Pdu MCP 
consists of a series of enzymes encapsulated within a multi-protein shell. The enzymes are used for degrading 
1,2-PD. The shell is composed of 9 polypeptides PduABB’JKMNTU. The enzymes encapsulated are four 1,2-
PD degrading enzymes dial dehydratase DDH (PduCDE), propionaldehyde (PPA) dehydrogenase (PduP), 1-
propanol dehydrogenase (PduQ) and phosphotransacylase (PduL). The proper function of DDH requires 
vitamin B12 in its active form Adenosyl-cobalamin (Ado B12). Both NAD
+ and HS-CoA is a required 
coenzyme for PduP. The proposed function of Pdu MCP is to retain aldehyde to avoid the toxicity to genomic 
DNA and to channel the intermediate to the downstream enzymes to increase the efficiency of the metabolic 
pathway. PduQ regenerate NAD+ inside of MCPs (52). PduL could recycle propionyl-CoA (prp-CoA) to 
regenerate HS-CoA which is a necessary coenzyme for the function of PduP (this study).  
 
      The shells of MCPs function as a barricade to keep volatile substrates or toxic metabolites 
inside MCPs and segregate them from cytoplasm. While at the same time the metabolic 
processes in MCPs require input of substrates as well as cofactors and output of products. 
PduW 
ADP        ATP 
propionate 
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Intensive studies have been focusing on solving how metabolites cross the shell. Analysis of 
crystal structures of MCP shell proteins indicated that major shell components of different types 
of MCPs contain small pores in the center of their disc-shaped homohexamers, which are the 
basic building blocks of the shell (35, 36). Caboxysome shells tend to have positive electrostatic 
potential around the central pores which may bring in negatively charged substrate bicarbonate 
(35). One abundant Pdu MCP shell protein PduA has been reported to contain hydrogen bond 
acceptors in the central pores which may facilitate the transport of the polar substrate 1,2-PD (36, 
73). Compared to the size of the substrates, cofactors NAD+ and HS-CoA are much bigger and 
hence harder to get through the shell. Recent studies revealed that tandem BMC-domain 
containing shell proteins CsoS1D and CcmP have conserved glutamate and arginine residues 
which adopt different conformations and causes the pores to either close or open (up to 14 
angstrom in diameter for CsoS1D) (87, 260). Yet so far these theories are based on analysis on 
protein structures and no direct experimental evidence has shown that bulky cofactors are 
transported through gated pores. Recently, Cheng et al. (52) showed that alcohol dehydrogenase 
PduQ regenerated NAD+ within the Pdu MCPs in Salmonella and thus provided the first 
evidence for cofactor internal recycling within bacterial MCPs. Soon after that, Huseby et al. (78) 
used genetic methods to demonstrate that NAD+ and coenzyme A were recycled and retained 
within the Eut MCPs by two enzymes EutD and EutG during ethanolamine catabolism. These 
two studies open up the possibilities that MCPs are capable of reusing cofactors independent of 
outside input. 
      One of the fundamental questions about MCP functions is that how the enzymes are 
encapsulated into MCPs during their assembly. Sequence alignment identified short N-terminal 
extra sequence on MCP-associated enzymes PduP, PduD and EutC compared to their 
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homologues which don’t have MCP associated genomic context (101, 261, 262). Following this 
prediction, Fan et al. (262) reported that N-terminal 18 amino acids on PduP sufficiently package 
the enzyme and several foreign protein tags into the lumen of MCP. Later N-terminal extension 
of the medium subunit of diol dehydrase was also found to package the whole enzyme into Pdu 
MCPs (261). Further in vivo targeting study proved that interaction between the targeting 
sequence on PduP and shell protein PduA is critical for encapsulation of PduP into MCPs (263).  
      In our previous model, PduL was proposed to be outside of MCPs. In this study, we 
demonstrated that PduL is a component of Pdu MCPs. We then investigated the specific 
functions of PduL related to MCPs and presented evidence that it recycles coenzyme A inside 
Pdu MCPs. These results support the earlier studies of cofactor recycling and suggest that 
internal recycling could be an alternative mechanism for MCPs to acquire cofactors. We also 
showed that N-terminal region of PduL has encapsulation effects. This finding, together with 
recent targeting studies, indicate that short targeting sequences use a general mechanism to direct 
protein encapsulation in MCPs. 
3.3. Materials and Methods 
      Chemicals and reagents. Antibiotics, CN-Cbl, DNase I were from Sigma-Aldrich (St. Louis, 
MO). Coenzyme A was from MP Biomedicals (Santa Ana, CA). Isopropyl b-D-1-
thiogalactopyranoside (IPTG) was from Diagnostic Chemicals Limited (Charlottesville PEI, 
Canada). KOD DNA polymerase was from Novagen (Cambridge, MA). Restriction enzymes and 
T4 DNA ligase were from New England Biolabs (Beverly, MA). Bacterial protein extraction 
reagent (B-PER II) was from Pierce (Rockford, IL). The cOmplete protease inhibitor was from 
Roche Diagnostics Corporation (Indianapolis, IN). Other chemicals were from Fisher Scientific 
(Pittsburgh, PA). 
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      Bacterial strains and growth conditions. The bacterial strains used in this study are 
derivatives of Salmonella enterica serovar Typhimurium LT2 (Table 3.1.) The rich media used 
were LB/Lennox medium (Difco, Detroit, MI) (237). The minimal medium used was no-carbon-
E (NCE) medium (239).  
 
Table 3.1. Bacterial strains used in this study. 
Strain  Genotype Source 
 S. enterica serovar Typhimurium LT2 
BE188  ∆pduL670 T.A.Bobik lab collection 
BE291  ∆pduL670, pta209::Tn10 T.A.Bobik lab collection 
BE527  pta209::Tn10 T.A.Bobik lab collection 
BE647  ∆pduABB’ T.A.Bobik lab collection 
BE717  pta209::Tn10∆pduABB’ T.A.Bobik lab collection 
BE881  ∆pduABB’∆pduL670 This study 
BE790  ∆pduL670, pta209::Tn10/Plac22 T.A.Bobik lab collection 
BE791  ∆pduL670, pta209::Tn10/Plac22-pduL T.A.Bobik lab collection 
BE1112  ∆pduL670, pta209::Tn10/Plac22- PduL∆1-5 This study 
BE1114  ∆pduL670, pta209::Tn10/Plac22- PduL∆1-10 This study 
BE1766  ∆pduL670, ∆pduABB’, pta209::Tn10 This study 
BE2021  ∆pduL670, pta209::Tn10 /Plac22- eGFP This study 
BE2022  ∆pduL670, pta209::Tn10 /Plac22- pduL1-20-eGFP This study 
BE2025  ∆pduL670, pta209::Tn10 /Plac22-pduL-linker-eGFP This study 
 
      MCP purification, SDS-PAGE and Western blots. Pdu MCPs were purified as previously 
described (39) except carbenicillin and IPTG were added to induce protein expression from a 
vector pLAC22. Protein assay was carried out by use of protein assay reagent (Bio-rad, Hercules, 
CA) with 1 mg/ml bovine serum albumin (BSA) as a standard. SDS-PAGE was performed using 
4–20% Mini-PROTEAN TGX gels from Bio-Rad followed by staining using Bio-Safe 
Coomassie Stain (Bio-Rad). For Western blots, the nitrocellulose membranes were probed using 
mouse monoclonal anti-GFP (Fisher Scientific) or rabbit polyclonal anti-PduL (Genscript, 
Piscataway, NJ) with 0.5 ug/ml in TBST buffer and goat anti-mouse or anti-rabbit IgG HRP 
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(horseradish peroxidase) conjugate at 40 ng/ml in TBST buffer (Santa Cruz Biotechnology, 
Santa Cruz, CA). Signal development was carried out by using SuperSignal West Pico 
Chemiluminescent Substrate (Pierce, Rockford, IL) according to the manufacturer’s instructions. 
The result was analyzed by ChemiDoc XRS+ Imager (Bio-Rad). 
      Growth studies. Growth studies were carried out using Synergy HT microplate reader 
(BioTek, Winooski, VT) as previously described (50). Each growth curve was a representative of 
three independent experiments in triplicate. Doubling times were calculated from semilog plots 
with the formula doubling time = 0.693/(2.303 X slope of the linear region of the plot). 
3.4. Results 
      Sequence analysis. Prior studies showed that short N-terminal are used to target proteins to 
the lumen of bacterial MCPs (261, 262). Sequence alignment of 8 representative PduL 
homologues from different bacterial organisms showed that N-terminal sequence extensions are 
present in four of the eight homologues whose genomic context suggests the potential formation 
of MCPs in the organism (Fig. 3.2A).  Prediction of secondary structure of PduL was carried out 
using programs PredictProtein (Fig. 3.2B). 14 residues on the N-terminus were predicted to have 
propensity for an α-helix formation, which was consistent with the recent reports that PduP and 
encapsulated proteins from more than one type of MCPs have terminal targeting sequence which 
was prone to form α-helices (262, 263). This findings suggested that PduL might be a component 
of the Pdu MCP even though it was not identified by prior proteomics analyses purified MCPs 
(49). 
      PduL is a component of Pdu MCP. To investigate the cellular location of PduL, MCPs 
purified from wild-type S. enterica as well as a pduL deletion mutant BE291 were analyzed by 
SDS-PAGE and Western blots. By Western blot (Fig. 3.3), a strong band near 24 kD was 
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detected in MCPs purified from Salmonella using anti-PduL sera, while a weaker band at same 
size was readily detected in crude extracts. No bands at this size were detected in either whole 
cell extracts or MCPs purified from a pduL deletion strain BE291. These results indicated that 
PduL is a component of Pdu MCP. 
 
 
Figure 3.2. Sequence analysis and structure prediction of PduL N-terminus. Panel A. Sequence alignment of 
the N-terminal region of 8 representative PduL homologues from different bacterial organisms. Terminal 
sequence extensions are present in four of the eight homologues whose genomic context suggests the potential 
formation of MCPs in the organism. PduL of S. enterica belongs to PduL superfamily (cl05584). The sequence 
contains two tandem domains. Several members in this superfamily catalyze interconversion of acetyl-CoA 
and acetyl-phosphate, and propionyl-CoA and propionyl-phosphate. The National Center for Biotechnology 
Information gene accession identifications, from the top to the bottom, are 496567468, 485596631, 515719363, 
239826378, 5069455, 16503278, 375257112, and 332161170. Panel B, C and D. Secondary structure 
prediction of N-terminal region of PduL by software B: Psipred; C: JPRED; D: PredictProtein.       
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Figure 3.3. PduL is a component of the Pdu MCP. A. Western blot for PduL with anti-PduL. Lane 1 and 2, 10 
μg whole-cell extract and 10 μg purified MCPs from wild-type strain LT2; lane 3 and 4, 10 μg whole-cell 
extract and 10 μg purified MCPs from a pduL deletion mutant (BE188). B. 10-20% SDS-PAGE gel stained 
with Bio-Safe Coomassie. Lane 1, molecular mass markers; lane 2, 10 μg Pdu MCPs purified from LT2; lane 3, 
10 μg Pdu MCPs purified from BE188.  
 
      A specific band with molecular mass close to PduL was not identified by SDS-PAGE. Most 
likely, PduL was obscured by major components of Pdu MCPs PduB’ and PduD, which had 
similar molecular mass as PduL (24.1 kD for PduB', 24.2 kD for PduD vs 23.1 kD for PduL). 
      PduL is capable of packing heterologous GFP into the Pdu MCPs. To further investigate 
the cellular location of PduL, we tested whether PduL could mediate the encapsulation of eGFP 
into Pdu MCPs. A PduL-eGFP fusion protein was expressed from plasmid pLAC22 in a pduL 
deletion mutant. PduL fused to eGFP was readily detected in purified MCPs as a strong band 
near 50 kD by anti-GFP monoclonal antibody (Fig. 3.4). eGFP was not detected in MCPs 
purified from wild type Salmonella or a ∆pduL mutant expressing native eGFP. The fusion 
proteins appeared in the whole-cell extract fraction, indicating the normal expression. Higher 
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amount of the fusion protein present in eMCPs versus the whole-cell lysate fraction was further 
evidence that PduL is targeted to MCPs.  
  
                           
 
 
 
 
 
 
 
 
 
Figure 3.4. PduL-eGFP fusion protein was detected in Pdu MCPs. Lane 1 and 6: Western standards; lane2-4: 
10ug Pdu MCPs purified from: a wild type S. enterica LT2, ∆pduL/pLac22-eGFP (BE2021), and 
∆pduL/pLac22-pduL1-20-eGFP (BE2025); lane 5-7: 10ug whole-cell extracts of LT2, BE2021 and BE2025.  
 
      N-terminal region of PduL is required for targeting into MCPs. To test for an N-terminal 
targeting sequence on PduL, we expressed truncated pduL lacking N-terminal 5, 10 and 20 
amino acids from vector pLAC22 in a pduL deletion background. To test the cellular location of 
the truncated PduL proteins, MCPs were purified from the mutants and analyzed by Western 
Blots for PduL. Compared to wild type, significantly less PduL was detected in purified MCPs 
from PduL∆1-5 and PduL∆1-10 (Fig. 3.5). Comparable amount of proteins in the whole-cell extracts 
for the mutants and control strain indicating proper expression of the mutants. We also examined 
targeting of PduL ∆1-20; however none could be detected by Western blot suggesting this mutant 
protein was unstable. As an additional control we did an in vivo test for PduL enzyme activity as 
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described (50). This test showed that PduL∆1-5 and PduL∆1-10 were active enzymes but that 
PduL∆1-20 was inactive enzymatically or unstable. 
 
                   
 
 
 
 
Figure 3.5. N-terminal deletion affects encapsulation of PduL into Pdu MCPs. Lane 1: Molecular mass marker; 
lane 2-4: 10, 25 and 7.5 ug purified Pdu MCPs from control strain ∆pduL/pLac22-pduL (BE791), 
∆pduL/pLac22-pduL∆1-5 (BE1112) and ∆pduL/pLac22-pduL∆1-10 (BE1114); lane 5-7: 10, 25 and 7.5 ug whole-
cell lysates from BE791, BE1112 and BE1114. 
 
      PduL N-terminal 20 amino acids can target eGFP to the Pdu MCP. To determine 
whether the N-terminal extension of PduL is sufficient for encapsulating proteins into the Pdu 
MCP, we fused PduL N-terminal 20 amino acids to eGFP and looked for the fusion proteins in 
the purified MCP by Western blots with anti-GFP. PduL1-20-eGFP was produced using the IPTG-
inducible promoter on plasmid pLAC22 in a background carrying a pduL deletion mutation. 
Western blots indicated that PduL1-20-eGFP (~28 kD) co-purified with Pdu MCPs while eGFP 
did not (Fig. 3.6). At the same IPTG level, similar amounts of eGFP and PduL1-20-eGFP were 
detected in cell lysates, indicating normal production and folding of both proteins. At lower 
IPTG levels (0.02 mM), Western blots of purified MCPs showed a band for PduL1-20-eGFP but 
not for eGFP. Low levels of both PduL1-20-eGFP and eGFP were present in cell lysates. These 
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results indicated that a short N-terminal 20 amino acid sequence from PduL is sufficient for 
packaging proteins into Pdu MCPs. 
 
                                
 
 
 
 
 
 
Figure 3.6. PduL N-terminal 20 amino acids showed targeting effect. Lane 1, 2: 15ug MCPs purified from: 
eGFP-expressing strain BE2021 and PduL1-20-eGFP expressing strain BE2022, respectively. Lane 3, 4: 15ug 
whole-cell extracts from: eGFP-expressing strain BE2021 and PduL1-20-eGFP expressing strain BE2022, 
respectively. 0.2mM IPTG induction was used for all samples.  
 
      Genetic effects of preventing MCP formation on the growth of a pduL deletion mutant. 
Prior studies showed that pduL deletion mutant had a reduced growth rate on 1,2-PD even 
though Salmonella expresses a housekeeping Pta enzyme which is active with propionyl-PO4
2- 
(the primary substrate of Pta is acetyl-PO4
2-) (50). Previously, it was proposed that PduL 
provides additional enzyme activity needed to support growth on 1,2-PD (50). However, an 
alternative explanation is that PduL might have an MCP-specific function such as internal HS-
CoA recycling (Fig. 3.1). To test for an MCP-specific function for PduL, we looked at the effect 
of breaking the Pdu MCP genetically (with a pduABB’ deletion which was shown to prevent 
formation of the Pdu MCP (70)) on the phenotype of a pduL deletion mutant. Results showed 
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that in a MCP+ background, a pduL deletion mutant grew slower than the wild type strain LT2 as 
was previously reported. In a MCP- background, the ∆pduL mutant actually grew faster than 
PduL+ (doubling time of 3.43 ± .1 h vs 4.16 ± .12 h) (Fig. 3.7).  
        
 
   
Figure 3.7. Genetic effects of preventing MCP formation on the growth of a pduL deletion mutant. Wild type 
LT2, a ∆pduL mutant (BE188), a ∆pduABB’ strain with broken MCP phenotype (BE647), and a ∆pduL 
∆pduABB’ triple mutant (BE881) were grown on 1,2-PD minimal medium supplemented with 100 nM CN-Cbl 
(cyanocobalamin, vitamin B12). 
 
      This suggested that PduL is necessary for the proper functioning of an intact Pdu MCP and 
might have a role in coenzyme A recycling (Fig. 3.1). This also argues against the idea that the 
role of PduL is to provide more activity. We noticed that PduL- MCP- grew faster than the wild 
type strain (PduL+ MCP+) (doubling time of 3.43 ± .1 h vs 4.85 ± .3 h). One possible 
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interpretation is that the PduL- strain accumulated propionyl-CoA to higher levels increasing flux 
through the methylcitrate pathway (Fig. 3.1) (264). 
      Slow growth of a pta mutant on acetate minimal medium was partially corrected by 
mutations that broke the MCPs. Next we tested whether the Pdu MCP restarts access of 
acetyl-CoA to PduL. Salmonella can growth on acetate by converting it first to acetyl-PO4
2- and 
then to acetyl-CoA by the ordered action of two house-keeping enzymes acetate kinase (AckA) 
and Pta (247). Prior studies showed a pta mutant grows poorly on acetate but this phenotype is 
corrected by production of PduL from a plasmid (PduL also converted acetyl-PO4
2- to acetyl-
CoA) (50). To test whether acetyl-PO4
2- and acetyl-CoA can move freely across the MCP shell 
we tested whether PduL encapsulated within the Pdu MCP could correct the growth defect of a 
Pta mutant on acetate. Results show that induction of the pdu operon (which leads to MCP 
formation) only slightly increased growth of a Pta strain on acetate (doubling time = 7.03 ± .05 h) 
(Fig. 3.8). This indicated that PduL could not effectively replace the function of Pta when 
encapsulated within the Pdu MCPs. However, when the pdu operon was induced in a background 
that cannot form the MCP shell (∆pduAB) much better growth of a Pta strain on acetate was 
observed (3.46 ± .07 h) (Fig. 3.8). The growth difference of PduL+ Pta- MCP+ strain and PduL+ 
Pta- MCP- suggest that the shell of the Pdu MCP restricts the movement acetyl-PO4
2- and/or 
acetyl-CoA and impairs the ability of PduL to correct that Pta defect. Restriction of metabolite 
movement by the shell of the Pdu MCP is consistent with the need for internal recycling of CoA 
as shown in Figure 3.1. For the experiments described above, expression of the pdu operon was 
induced by supplementation of the growth medium with 1,2-PD. No 1,2-PD metabolism 
occurred under these conditions because coenzyme B12 (a required cofactor for 1,2-PD 
degradation) is not present. 
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Figure 3.8. Slow growth of a pta mutant on acetate minimal medium was partially corrected by mutations that 
broke the MCPs. LT2 and the Mutants were grown in acetate minimal medium with or without 1,2-PD 
induction. 
 
      N-terminal deletion of pduL showed targeting defect. Based on the above finding that 
acetyl-PO4
2-/acetyl-CoA do not pass freely through the shell of the Pdu MCP, we developed a 
growth test for PduL targeting. As mentioned above, the pduL gene expression was induced by 
addition of 1,2-PD to the acetate growth medium. Mutations that prevent encapsulation of PduL 
within the Pdu MCP should enhance growth on acetate in a Pta- background. Tests showed that 
both PduL∆1-5 and PduL∆1-10 grew faster than the Pta- control with 1,2-PD supplementation, 
indicating more PduL enzyme was present in the cytosol (Fig. 3.9). This finding further 
supported the western blots shown above which indicated PduL has an N-terminal targeting 
sequence. The comparison between the control and each mutant was calculated for both doubling 
time and cell density (Table. 3.2). Both PduL∆1-5 and PduL∆1-10 grew faster than the control. It is 
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possible that the partial deletions resulted in either higher phosphotransacylase activity or more 
efficient protein expression and folding. Here the growth test was done at 30 °C instead of 37 °C 
due to the concern that, at higher temperature, the fast growth of the mutants might exceed the 
MCP assembling rate which would artificially result in more significant results. This growth test 
further quantitatively showed that deletion of N-terminal 10 amino acids had more severe effect 
on targeting compared to N5 deletion (50% of control strain vs 78% of control strain, table 3.2). 
 
A       B 
          
Figure 3.9. N-terminal deletion of pduL showed targeting defect. The growth of the control strain with wild 
type PduL (BE791), a PduL∆1-5 mutant (BE1112, panel A), and a PduL∆1-10 mutant (BE1114, panel B) in 
acetate minimal medium were adjusted to the same level, then the growth of BE1112 (panel A) and BE1114 
(panel B) were compared to BE791 in acetate medium supplemented with 1,2-PD, respectively. All strains 
contained a pduL and pta double mutation. 
 
3.5. Discussion 
      In our previous study, Havemann and Bobik (49) identified 15 polypeptides associated with 
Pdu MCPs by using of two-dimensional electrophoresis followed by N-terminal sequencing and 
protein mass fingerprinting. PduL was not found in this process. We thought PduL might not be 
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detected on the acrylamide gel due to its low abundance in the purified MCPs and its high 
theoretical pI (9.09) which might cause the migration of PduL off the gel during isoelectric 
focusing (49). In this study, we provided evidence that PduL is a component of Pdu MCP. 
Western blots clearly showed the presence and enrichment of PduL in purified MCPs. PduL 
fused to eGFP was readily detected in purified MCPs, which further suggested that PduL is 
associated with Pdu MCPs. Although we didn’t visualize PduL on SDS-PAGE. We also 
measured the phosphotransacylase activity and didn’t observe higher enzymatic activity in 
purified MCPs versus that of whole-cell lysate, which is possibly due to the unstable nature of 
PduL and also the interference of enzymatic activity by nonionic detergent B-per II used for 
MCP purification (50, 265).  
 
Table 3.2. N-terminal deletion of pduL showed targeting defect on acetate/PD growth assay. 
Strain IPTG conc: mM % of cell density (OD600)
a % of doubling time (h)b 
BE1112                         .01           77.7 ± 2.5                                               80 ± 5 
          .02           73.7 ± 6.5          73.3 ± 14.3 
BE1114          .003              59 ± 9             49 ± 10 
          .005              57 ± 11             46 ± 9 
 
Each growth curve was repeated three times in triplicate. The numbers are mean value ± 1 standard deviation.  
a% of cell density = (difference in cell density of the mutant growing in acetate medium and  acetate/PD 
medium)/(difference in cell density of strain BE791 at the time point when BE791 reached maximum optical 
density measured at a wavelength of 600 nm). 
b% of doubling time = (difference in the doubling time of a mutant growing in acetate medium and  acetate/PD 
medium)/(difference in the doubling time of control strain BE791 growing in acetate medium and  acetate/PD 
medium) 
 
      We also investigated the reasons that PduL is associated with the Pdu MCP. Our recent study 
indicated that PduQ functions by recycling NAD+ internally within the Pdu MCPs (52). Cofactor 
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NAD+ can’t diffuse freely through the shell, thus regeneration of NAD+ provides a possible way 
for the MCP to acquire cofactors. This proposed theory was further supported by another study 
showing that Eut MCP retains a private pool of HS-CoA (78). Considering that large coenzyme 
A may also be reused in Pdu MCPs, we carried out growth study to test the effects of breaking 
MCPs on PduL. The results showed reduced growth of a pduL mutant with intact MCPs on 1,2-
PD compared to wild type Salmonella and faster growth of PduL- versus PduL+ with broken 
MCPs, indicating that PduL is required for an intact Pdu MCP to function properly. Further 
investigation of growth on acetate showed that PduL only slightly corrected the growth defect of 
a Pta- strain, suggesting PduL within the Pdu MCP could barely replace the function of Pta. After 
the MCPs were broken, PduL functioned more efficiently in the cytoplasm and partially 
corrected the growth of the Pta- strain. These results indicated that the access to substrate acetyl-
CoA is restricted by the shell, and coenzyme A internal recycling inside the Pdu MCP is strongly 
suggested. Based on our results and the aforementioned findings, we propose that internal 
recycling of both HS-CoA and NAD+ helps Pdu MCPs function as a self-supporting metabolism 
system and contribute to optimal growth of S. enterica on 1,2-PD. Our proposed theory didn’t 
rule out the possibility that CoA might also be transported through the shell. In fact, we observed 
very slow growth of Pta- PduL+ MCP+ on acetate, indicating that limited but not eliminated 
amount of acetyl-CoA manage to trespass the MCP shell.  
      Function of MCP requires lumen enzymes are encapsulated into the protein shell. Fan et al. 
(261, 262) showed that the short N-terminal sequences of PduD and PduP efficiently package 
core enzymes PduCDE and PduP into the MCPs, respectively. Their bioinformatics analysis also 
predicted N-terminal targeting sequences for EutC and EutG, lumen proteins associated with Eut 
MCPs. Later studies by Choudhary et al. (101) demonstrated that N-terminal 19 amino acids of 
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EutC is sufficient to target eGFP and β-galactosidase into native and recombinant Eut MCPs. 
Our sequence alignment and structure predictions suggested that PduL homologues from MCP-
associated bacterial genomes feature a short N-terminal sequence containing alternative charged 
and hydrophobic residues with potential of forming an α-helix, which is conservative among 
MCP-encapsulated proteins. Western blots showed that PduL lacking N-terminal residues 
appeared at significantly lower levels in purified MCPs, indicating targeting is affected by the N-
terminal deletion. We also detected the presence of PduL1-20-eGFP in purified MCPs, which 
suggested that N-terminal 20 amino acids of PduL is efficient in packaging the enzyme into 
MCPs. These results, in conjunction with the above studies, expands our understanding of how 
MCP-associated enzymes and shell components form the highly organized protein structures.  
      Self-assemble and compartmentalization significantly increase metabolic efficiency by 
sequestering toxic and volatile intermediates, and promoting substrate channeling, which make 
MCPs great candidates as bioreactors. This study, together with other targeting and recycling 
explorations, promotes the discovery of short targeting sequences and a thorough understanding 
of molecular transport mechanisms of MCPs. The acquired knowledge makes it possible for 
genetic and biochemical engineering of self-assembling bioreactors with desired metabolic 
enzymes encapsulated into the MCP shell (266). Successful encapsulation of functional 
heterologous enzymes into reconstructed MCPs have been observed (101, 187). As a proof of 
concept, an ethanol bioreactor was generated in vivo by packaging ethanol producing enzymes 
with a targeting sequence into recombinant Pdu MCPs (102). A recent study showed that Pdu 
MCPs retain integrity over time and at various temperatures, and breaking of MCPs could be 
controlled by changing pH (89). This further indicates the robustness of MCPs and provides a 
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possible drug releasing mechanism. To utilize MCPs for delivery of chemotherapeutic drugs 
might protect normal tissues without compromising enzymatic efficiency of therapeutic peptides. 
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CHAPTER 4. PROTEIN-PROTEIN INTERACTIONS IN THE PDU MCP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Part of this work has been incorporated into a paper and submitted to the journal PLoS 
Computational Biology.  
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4.1. Abstract 
      Studies on diverse MCPs indicated that protein-protein interactions (PPIs) between the lumen 
enzymes and the shell components are crucial in assembly of MCPs and in the organization of 
these protein complexes. Our targeting studies (see chapter 3) indicated that lumen enzyme PduL, 
similar to major lumen enzymes PduP and PduD, also has a short N-terminal targeting sequence, 
while the shell protein which interacts with PduL to mediate the encapsulation was not identified. 
Here we provided preliminary evidence that PduL binds to PduBB’. In vivo bacterial two-hybrid 
screening test indicated the possible binding interaction between PduL and PduB’. Further 
investigation using in vitro nickel-affinity pull-down tests followed by Western blotting provided 
another evidence of L-BB’ binding. Our data is consistent with the Pdu interactome prediction 
by Jorda et al. (unpublished data) using computer based docking simulations. Our two-hybrid 
system also suggested a positive interaction between PduV, a protein with unknown functions, 
and shell protein PduU, which was also predicted within the PPI network. Prediction by 
interactome model followed by experimental confirmation may significantly improve the 
accuracy and efficiency in discovering PPIs which underlie MCP functions. 
4.2. Introduction 
      Various mechanisms are utilized for targeting proteins into organelles or certain parts within 
eukaryotic and prokaryotic cells. As more studies revealed the encapsulation of enzymes into 
MCPs and the molecular transport through the shell to meet the needs of the enzymatic functions, 
a picture emerges that fully functional MCPs are highly organized through the network of 
interactions between proteins associated with MCPs. Recent studies showed that some interior 
enzymes in Pdu MCPs contain special short N-terminal extensions which are necessary and 
sufficient for targeting into the Pdu MCPs (101, 261, 262). Alignment of targeting sequences 
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from various enzymes showed little sequence similarity. But the targeting sequence generally 
have propensity of forming an amphipathic α-helix. Further studies indicated that these α-helices 
might interact and bind to certain BMC domain proteins on MCP shells. Subsequent studies by 
Fan et al. (263) carried out in vitro binding studies, in vivo targeting studies together with 
structural model analysis which provided evidence that targeting sequence on N-terminal region 
of enzyme PduP binds to C-terminus of shell proteins PduA and PduJ to mediates the 
encapsulation of PduP into the lumen of MCPs.  
      Several studies have successfully utilized short N-terminal targeting sequences to direct 
green fluorescence proteins and β-galactosidase into MCPs. Another group reported the solution 
structure of the N-terminal 18-amino-acid peptide of PduP from Citrobacter freundii and 
confirmed that the peptide has a helical conformation (102). They further identified the binding 
interaction between the P18 peptide with another shell protein PduK. These results indicated that 
the processes controlling the interactions among MCP-associated proteins may vary between 
different MCP types across bacterial species. In the case of Eut MCPs, an N-terminal targeting 
sequence on EutC is crucial for this enzyme to be packaged into Eut MCP (101). Also EutC 
preferentially bind shell protein EutS, a shell protein with the capability of forming a properly 
delimited MCP on its own (101).  These results indicated the targeting of EutC into Eut MCPs 
may be mediated by the interaction between EutC and EutS (101). 
      Besides the targeting related interactions between encapsulated enzymes and MCP shell 
proteins, protein-protein interactions associated with MCPs might have broader significance. 
CcmN is an essential carboxysomal component. According to Kinney et al. (267), its N-terminal 
domain binds the encapsulated CcmM which interacts with RuBisCO and CA. Its C-terminal 
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peptide, which binds major shell component CcmK2, is crucial for carboxysome formation, 
suggesting that CcmM may function as a scaffolding protein during MCP assembly.  
      Packaging of metabolic enzymes into MCPs via interactions between shell components and 
targeting sequences on lumen enzymes may represent a general mechanism across the MCP 
systems. But to this date, details about atomic interactions between shell protein and lumen 
enzymes were all based on mutagenesis studies and computer modeling. By far only one study 
extensively investigated and determined the mechanism by which the MCP targeting sequence 
functions (263). Comprehensive investigative system is needed to fill in this knowledge gap and 
provide directions for the potential applications of MCPs in biotechnology. 
      In this chapter, we performed in vivo two-hybrid tests together with in vitro nickel affinity 
pull-down experiments and identified more possible interacting proteins PduL and PduBB’ as 
well as PduU and PduV. Our experimental data was consistent with MCP interactome model 
predicted by Jorda et al. (unpublished data) using a coevolution-based machine learning 
algorithm. This work may help direct future work on protein-protein interactions in MCPs. 
4.3. Material and Methods 
      Bacterial strains and growth conditions. Bacterial strains used in this chapter are 
derivatives of E. coli and are listed in Table 4.1. The minimal medium used for two-hybrid 
assays were M9 media with Histidine-dropout supplement (BD/clontech), 5mM 3-amino-1,2,4-
triazole (3-AT) and streptomycin was also added into the selective minimal medium.  
      Two-hybrid assay. The BacterioMatch II Two-Hybrid System (Agilent technologies) was 
used according to the manufacturer's instructions with the following modification: co-
transformation was carried out by using 30 ng each of the bait and target vector. To construct the 
needed plasmids, each pdu protein encoding DNA sequences were amplified by PCR and then 
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restricted and ligated into pBT for expression as fusions with the λcI protein, and into pTRG for 
expression as fusions with the RNAPα protein. Ligation reactions were used to transform E. coli 
XL1-Blue MRF’. Plasmid DNA was purified using a Qiagen mini prep kit, and all clones were 
verified by DNA sequencing. The bacterial strains used for preparation of recombinant plasmids 
for two-are listed in Table 4.1. Self-activation by each recombinant bait and target was tested 
before the two-hybrid interaction assays to determine if the bait or target was capable of 
activating the reporter cassette on its own. Determination of protein-protein interaction was 
carried out by co-transforming BacterioMatch II validation reporter competent cells using 
recombinant bait and target.  
 
Table 4.1. Bacterial strains used in this study. 
Strain  Genotype Source 
 E. coli XL1 Blue MRF’ 
BE768  pTRG-pduU This study 
BE797  pBT-LGF2 T.A. Bobik laboratory collection 
BE798  pTRG-Gal11P T.A. Bobik laboratory collection 
BE984  pBT-pduU This study 
BE991  pBT-pduL This study 
BE998  pBT-pduV This study 
BE1004  pTRG-pduB’ This study 
BE1013  pTRG-pduV This study 
BE1017  pBT-pduB’ This study 
BE1034  pTRG-pduL This study 
 E. coli BL21(DE3) 
Rosetta 2 
  
BE1795  pCDF-pduLHis6-pduB’ This study 
BE1804  pCDF-pduLHis6-pduBB’ This study 
BE1816  pCDF-pduL-His6pduBB’ This study 
BE1827  pCDF-pduL-His6pduB’ This study 
BE1858  pCDF-pduLHis6-no insert at MCS2 This study 
BE2000  pCDF-no insert at MCS1-
pduBB’102/207AHis6 
This study 
BE2001  pCDF-no insert at MCS1-
His6pduBB’102/207A 
This study 
BE2002  pCDF-pduL-no insert at MCS2 This study 
BE2003  pCDF-pduL-pduBB’102/207AHis6 This study 
BE2004  pCDF-pduL-His6pduBB’102/207A This study 
BE2024  pCDF-no insert at MCS1-
His6pduBB’ 
This study 
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       Protein purification and nickel-affinity pull-down assay. pCDFDuet-1 (Novagen) was 
used for cloning and the constructs were transformed into E. coli BL21 (DE3) Rosetta 2 cells 
(Stratagene). The transformants were grown in Luria–Bertani medium. When the OD600 
reached early log phase, protein production was induced with 0.5 mM isopropyl-β-D-1-
thiogalactopyranoside (IPTG) at 16 °C for 16 h. The cells were collected and suspended in 50 
mM 2-(Cyclohexylamino) ethanesulfonic acid (CHES) (pH 7.4), 300 mM NaCl, 10 mM 
imidazole and broken with a French press (Thermo Electron) operated at 20,000 psi. The cell 
lysate was clarified at 35,000 × g for 20 min at 4 °C. The supernatant was loaded onto a column 
containing 4 mL Ni-NTA Superflow resin (Qiagen) pre-equilibrated with 50 mM CHES (pH 
7.5), 300 mM NaCl, 10 mM imidazole. The column was washed with 80 mM imidazole, and 
then eluted with 1 mL 50 mM CHES (pH 8.5), 300 mM NaCl, and 300 mM imidazole. All 
elution fractions were analyzed by SDS-PAGE to test for coelution of the His-tagged and 
untagged protein. 
4.4. Results 
      BacterioMatch II two-hybrid screening for binding partners for PduL. To screen for the 
possible binding partners for PduL, we carried out a BacterioMatch II two-hybrid test using 
E.coli as the host strain. Using this system, we identified several proteins including PduB’, PduD, 
PduN and PduW as candidates for further investigating their possible interactions with PduL. In 
this system, a reporter strain is co-transformed with appropriate target and bait fusion proteins. A 
protein-protein interaction between the target and bait activates the HIS3 gene allowing growth 
in the presence of 3-amino-1,2,4-triazole (3-AT), a competitive inhibitor of the His3 enzyme. If a 
large number of colonies is obtained following co-transformation, an interaction between the 
target and bait proteins is indicated. We fused pduL into the bait vector pBT and introduced each 
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of the shell protein PduABB’JKNTU into the target plasmid pTRG. The reciprocal clones were 
also constructed. For each protein pair, the number of colonies obtained following co-
transformation was comparable to that of a positive control with bait and prey proteins (LGF2 
and Gal11P) that are known to strongly interact (Table 4.2). The cfu number on selective medium 
was significantly higher compared to the respective self-test (negative control) but lower than the 
positive control, suggesting medium or weak interactions. Although other possibilities can’t be 
ruled out, for example, the interacting protein pair needs other proteins or molecules for optimal 
binding. We found pBT-pduL construct produced much less colonies during self-test and the 
interacting tests, indicating more severe cellular toxicity caused to the host cells.  
Table 4.2. Two hybrid assay to test the interaction with PduL 
Pairs tested                NSa Sb 
pBT-LGF2, pTRG-Gal11P              1000 ± 87                                            1000 ± 72 
pBT, pTRG w/  
pduL             TNTCc 9 ± 5 
pduB’            TNTC                                             35 ± 5 
pduB           39 ± 9 1 ± 0 
pTRG, pBT w/    
pduL            75 ± 21 6 ± 1 
pduB           19 ± 10 0 ± 0 
pduB’         895 ± 65 7 ± 3 
pduW          TNTC                                             14 ± 4 
pduN        1000 ± 50                                             45 ± 6 
pBT-pduB’, pTRG-pduL          960 ± 40                                           490 ± 55 
pBT-pduW, pTRG-pduL         TNTC                                           123 ± 49 
pBT-pduD, pTRG-pduL         TNTC                                           450 ± 26 
pBT-pduN, pTRG-pduL         TNTC                                           240 ± 61 
pBT-pduL, pTRG-pduB’         1 ± 0 0 ± 0 
pBT-pduL, pTRG-pduB         14 ± 13 0.3 ± 0.6 
Different combinations of bait (pBT) and prey (pTRG) genotypes are tested. The LGF2 and Gal11p pair serves 
as a positive control. Tests with each pair were repeated three times and the numbers shown are the mean ± 1 
standard deviation. 
acfu obtained on nonselective (NS) screening medium plates (no 3-AT) with 1:100 diluted cells. 
bcfu obtained on selective (S) screening medium (3-AT) plates. 
ccfu too numerous to count.        
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Figure 4.1. SDS-PAGE analysis of nickel-affinity pull-downs showed binding interactions between PduL and 
PduBB’. Panel A (using pduBB’ double mutants with higher solubility). Lane 1, -His6pduBB’102/207A 
(BE2001); lane 2, pduL-His6pduBB’102/207A (BE2004); lane 3, molecular markers; lane 4, -
pduBB’102/207AHis6 (BE2000); lane 5, pduBB’102/207AHis6 (BE2003). Panel B (using w.t. pduBB’). Lane 1, 
molecular markers; lane 2 and 3, whole-cell extract and soluble fraction from strain BE2024 (His6pduBB’); 
lane 4 and 5, whole-cell extract, soluble fraction and eluted fraction from strain BE1816 (pduL-His6pduBB’). 
 
PduL interacts with PduBB’. To further identify the protein-protein interactions suggested by 
the two-hybrid system, we performed nickel affinity copurification followed by Western blots. 
The results indicated a binding interaction between PduL and PduB or/and PduB’. Due to the 
presence of a restriction cutting site in pduL sequence, we chose to introduce pduL into MCS1 of 
Duet vector. The test of L-BB’ resulted in a weak band with the size of PduL on the SDS-PAGE. 
The control strain with only BB’ cloned into MCS2 site on Duet didn’t produce enough protein 
in the eluted samples for a conclusive result. We next tested the pair of L and edge mutant of 
PduBB’ which allows much better solubility of the shell protein. We got the positive results by 
using BB’ mutant with six histidine residues tagged to both N-terminus and C-terminus (Fig. 4.1). 
Next, we did Western blots to test the presence of PduL and PduBB’ in the elution fraction using 
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both anti-PduL and anti-PduB antibodies. The results indicated PduL coeluted with PduBB’ (Fig. 
4.2). 
 
 
 
 
 
 
 
Figure 4.2. Western blots supported that PduL coeluted with PduBB’. Lane 1-4: elution fraction of strains 
expressing pduL-His6pduBB’102/207A (BE2004), -His6pduBB’102/207A (BE2001), pduL-
pduBB’102/207AHis6 (BE2003), and -pduBB’102/207AHis6 (BE2000), respectively. 
 
 
 
Table 4.3. Two hybrid assay to test the interaction between PduU and PduV. 
Pairs tested  NSa Sb 
pBT-LGF2, pTRG-Gal11P           1000 ± 87                                            1000 ± 72 
pBT-pduU, pTRG          11 ± 3                                        0 ± 0 
pBT-pduV, pTRG          19 ± 10                                        0 ± 0 
pBT, pTRG-pduU        167 ± 21                                        0 ± 0 
pBT, pTRG-pduV        740 ± 75                                        7 ± 3 
pBT-pduU, pTRG-pduV      1000 ± 66                                    600 ± 12 
pBT-pduV, pTRG-pduU        840 ± 79                                      TNTCc 
acfu obtained on nonselective (NS) screening medium plates (no 3-AT) with 1:100 diluted cells. 
bcfu obtained on selective (S) screening medium (3-AT) plates. 
ccfu too numerous to count.  
 
   Sample             L-hisBB’   -hisBB’     L-BB’his    -BB’his 
Anti-PduL 
 
Anti-PduBB’ 
1           2            3              4 
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      A binding interaction between PduU and PduV. The BacterioMatch II Two-Hybrid 
system was used to test for interactions between the PduU and PduV proteins. Results showed 
that PduU and PduV interacted in reciprocal tests, that is, when used as bait and prey, or prey 
and bait (Table 4.3). Negative controls showed the PduU or PduV alone did interact spuriously 
to confer 3-AT resistance (Table 4.3). The positive results of the UV pairs were confirmed by 
testing the expression of a second reporter gene aadA which confers streptomycin resistance in 
co-transformed E. coli (data not shown). Thus, overall, these results support an interaction 
between PduU and PduV. 
4.5. Discussion 
      The nickel affinity pull-down study of PduL and PduBB’ provided valuable information on 
their possible interactions. A small histidine tag on N- and C- terminal region both produced 
positive results, which might indicate that a small six histidine tag doesn’t interfere with binding 
interaction, or PduL doesn’t bind to termini on PduBB’, which is consistent with the recent 
docking simulation of interaction between L and BB’ which predicted PduL might bind to the 
middle part on PduBB’.  
      We observed that some bacterial two-hybrid data were inconsistent with the co-pulldown 
results. According to the pull-downs, PduL co-eluted with PduBB’, while two-hybrid only 
suggested L/B’ but not L/B binding. One possible explanation is that certain reconstructed bait 
and/or target plasmids used in the two-hybrid system became toxic when growing in the host, 
resulting in low number of colonies even on nonselective medium plates and difficulty 
interpreting the data.  
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      This study promotes our understanding of higher level organization in MCP systems. 
Computer based prediction followed by experimental confirmation may provide more efficient 
model system for further MCP-associated protein-protein interaction studies.  
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CHAPTER 5. SUMMARY AND CONCLUSIONS 
      This dissertation focuses on biochemical and genetic analysis of the distinct 
phosphotransacylase PduL, its coenzyme A recycling functions specifically associated with Pdu 
MCPs as well as protein-protein interactions in Pdu MCPs.  
      Chapter 2 is about the identification of a new class phosphotransacylase PduL involved in 
1,2-PD metabolism associated with Pdu MCPs. preliminary data indicated the presence of a 
phosphotransacylase in this process, but the exact enzyme involved was not initially found. Here, 
we showed that the house-keeping PTAC pta is not involved in 1,2-PD metabolism. Next we 
conducted a series of biochemical and genetic studies and established the role of PduL as a 
phosphotransacylase in 1,2-PD utilization in Salmonella. Further bioinformatics analysis showed 
that PduL lacks sequence similarity with currently known phosphotransacylases, indicating that 
PduL is an evolutionarily distinct PTAC found in bacteria. Also PduL is a much smaller enzyme 
compared to other classes of PTACs in Salmonella. Further studies on the origin of PduL may 
disclose unique events during evolution.  
      Chapter 3 aims to determine the Pdu MCP-specific role of PduL and interpret how PduL is 
targeted into MCPs. Prior studies showed that another PTAC enzyme EutD is recycling HS-CoA 
internally within the Eut MCP, and an alcohol dehydrogenase PduQ regenerates cofactor NAD+ 
inside the Pdu MCP. PduL, in this work, was demonstrated to be an MCP component, might also 
function in cofactor recycling. Therefore, we performed a series of genetic and growth studies 
which showed that PduL is required for the proper function of intact MCPs, and furthermore, 
PduL in MCPs can’t utilize acetyl-CoA in the cytoplasm to support Salmonella growth. Together, 
coenzyme A internal recycling by PduL within the Pdu MCP is indicated. Sequence alignment 
and structure prediction indicated PduL has a targeting sequence, protein immunoblots provided 
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evidence that N-terminal region of PduL functions as a targeting sequence for MCP 
encapsulation. 
      Chapter 4 explores the protein-protein interactions in the Pdu MCPs. Here we used the 
bacterial two-hybrid screen tests and nickel-affinity pull-down experiments followed by 
immunoblots to show that PduL may have binding interaction with main shell protein PduBB’, 
which might mediate the encapsulation of PduL into the Pdu MCP. Our results also indicated 
that PduV, a protein with unknown functions, interacts with shell protein PduU. Protein-protein 
interactions among the MCP-associated proteins are crucial for assembly and spatial 
organization of MCPs. 
      Through the above series of studies in this dissertation, we drew the following conclusions. 
1. The PduL enzyme was established to function as a phosphotransacylase in 1,2-PD 
utilization. PduL represents a new class of phosphotransacylase. 
2. The primary role of PduL specifically associated with MCPs is to recycle HS-CoA within 
the Pdu MCP, which provides a way for MCPs to acquire and replenish cofactors. This 
enhances our knowledge level of the working mechanisms of MCPs. 
3. A short N-terminal targeting sequence of PduL is responsible for its encapsulation into 
the Pdu MCP. Targeting sequence-mediated interactions between lumen enzymes and 
shell proteins direct protein encapsulation into MCPs. These mechanisms advance our 
understanding of the self-assembly and the higher-level organization of bacterial MCPs. 
4. A complete understanding of the mechanisms of the functions of MCPs may allow their 
potential applications as bioreactors for industrial chemical production, biochemical 
pathway optimization, and as drug delivery systems for therapeutic applications. 
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NOMENCLATURE 
1,2-PD   1,2-Propanediol 
3-AT   3-Amino-1,2,4-Triazole 
3-HPA   3-Hydroxypropioaldehyde 
3-PGA   3-Phosphoglycerate 
ACP   Acyl Carrier Protein 
AdoCbl  Adenosylcobalamin 
AEBSF  4-(2-Aminoethyl) Benzenesulfonylfluoride.HCl 
ALA   5-Aminolaevulinic Acid 
ATP   Adenosine Triphosphate 
BMC   Bacterial Microcompartment 
BMV   Bacterial Microcompartment Vertex 
BSA   Bovine Serum Albumin 
CA   Carbonic Anhydrase 
Cbl   Cobalamin 
CCM   Carbon-Concentrating Mechanism 
CCMV  Cowpea Chlorotic Mottle Virus 
CDC   Centers for Disease Control and Prevention 
CFU   Colony Forming Unit 
CH3Cbl   Methylcobalamin 
CI   Competitive Index 
CNCbl   Cyanocobalamin  
CoA   Coenzyme A 
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CoAsy   Coenzyme A synthase 
CI   Competitive Index Assay 
DDH   Diol Dehydratase 
DHAP   Dihydroxyacetone Phosphate 
DLG1   Drosophila Disc Large Tumor Suppressor 
DMAPP  Dimethylallyl Pyrophosphate 
DMB   Dimethylbenzimidazole 
DPCK   Dephospho-CoA Kinase 
DyP   Dye Decolorizing Peroxidase 
EM   Electron Microscopy 
EPA   Environmental Protection Agency 
Eut MCP  Ethanolamine Utilization Microcompartment 
FAS   Fatty Acid Synthase 
Ffh   Fifty-Four Homologue 
Flp   Ferritin Like Protein 
GRIP   Glutamate Receptor-Interacting Protein 
Grp MCP   Glycyl Radical-based Propanediol Utilization Microcompartment 
HMG-CoA  3-Hydroxy-3-Methylglutaryl-CoA 
HPLC   High-Pressure Liquid Chromatography 
HPLC-ESI-MS HPLC electrospray ionization mass spectrometry 
IPP   Isopentenyl Pyrophosphate 
IPTG   Isopropyl--D-Thiogalactopyranoside 
IVET   In Vivo Expression Technology 
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LB   Luria-Bertani/Lennox 
MCP   Microcompartment 
MMA    Methylmalonic Acid 
MVP   Major Vault Protein 
NAD+   Nicotinamide adenine dinucleotide 
NBIA   Neurodegeneration with Brain Iron Accumulation 
NCE   No-Carbon-E 
NHERF  Na+/H+ Exchanger Regulatory Factor 
nNOS   Neuronal Nitric Oxide Synthase 
iNTS   Invasive Non-Typhoidal Salmonella 
NTS   Non-Typhoidal Salmonella 
OH-Cbl   Hydroxycobalamin  
PAGE   Polyacrylamide Gel Electrophoresis 
PanF   Pantothenate Permease 
PanK   Pantothenate Kinase 
PCB   Polychlorinated Biphenyl 
Pdu MCP  Propanediol Utilization Microcompartment 
PI3K   Phosphoinositide 3-Kinase 
PIP2   Phosphatidylinositol 4,5-Bisphosphate 
PKAN   PANK-Associated Neurodegeneration 
PPAT   Phosphopantetheine Adenylyltransferase 
PPCDC  Phosphopantothenoylcysteine Decarboxylase 
PPCS   Phosphopantothenoylcysteine Synthase 
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PPIs   Protein-Protein Interactions 
PSD95   Postsynaptic Density Protein 
PTAC   Phosphotransacylase 
RNP   Ribonucleoprotein 
RuBisCO  Ribulose Bisphosphate Carboxylase/Oxygenase 
RuBP   Ribulose-1,5-Bisphosphate 
SAM   S-Adenosyl-Methionine 
Shp2PTP  Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase 
SPR   Surface Plasmon Resonance 
SPI   Salmonella Pathogenicity Island 
SRP   Signal Recognition Particle 
SR   Signal Recognition Particle Receptor 
PCB   Polychlorinated Biphenyl 
PI3K   Phosphoinositide 3-Kinase 
PPA   propionaldehyde 
T3SS/TTSS  Type III Secretion System 
TEM   Transmission Electron Microscopy 
TEP1   Telomerase Associated Protein I 
TF   Trigger Factor 
TFP   Teal Fluorescent Protein 
THF   Tetrahydrofolate 
TM   Transmembrane 
TNTC   Too Numerous to Account 
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Uro III   Uroporphyrinogen III 
VLP   Virus Like Particle 
VPARP   Vault Poly (ADP-Ribose)-Polymerase 
ZO1   Zonular Occludens-1 
 
